broad_sample	broad_id	pert_iname	InChIKey14	moa	target	broad_date	clinical_phase	alternative_moa	alternative_target
BRD-A00147595-001-01-5	BRD-A00147595	balaglitazone	IETKPTYAGKZLKY	insulin sensitizer|PPAR receptor partial agonist	PPARG	broad_id_20170327	Phase 3		
BRD-A00218260-001-03-4	BRD-A00218260	flutrimazole	QHMWCHQXCUNUAK	sterol demethylase inhibitor		broad_id_20170327	Launched		
BRD-A00376169-001-01-6	BRD-A00376169	KBG	FOLRUCXBTYDAQK	neprilysin inhibitor	MME	broad_id_20170327	Phase 2		
BRD-A00546892-001-02-6	BRD-A00546892	biperiden	YSXKPIUOCJLQIE	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-A00938334-001-01-3	BRD-A00938334	drospirenone	METQSPRSQINEEU	mineralocorticoid receptor antagonist	AR|NR3C2|PGR	broad_id_20170327	Launched		
BRD-A01636364-003-15-1	BRD-A01636364	bupivacaine	LEBVLXFERQHONN	sodium channel blocker	KCNA5|SCN10A	broad_id_20170327	Launched		
BRD-A01787639-003-16-9	BRD-A01787639	naftopidil	HRRBJVNMSRJFHQ	adrenergic receptor antagonist	ADRA1A	broad_id_20170327	Launched		
BRD-A02006392-001-10-7	BRD-A02006392	nitrendipine	PVHUJELLJLJGLN	calcium channel blocker	CACNA1D|CACNA2D1|KCNN4	broad_id_20170327	Launched		
BRD-A02367930-001-04-5	BRD-A02367930	ethinyl-estradiol	BFPYWIDHMRZLRN	estrogen receptor agonist|estrogenic hormone	ESR1|ESR2|NR1I2	broad_id_20170327	Launched		
BRD-A02710418-003-11-8	BRD-A02710418	meptazinol	JLICHNCFTLFZJN	opioid receptor agonist	BCHE	broad_id_20170327	Launched		
BRD-A02990301-003-06-6	BRD-A02990301	lofexidine	KSMAGQUYOIHWFS	adrenergic receptor agonist		broad_id_20170327	Launched		
BRD-A03061970-003-07-3	BRD-A03061970	alizapride	KSEYRUGYKHXGFW	dopamine receptor antagonist		broad_id_20170327	Launched		
BRD-A03216249-003-24-3	BRD-A03216249	mepivacaine	INWLQCZOYSRPNW	potassium channel blocker|sodium channel blocker		broad_id_20170327	Launched		
BRD-A03249105-001-01-9	BRD-A03249105	fulvestrant	VWUXBMIQPBEWFH	estrogen receptor antagonist	ESR1|ESR2|GPER1	broad_id_20170327	Launched		
BRD-A03506276-001-01-5	BRD-A03506276	XL888	LHGWWAFKVCIILM	HSP inhibitor		broad_id_20170327	Phase 1		
BRD-A03623303-045-09-5	BRD-A03623303	metoprolol	IUBSYMUCCVWXPE	adrenergic receptor antagonist	ADRB1|ADRB2	broad_id_20170327	Launched		
BRD-A04352665-001-05-3	BRD-A04352665	maraviroc	GSNHKUDZZFZSJB	CC chemokine receptor antagonist	CCR5	broad_id_20170327	Launched		
BRD-A04553218-050-16-2	BRD-A04553218	chlorphenamine	SOYKEARSMXGVTM	histamine receptor antagonist		broad_id_20170327	Launched		
BRD-A05186015-003-19-8	BRD-A05186015	bupropion	SNPPWIUOZRMYNY	dopamine reuptake inhibitor	SLC6A2|SLC6A3	broad_id_20170327	Launched		
BRD-A05334458-001-02-8	BRD-A05334458	lisofylline	NSMXQKNUPPXBRG	interleukin receptor antagonist|STAT inhibitor		broad_id_20170327	Phase 2		
BRD-A05457250-001-05-0	BRD-A05457250	BAY-K-8644-(+/-)	ZFLWDHHVRRZMEI	L-type calcium channel blocker		broad_id_20170327	Preclinical	L-type calcium channel activator	CACNA1C
BRD-A05523972-001-01-5	BRD-A05523972	telmesteine	XBJWOGLKABXFJE	mucolytic agent		broad_id_20170327	Launched		
BRD-A05821830-341-01-5	BRD-A05821830	docetaxel	ZDZOTLJHXYCWBA	tubulin polymerization inhibitor	BCL2|MAP2|MAP4|MAPT|NR1I2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8	broad_id_20170327	Launched		
BRD-A06916187-001-02-9	BRD-A06916187	CPI-613	ZYRLHJIMTROTBO	pyruvate dehydrogenase inhibitor	PDHA1	broad_id_20170327	Phase 3		
BRD-A06935312-001-04-3	BRD-A06935312	fusidic-acid	IECPWNUMDGFDKC	bacterial 30S ribosomal subunit inhibitor		broad_id_20170327	Launched		
BRD-A07395371-003-10-0	BRD-A07395371	esmolol	AQNDDEOPVVGCPG	adrenergic receptor antagonist	ADRB1	broad_id_20170327	Launched		
BRD-A07440155-003-25-4	BRD-A07440155	labetalol	SGUAFYQXFOLMHL	adrenergic receptor antagonist	ADRA1D|ADRB1|ADRB2	broad_id_20170327	Launched		
BRD-A07563059-035-01-3	BRD-A07563059	bopindolol	UUOJIACWOAYWEZ	adrenergic receptor antagonist		broad_id_20170327	Launched		
BRD-A07704283-001-01-3	BRD-A07704283	isofloxythepin	XDBMBHVYXPBOPL	dopamine receptor antagonist		broad_id_20170327	Phase 2		
BRD-A07815743-001-01-1	BRD-A07815743	kakonein	HKEAFJYKMMKDOR	GABA receptor antagonist|serotonin receptor antagonist		broad_id_20170327	Phase 2	serotonin receptor antagonist	nan
BRD-A07986123-001-02-8	BRD-A07986123	galeterone	PAFKTGFSEFKSQG	androgen receptor modulator	AR|CYP17A1	broad_id_20170327	Phase 3		
BRD-A08187463-001-12-9	BRD-A08187463	racecadotril	ODUOJXZPIYUATO	enkephalinase inhibitor	MME	broad_id_20170327	Launched		
BRD-A08545410-311-01-8	BRD-A08545410	E-64	LTLYEAJONXGNFG	calpain inhibitor|cysteine protease inhibitor	CTSS	deprecated_broad_id_20180516	Preclinical		
BRD-A09349126-001-10-7	BRD-A09349126	norethindrone-acetate	IMONTRJLAWHYGT	progesterone receptor agonist	PGR	broad_id_20170327	Launched		
BRD-A09472452-015-23-4	BRD-A09472452	flecainide	DJBNUMBKLMJRSA	sodium channel blocker	KCNA5|KCNA7|SCN5A	broad_id_20170327	Launched		
BRD-A09533288-003-31-2	BRD-A09533288	verapamil	SGTNSNPWRIOYBX	calcium channel blocker	CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CYP3A4|KCNA10|KCNA7|KCNH2|KCNJ11|NALCN|SCN5A|SLC29A4|SLC6A4	broad_id_20170327	Launched		
BRD-A10012892-001-01-9	BRD-A10012892	argatroban	KXNPVXPOPUZYGB	thrombin inhibitor	F2	broad_id_20170327	Launched		
BRD-A10039652-001-01-2	BRD-A10039652	tipranavir	MYXACKZCYFKMTE	HIV protease inhibitor		broad_id_20170327	Launched		
BRD-A10070317-003-28-3	BRD-A10070317	propranolol	AQHHHDLHHXJYJD	adrenergic receptor antagonist	ADRB1|ADRB2	broad_id_20170327	Launched	adrenergic receptor antagonist;adrenergic receptor antagonist	ADRB2|ADRB3;ADRB1|HTR1A|HTR5A|SLC10A1
BRD-A10903566-003-07-7	BRD-A10903566	imiloxan	UXABARREKCJULM	adrenergic receptor antagonist	ADRA2A|ADRA2B	broad_id_20170327	Phase 1		
BRD-A10967948-003-06-3	BRD-A10967948	granisetron	MFWNKCLOYSRHCJ	serotonin receptor antagonist	HTR3A	broad_id_20170327	Launched		
BRD-A10977446-001-12-1	BRD-A10977446	carvedilol	OGHNVEJMJSYVRP	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3	broad_id_20170327	Launched		
BRD-A11319535-001-03-6	BRD-A11319535	beclomethasone-dipropionate	KUVIULQEHSCUHY	glucocorticoid receptor agonist	GPR97|NR3C1	broad_id_20170327	Launched		
BRD-A11990600-001-03-4	BRD-A11990600		DIWRORZWFLOCLC			broad_id_20170327			
BRD-A12077521-003-01-5	BRD-A12077521	cefepime	HVFLCNVBZFFHBT	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-A12230535-001-06-7	BRD-A12230535	nutlin-3	BDUHCSBCVGXTJM	MDM inhibitor	MDM2|TP53	broad_id_20170327	Preclinical		
BRD-A12237696-001-04-2	BRD-A12237696	L-citrulline	RHGKLRLOHDJJDR	nitric oxide stimulant	ASS1|DDAH1|DDAH2|GPRC6A|NOS1|NOS2|NOS3|OTC|PADI1|PADI2|PADI3|PADI4|PADI6	broad_id_20170327	Launched		
BRD-A12896037-001-04-3	BRD-A12896037	cisapride	DCSUBABJRXZOMT	serotonin receptor agonist	HTR2A|HTR3A|HTR4|KCNH2	broad_id_20170327	Withdrawn		
BRD-A12994259-001-02-1	BRD-A12994259	pomalidomide	UVSMNLNDYGZFPF	angiogenesis inhibitor|tumor necrosis factor production inhibitor		broad_id_20170327	Launched		
BRD-A13084692-001-17-3	BRD-A13084692	troglitazone	GXPHKUHSUJUWKP	insulin sensitizer|PPAR receptor agonist	CYP2C8|PPARG|TRPM3	broad_id_20170327	Withdrawn		
BRD-A13133631-001-04-0	BRD-A13133631	fluorometholone	FAOZLTXFLGPHNG	glucocorticoid receptor agonist	NR3C1	broad_id_20170327	Launched		
BRD-A13188892-066-21-5	BRD-A13188892	doxazosin	RUZYUOTYCVRMRZ	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D	broad_id_20170327	Launched		
BRD-A14262390-065-01-8	BRD-A14262390	guanadrel	HPBNRIOWIXYZFK	adrenergic inhibitor		broad_id_20170327	Launched		
BRD-A14798026-001-02-6	BRD-A14798026	mestranol	IMSSROKUHAOUJS	estrogen receptor agonist	ESR1	broad_id_20170327	Launched		
BRD-A14886633-001-01-6	BRD-A14886633	levonorgestrel	WWYNJERNGUHSAO	estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist	PGR	broad_id_20170327	Launched	progesterone receptor agonist	AR|ESR1|PGR|SRD5A1
BRD-A14941520-051-01-0	BRD-A14941520	dofequidar	KLWUUPVJTLHYIM	MRP inhibitor|P glycoprotein inhibitor	ABCB1	broad_id_20170327	Phase 3		
BRD-A14966924-003-07-7	BRD-A14966924	alaproclate	FZSPJBYOKQPKCD	serotonin receptor antagonist	SLC6A4	broad_id_20170327	Phase 2		
BRD-A15202882-003-02-7	BRD-A15202882	milnacipran	GJJFMKBJSRMPLA	serotoninânorepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-A15297126-001-04-3	BRD-A15297126	fluocinonide	WJOHZNCJWYWUJD	glucocorticoid receptor agonist	NR3C1|SERPINA6|SMO	broad_id_20170327	Launched		
BRD-A15435692-003-02-3	BRD-A15435692	BMY-14802	ZXUYYZPJUGQHLQ	sigma receptor antagonist	HTR1A	broad_id_20170327	Phase 2		
BRD-A15909516-001-06-6	BRD-A15909516	rebamipide	ALLWOAVDORUJLA	free radical scavenger	FPR1	broad_id_20170327	Launched		
BRD-A15931911-001-03-8	BRD-A15931911	bucladesine	CJGYSWNGNKCJSB	adenosine receptor agonist|cAMP stimulant	PRKACA	broad_id_20170327	Launched		
BRD-A16296925-001-01-3	BRD-A16296925	indobufen	AYDXAULLCROVIT	cyclooxygenase inhibitor|platelet aggregation inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-A16347691-001-13-1	BRD-A16347691	thioctic-acid	AGBQKNBQESQNJD	reducing agent	ACHE|PTGS2	broad_id_20170327	Launched		
BRD-A16665823-001-02-0	BRD-A16665823	butoconazole	SWLMUYACZKCSHZ	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-A16997652-001-02-3	BRD-A16997652	protirelin	XNSAINXGIQZQOO	thyrotropin releasing hormone receptor agonist	TRHR	broad_id_20170327	Launched		
BRD-A17411484-001-11-9	BRD-A17411484	carprofen	PUXBGTOOZJQSKH	cyclooxygenase inhibitor	PTGS2	broad_id_20170327	Launched		
BRD-A17462676-003-11-6	BRD-A17462676	bambuterol	ANZXOIAKUNOVQU	adrenergic receptor agonist	ADRB2|BCHE	broad_id_20170327	Launched		
BRD-A17655518-001-24-4	BRD-A17655518	ibuprofen	HEFNNWSXXWATRW	cyclooxygenase inhibitor		broad_id_20170327	Launched	cyclooxygenase inhibitor	ASIC1|PTGS1|PTGS2|SLC5A8
BRD-A17883755-001-06-1	BRD-A17883755	lenalidomide	GOTYRUGSSMKFNF	anticancer agent	TNF	broad_id_20170327	Launched		
BRD-A18043272-001-09-9	BRD-A18043272	phensuximide	WLWFNJKHKGIJNW	succinimide antiepileptic		broad_id_20170327	Launched		
BRD-A18611368-001-01-5	BRD-A18611368	tazobactam	LPQZKKCYTLCDGQ	beta lactamase inhibitor		broad_id_20170327	Launched		
BRD-A18620900-001-05-2	BRD-A18620900	estriol	PROQIPRRNZUXQM	estrogen receptor agonist	ESR1|ESR2	broad_id_20170327	Launched		
BRD-A18917088-001-04-9	BRD-A18917088	estradiol	VOXZDWNPVJITMN	estrogen receptor agonist	ESR1|ESR2|GPER1|KCNMA1|NR1I2	broad_id_20170327	Launched		
BRD-A19195498-050-14-1	BRD-A19195498	trimipramine	ZSCDBOWYZJWBIY	norepinephrine reputake inhibitor|tricyclic antidepressant	SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-A19633847-050-32-1	BRD-A19633847	perhexiline	CYXKNKQEMFBLER	carnitine palmitoyltransferase inhibitor	CPT1A	broad_id_20170327	Launched		
BRD-A19661776-003-27-6	BRD-A19661776	mianserin	UEQUQVLFIPOEMF	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|HRH1|HRH2|HTR2A|HTR2B|HTR2C|HTR6|HTR7	broad_id_20170327	Launched		
BRD-A19736161-001-06-7	BRD-A19736161	ondansetron	FELGMEQIXOGIFQ	serotonin receptor antagonist	HTR3A|HTR3B	broad_id_20170327	Launched		
BRD-A19795905-001-08-0	BRD-A19795905	atovaquone	UYFLKEIEOREOFC	mitochondrial electron transport inhibitor		broad_id_20170327	Launched		
BRD-A19952358-001-11-3	BRD-A19952358	closantel	JMPFSEBWVLAJKM	chitinase inhibitor|NFkB pathway inhibitor		broad_id_20170327	Launched		
BRD-A20119038-003-07-8	BRD-A20119038	mecamylamine	IMYZQPCYWPFTAG	acetylcholine receptor antagonist	CHRNA1|CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB4	broad_id_20170327	Launched		
BRD-A20126139-001-04-2	BRD-A20126139	medrysone	GZENKSODFLBBHQ	glucocorticoid receptor agonist	NR3C1	broad_id_20170327	Launched		
BRD-A20131130-001-01-7	BRD-A20131130								
BRD-A20239487-001-24-9	BRD-A20239487	atenolol-(+)	METKIMKYRPQLGS	adrenergic receptor antagonist		broad_id_20170327	Preclinical	adrenergic receptor antagonist	ADRB1|ADRB2|LTF|PLA2G2E
BRD-A20348246-001-15-8	BRD-A20348246	chlormezanone	WEQAYVWKMWHEJO	GABA receptor modulator	GABRA1	broad_id_20170327	Withdrawn		
BRD-A21607826-003-05-1	BRD-A21607826	dexmedetomidine	CUHVIMMYOGQXCV	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C	broad_id_20170327	Launched	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C
BRD-A21858158-001-23-5	BRD-A21858158	praziquantel	FSVJFNAIGNNGKK	anthelmintic agent		broad_id_20170327	Launched		
BRD-A22032524-074-06-5	BRD-A22032524	amlodipine	HTIQEAQVCYTUBX	calcium channel blocker	CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNA2D1	broad_id_20170327	Launched	calcium channel blocker	nan
BRD-A22081593-001-11-1	BRD-A22081593	sulmazole	XMFCOYRWYYXZMY	adenosine receptor antagonist		broad_id_20170327	Phase 1		
BRD-A22305049-003-13-6	BRD-A22305049	benfluorex	CJAVTWRYCDNHSM	gluconeogenesis inhibitor	HMGCR	broad_id_20170327	Withdrawn		
BRD-A22380646-236-05-8	BRD-A22380646	pantoprazole	IQPSEEYGBUAQFF	ATPase inhibitor	ATP4A	broad_id_20170327	Launched		
BRD-A22642447-001-01-9	BRD-A22642447	licarbazepine	BMPDWHIDQYTSHX	voltage-gated sodium channel blocker	SCN5A	broad_id_20170327	Phase 3		
BRD-A22769835-300-05-7	BRD-A22769835	homochlorcyclizine	WEUCDJCFJHYFRL	antihistamine	HRH1	broad_id_20170327	Launched		
BRD-A23067620-300-01-3	BRD-A23067620	itraconazole	VHVPQPYKVGDNFY	cytochrome P450 inhibitor		broad_id_20170327	Launched		
BRD-A24191444-046-02-1	BRD-A24191444	ifenprodil	UYNVMODNBIQBMV	adrenergic receptor antagonist|glutamate receptor antagonist	GRIN2B	broad_id_20170327	Launched		
BRD-A24228527-213-01-9	BRD-A24228527	levofloxacin	GSDSWSVVBLHKDQ	bacterial DNA gyrase inhibitor	TOP2A	broad_id_20170327	Launched	bacterial DNA gyrase inhibitor	nan
BRD-A24514565-001-09-7	BRD-A24514565	warfarin	PJVWKTKQMONHTI	vitamin K antagonist	VKORC1	broad_id_20170327	Launched		
BRD-A24560335-300-01-2	BRD-A24560335	efatutazone	JCYNMRJCUYVDBC	PPAR receptor agonist	PPARG	broad_id_20170327	Phase 2		
BRD-A25234499-001-18-3	BRD-A25234499	aminoglutethimide	ROBVIMPUHSLWNV	glucocorticoid receptor antagonist	CYP11A1|CYP19A1	broad_id_20170327	Launched		
BRD-A25619068-003-03-4	BRD-A25619068	fadrozole	CLPFFLWZZBQMAO	aromatase inhibitor	CYP11B1|CYP19A1	broad_id_20170327	Launched		
BRD-A26032986-050-02-1	BRD-A26032986	zaldaride	HTGCJAAPDHZCHL	calmodulin antagonist	CALM1	broad_id_20170327	Phase 3		
BRD-A26095496-001-04-0	BRD-A26095496	clobetasol-propionate	CBGUOGMQLZIXBE	glucocorticoid receptor agonist	NR3C1|PLA2G1B	broad_id_20170327	Launched		
BRD-A26334849-001-06-2	BRD-A26334849	propafenone	JWHAUXFOSRPERK	antiarrhythmic	ADRB1|ADRB2|KCNA5|KCNH2	broad_id_20170327	Launched		
BRD-A26384407-001-25-1	BRD-A26384407	chlorthalidone	JIVPVXMEBJLZRO	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA7|SLC12A1	broad_id_20170327	Launched		
BRD-A26423207-001-01-0	BRD-A26423207	sparfloxacin	DZZWHBIBMUVIIW	bacterial DNA gyrase inhibitor	TOP2A	broad_id_20170327	Withdrawn		
BRD-A26503646-001-16-6	BRD-A26503646	formestane	ZMEULISFKSVRLQ	aromatase inhibitor	CYP19A1	broad_id_20170327	Launched		
BRD-A26690767-066-01-9	BRD-A26690767	saquinavir	QWAXKHKRTORLEM	HIV protease inhibitor	CYP3A4	broad_id_20170327	Launched		
BRD-A26711594-003-10-6	BRD-A26711594	nicardipine	ZBBHBTPTTSWHBA	calcium channel blocker	ADORA3	broad_id_20170327	Launched		
BRD-A27376179-001-01-3	BRD-A27376179	lestaurtinib	UIARLYUEJFELEN	FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor	FLT3|NTRK1	broad_id_20170327	Phase 3		
BRD-A27732521-003-08-3	BRD-A27732521	tolperisone	FSKFPVLPFLJRQB	voltage-gated sodium channel blocker	CYP2C19|CYP2D6	broad_id_20170327	Launched		
BRD-A28467416-002-01-0	BRD-A28467416	PKI-179	WXUUCRLKXQMWRY	mTOR inhibitor|PI3K inhibitor	MTOR	broad_id_20170327	Phase 1		
BRD-A28545468-003-16-6	BRD-A28545468	selegiline	MEZLKOACVSPNER	monoamine oxidase inhibitor	MAOA|MAOB	broad_id_20170327	Launched		
BRD-A28746609-001-11-5	BRD-A28746609	paclitaxel	RCINICONZNJXQF	tubulin polymerization inhibitor	BCL2|MAP2|MAP4|MAPT|NR1I2|TLR4|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8	broad_id_20170327	Launched		
BRD-A28787076-001-04-8	BRD-A28787076	inosine	UGQMRVRMYYASKQ	neurotrophic agent	PARP1|PNP	broad_id_20170327	Launched		
BRD-A29260609-003-26-0	BRD-A29260609	acebutolol	GOEMGAFJFRBGGG	adrenergic receptor antagonist	ADRB1	broad_id_20170327	Launched		
BRD-A29289453-001-04-7	BRD-A29289453	PCA-4248	DHCNAWNKZMNTIS	platelet activating factor receptor antagonist	PTAFR	broad_id_20170327	Phase 1		
BRD-A29322418-237-04-0	BRD-A29322418	potassium-canrenoate	PBKZPPIHUVSDNM	mineralocorticoid receptor antagonist	NR3C2	broad_id_20170327	Launched		
BRD-A29485665-001-12-8	BRD-A29485665	bicalutamide	LKJPYSCBVHEWIU	androgen receptor antagonist	AR	broad_id_20170327	Launched		
BRD-A29520968-001-02-7	BRD-A29520968	acifran	DFDGRKNOFOJBAJ	cholesterol inhibitor	HCAR2|HCAR3	broad_id_20170327	Phase 3		
BRD-A29623586-001-01-3	BRD-A29623586	anisodamine	WTQYWNWRJNXDEG	lipid peroxidase inhibitor	ADRA1A	broad_id_20170327	Phase 3		
BRD-A29731977-001-04-5	BRD-A29731977	17-hydroxyprogesterone-caproate	DOMWKUIIPQCAJU	progesterone receptor agonist	AR|ESR1|ESR2|NR1H4|NR1I2|NR3C1|PGR	broad_id_20170327	Launched		
BRD-A29734509-011-13-6	BRD-A29734509	disopyramide	UVTNFZQICZKOEM	sodium channel blocker	CHRM1|CHRM2|CHRM3|KCND2|KCND3|KCNH2|SCN5A	broad_id_20170327	Launched		
BRD-A29844814-300-01-5	BRD-A29844814	ABT-202	LVGMMVAWLISWJD	acetylcholine receptor agonist		broad_id_20170327	Phase 1		
BRD-A29854054-236-12-6	BRD-A29854054	lorglumide	IEKOTSCYBBDIJC	CCK receptor antagonist	CCKAR|CCKBR	broad_id_20170327	Phase 1		
BRD-A30051119-002-01-8	BRD-A30051119	amikacin	LKCWBDHBTVXHDL	bacterial 30S ribosomal subunit inhibitor		broad_id_20170327	Launched		
BRD-A30815329-001-10-5	BRD-A30815329	felodipine	RZTAMFZIAATZDJ	calcium channel blocker	CFTR	broad_id_20170327	Launched		
BRD-A30984645-001-01-5	BRD-A30984645	GDC-0834	CDOOFZZILLRUQH	Bruton's tyrosine kinase (BTK) inhibitor	BTK	broad_id_20170327	Phase 1		
BRD-A31095847-001-02-3	BRD-A31095847	mozavaptan	WRNXUQJJCIZICJ	vasopressin receptor antagonist	AVPR1A|AVPR1B|AVPR2	broad_id_20170327	Launched		
BRD-A31159102-003-30-4	BRD-A31159102	fluoxetine	RTHCYVBBDHJXIQ	selective serotonin reuptake inhibitor (SSRI)	ANO1|HTR2B|SLC6A4	broad_id_20170327	Launched		
BRD-A31521121-001-26-4	BRD-A31521121	methocarbamol	GNXFOGHNGIVQEH	muscle relaxant	CA1	broad_id_20170327	Launched		
BRD-A31811760-001-06-7	BRD-A31811760	miltefosine	PQLXHQMOHUQAKB	membrane integrity inhibitor	PLA2G1B	broad_id_20170327	Launched		
BRD-A32172948-001-07-6	BRD-A32172948	methiopril	JHFOAISYWJRTIM	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Phase 2		
BRD-A32269193-001-01-5	BRD-A32269193	VGX-1027	MUFJHYRCIHHATF	tumor necrosis factor receptor antagonist	TLR4	broad_id_20170327	Phase 1		
BRD-A33084557-001-06-6	BRD-A33084557	tioconazole	QXHHHPZILQDDPS	sterol demethylase inhibitor		broad_id_20170327	Launched		
BRD-A33168282-003-18-0	BRD-A33168282	sotalol	ZBMZVLHSJCTVON	adrenergic receptor antagonist	ADRB1|ADRB2|KCNH2	broad_id_20170327	Launched		
BRD-A33280134-001-04-7	BRD-A33280134	etoposide	VJJPUSNTGOMMGY	topoisomerase inhibitor	TOP2A|TOP2B	broad_id_20170327	Launched		
BRD-A33447119-001-10-8	BRD-A33447119	oxfendazole	BEZZFPOZAYTVHN	anthelmintic agent		broad_id_20170327	Launched		
BRD-A33692381-001-01-9	BRD-A33692381	zidovudine	HBOMLICNUCNMMY	nucleoside reverse transcriptase inhibitor	TERT	broad_id_20170327	Launched		
BRD-A33697453-008-02-4	BRD-A33697453	fenticonazole	ZCJYUTQZBAIHBS	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-A33711280-003-03-1	BRD-A33711280	metixene	MJFJKKXQDNNUJF	acetylcholine receptor antagonist	CHRM5	broad_id_20170327	Launched		
BRD-A34006693-001-15-4	BRD-A34006693	suprofen	MDKGKXOCJGEUJW	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Withdrawn		
BRD-A34255068-001-34-5	BRD-A34255068	(R)-(-)-rolipram	HJORMJIFDVBMOB	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D|PDE5A	broad_id_20170327	Phase 1	phosphodiesterase inhibitor;phosphodiesterase inhibitor	PDE4B|PDE4D;nan
BRD-A34513497-002-02-3	BRD-A34513497	lacitol	VQHSOMBJVWLPSR	laxative		broad_id_20170327	Launched		
BRD-A36010170-001-04-0	BRD-A36010170	amcinonide	ILKJAFIWWBXGDU	glucocorticoid receptor agonist	NR3C1	broad_id_20170327	Launched		
BRD-A36057565-001-01-0	BRD-A36057565	bruceantin	KMCZIPGKKBSLEX	protein synthesis inhibitor		broad_id_20170327	Phase 2		
BRD-A36331462-001-02-1	BRD-A36331462	oprozomib	SWZXEVABPLUDIO	proteasome inhibitor		broad_id_20170327	Phase 1/Phase 2		
BRD-A37288617-003-02-2	BRD-A37288617		XXEPPPIWZFICOJ			broad_id_20170327			
BRD-A37780065-001-04-5	BRD-A37780065	triamcinolone	GFNANZIMVAIWHM	glucocorticoid receptor agonist	NR3C1	broad_id_20170327	Launched		
BRD-A37959677-001-04-5	BRD-A37959677	estrone	DNXHEGUUPJUMQT	estrogen receptor agonist|estrogenic hormone	ESR1|ESR2	broad_id_20170327	Launched		
BRD-A38076815-003-10-3	BRD-A38076815	glafenine	GWOFUCIGLDBNKM	DeltaF508-CFTR Correctors	CFTR	broad_id_20170327	Withdrawn		
BRD-A38218502-001-01-2	BRD-A38218502	metenkephalin	YFGBQHOOROIVKG	immunostimulant	OPRD1	broad_id_20170327	Phase 2		
BRD-A38350138-001-04-9	BRD-A38350138	ketoconazole	XMAYWYJOQHXEEK	sterol demethylase inhibitor	KCNA10	broad_id_20170327	Launched		
BRD-A38592941-001-02-7	BRD-A38592941	timonacic	DZLNHFMRPBPULJ	antioxidant		broad_id_20170327	Launched		
BRD-A39390670-236-10-7	BRD-A39390670	rabeprazole	YREYEVIYCVEVJK	ATPase inhibitor|gastrin inhibitor	ATP4A	broad_id_20170327	Launched		
BRD-A39415247-001-10-4	BRD-A39415247	norethindrone	VIKNJXKGJWUCNN	progesterone receptor agonist	PGR	broad_id_20170327	Launched		
BRD-A39935389-001-05-9	BRD-A39935389	teroxirone	OUPZKGBUJRBPGC	DNA inhibitor		broad_id_20170327	Phase 1		
BRD-A40084411-003-07-7	BRD-A40084411	CGP-12177	UMQUQWCJKFOUGV	adrenergic receptor agonist	ADRB1|ADRB2|ADRB3	broad_id_20170327	Phase 1		
BRD-A40639672-234-18-0	BRD-A40639672	ketorolac	OZWKMVRBQXNZKK	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-A40787240-066-04-6	BRD-A40787240	gemifloxacin	ZRCVYEYHRGVLOC	bacterial DNA gyrase inhibitor		broad_id_20170327	Launched		
BRD-A41451487-001-11-2	BRD-A41451487	PK-11195	RAVIZVQZGXBOQO	benzodiazepine receptor antagonist	TSPO	broad_id_20170327	Phase 1		
BRD-A42699921-001-02-8	BRD-A42699921	teriflunomide	NABQBYDEMLGCEO	dihydroorotate dehydrogenase inhibitor	DHODH	broad_id_20170327	Launched		
BRD-A42759514-001-20-5	BRD-A42759514	ornidazole	IPWKIXLWTCNBKN	antiprotozoal agent		broad_id_20170327	Launched		
BRD-A43082555-001-01-1	BRD-A43082555	loxoprofen	YMBXTVYHTMGZDW	cyclooxygenase inhibitor|prostanoid receptor antagonist	PTGS2	broad_id_20170327	Launched		
BRD-A43331270-001-01-6	BRD-A43331270								
BRD-A43882281-001-15-5	BRD-A43882281	pinacidil	IVVNZDGDKPTYHK	ATP channel activator|potassium channel activator	ABCC8|ABCC9	broad_id_20170327	Launched		
BRD-A44090213-001-25-6	BRD-A44090213	indoprofen	RJMIEHBSYVWVIN	cyclooxygenase inhibitor|prostanoid receptor antagonist	CXCR1|CXCR2|PTGS1|PTGS2	broad_id_20170327	Withdrawn		
BRD-A44448661-001-04-8	BRD-A44448661		WEXRUCMBJFQVBZ			broad_id_20170327			
BRD-A44863528-001-13-2	BRD-A44863528	proglumide	DGMKFQYCZXERLX	CCK receptor antagonist	CCKAR|CCKBR	broad_id_20170327	Withdrawn		
BRD-A45153512-001-01-0	BRD-A45153512	bimatoprost	AQOKCDNYWBIDND	prostanoid receptor agonist	AKR1C3|PTGER1|PTGER3|PTGFR	broad_id_20170327	Launched		
BRD-A45889380-300-07-1	BRD-A45889380	mepacrine	GPKJTRJOBQGKQK	cytokine production inhibitor|NFkB pathway inhibitor|TP53 activator	PLA2G1B	broad_id_20170327	Launched		
BRD-A46179541-311-02-0	BRD-A46179541	doxapram	XFDJYSQDBULQSI	potassium channel blocker		broad_id_20170327	Launched		
BRD-A47364545-003-02-6	BRD-A47364545	SK&F-10047-(+)	LGQCVMYAEFTEFN	sigma receptor agonist	SIGMAR1	broad_id_20170327	Phase 1		
BRD-A47598013-004-16-0	BRD-A47598013	citalopram	WSEQXVZVJXJVFP	selective serotonin reuptake inhibitor (SSRI)	ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched	selective serotonin reuptake inhibitor (SSRI)	SLC6A4
BRD-A48237631-001-04-8	BRD-A48237631	mitomycin-C	NWIBSHFKIJFRCO	DNA alkylating agent|DNA synthesis inhibitor		broad_id_20170327	Launched		
BRD-A48430263-003-17-2	BRD-A48430263	pioglitazone	HYAFETHFCAUJAY	insulin sensitizer|PPAR receptor agonist	PPARG|TRPM3	broad_id_20170327	Launched		
BRD-A48570745-001-02-9	BRD-A48570745	ivermectin	AZSNMRSAGSSBNP	benzodiazepine receptor agonist	CHRNA7|P2RX7	broad_id_20170327	Launched		
BRD-A49160188-003-12-7	BRD-A49160188	donepezil	ADEBPBSSDYVVLD	acetylcholinesterase inhibitor	ACHE	broad_id_20170327	Launched		
BRD-A49399758-015-01-8	BRD-A49399758	desmopressin-acetate	NFLWUMRGJYTJIN	vasopressin receptor agonist	AVPR1A|AVPR1B|AVPR2|OXTR	broad_id_20170327	Launched		
BRD-A49622760-001-01-9	BRD-A49622760	faropenem	HGGAKXAHAYOLDJ	lactamase inhibitor		broad_id_20170327	Launched		
BRD-A49765801-001-04-1	BRD-A49765801	fludroxycortide	POPFMWWJOGLOIF	glucocorticoid receptor agonist	NR3C1|SERPINA6	broad_id_20170327	Launched		
BRD-A49838158-001-01-1	BRD-A49838158	phenprocoumon	DQDAYGNAKTZFIW	vitamin K antagonist	VKORC1	broad_id_20170327	Launched		
BRD-A50033377-001-02-8	BRD-A50033377	rivaroxaban	KGFYHTZWPPHNLQ	coagulation factor inhibitor	F10	broad_id_20170327	Launched		
BRD-A50311610-300-10-4	BRD-A50311610	meclizine	OCJYIGYOJCODJL	constitutive androstane receptor (CAR) agonist	NR1I3	broad_id_20170327	Launched		
BRD-A50675702-001-07-1	BRD-A50675702	fipronil	ZOCSXAVNDGMNBV	chloride channel blocker|GABA gated chloride channel blocker		broad_id_20170327	Launched		
BRD-A50684349-003-02-9	BRD-A50684349	fenoldopam	TVURRHSHRRELCG	dopamine receptor agonist	DRD1|DRD4	broad_id_20170327	Launched		
BRD-A50764878-003-02-8	BRD-A50764878	MDL-73005EF	BVMYCHKQPGEOSI	serotonin receptor antagonist	HTR1A	broad_id_20170327	Phase 1		
BRD-A50998626-001-02-1	BRD-A50998626	palomid-529	YEAHTLOYHVWAKW	AKT inhibitor|mTOR inhibitor	MTOR	broad_id_20170327	Phase 1		
BRD-A51078674-003-01-0	BRD-A51078674	diclofensine	ZJDCGVDEEHWEIG	dopamine reuptake inhibitor	DRD1|MAOA|MAOB	broad_id_20170327	Phase 3		
BRD-A51382177-236-03-0	BRD-A51382177	fosinopril	BIDNLKIUORFRQP	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Launched		
BRD-A51714012-003-13-6	BRD-A51714012	venlafaxine	PNVNVHUZROJLTJ	adrenergic inhibitor|norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-A51820102-008-28-9	BRD-A51820102	econazole	LEZWWPYKPKIXLL	lanosterol demethylase inhibitor|sterol demethylase inhibitor	NPY1R|NPY2R|TRPM2|TRPV5	broad_id_20170327	Launched		
BRD-A51964809-003-12-6	BRD-A51964809	halofantrine	FOHHNHSLJDZUGQ	antimalarial agent	KCNN4	broad_id_20170327	Launched		
BRD-A52252998-001-01-3	BRD-A52252998	clindamycin	KDLRVYVGXIQJDK	protein synthesis inhibitor		broad_id_20170327	Launched		
BRD-A52660433-066-02-1	BRD-A52660433	tetrindole	AUXCHYJDVJZEPG	monoamine oxidase inhibitor	MAOA	broad_id_20170327	Phase 3		
BRD-A52922642-001-03-7	BRD-A52922642	gallopamil	XQLWNAFCTODIRK	L-type calcium channel blocker	ATP2A2	broad_id_20170327	Launched		
BRD-A53176877-001-04-3	BRD-A53176877	methylprednisolone	VHRSUDSXCMQTMA	glucocorticoid receptor agonist	NR3C1	broad_id_20170327	Launched		
BRD-A53566267-001-01-9	BRD-A53566267	anecortave-acetate	YUWPMEXLKGOSBF	angiogenesis inhibitor		broad_id_20170327	Launched		
BRD-A53576514-048-14-3	BRD-A53576514	orphenadrine	QVYRGXJJSLMXQH	acetylcholine receptor antagonist		broad_id_20170327	Launched		
BRD-A54880345-001-20-9	BRD-A54880345	etomidate	NPUKDXXFDDZOKR	GABA receptor modulator	ADRA2B|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ	broad_id_20170327	Launched		
BRD-A55272860-001-15-3	BRD-A55272860	levosulpiride	BGRJTUBHPOOWDU	dopamine receptor antagonist	CA1|CA12|CA7|DRD2|DRD3	broad_id_20170327	Launched	dopamine receptor antagonist	nan
BRD-A55393291-001-09-9	BRD-A55393291		MUMGGOZAMZWBJJ			broad_id_20170327			
BRD-A55579717-001-04-0	BRD-A55579717	cytisine	ANJTVLIZGCUXLD	acetylcholine receptor agonist	CHRNA2|CHRNA3|CHRNA4|CHRNA6|CHRNA7|CHRNB2|CHRNB4	broad_id_20170327	Launched		
BRD-A55913614-316-09-6	BRD-A55913614	primaquine	INDBQLZJXZLFIT	antimalarial agent|DNA inhibitor		broad_id_20170327	Launched	acetylcholine receptor antagonist	nan
BRD-A55962179-001-22-1	BRD-A55962179	esomeprazole	SUBDBMMJDZJVOS	ATPase inhibitor	ATP4A	broad_id_20170327	Launched	ATPase inhibitor	ATP4A|CLCN2
BRD-A56085258-001-01-8	BRD-A56085258	encorafenib	CMJCXYNUCSMDBY	RAF inhibitor	BRAF	broad_id_20170327	Launched		
BRD-A56359832-001-11-1	BRD-A56359832	zileuton	MWLSOWXNZPKENC	leukotriene synthesis inhibitor|lipoxygenase inhibitor	ALOX5	broad_id_20170327	Launched		
BRD-A56371469-001-03-3	BRD-A56371469	AGI-5198	FNYGWXSATBUBER	isocitrate dehydrogenase inhibitor	IDH1	broad_id_20170327	Preclinical		
BRD-A56592690-001-04-3	BRD-A56592690	PX-12	BPBPYQWMFCTCNG	thioredoxin inhibitor	CNR1|TXN	broad_id_20170327	Phase 2		
BRD-A57382968-001-29-0	BRD-A57382968		MNSCVRXKDINXEY			broad_id_20170327			
BRD-A58048407-001-18-8	BRD-A58048407	nimodipine	UIAGMCDKSXEBJQ	calcium channel blocker	CFTR|NR3C2	broad_id_20170327	Launched		
BRD-A58280226-312-01-3	BRD-A58280226								
BRD-A58564983-001-04-6	BRD-A58564983	selamectin	AFJYYKSVHJGXSN	nematocide		broad_id_20170327	Launched		
BRD-A58955223-001-03-8	BRD-A58955223	sulforaphane	SUVMJBTUFCVSAD	anticancer agent|aryl hydrocarbon receptor antagonist	NFE2L2	broad_id_20170327	Phase 2		
BRD-A59174698-003-18-5	BRD-A59174698	ritodrine	IOVGROKTTNBUGK	adrenergic receptor agonist		broad_id_20170327	Withdrawn		
BRD-A61154809-001-15-9	BRD-A61154809	gliclazide	BOVGTQGAOIONJV	ATP channel blocker|insulin secretagogue		broad_id_20170327	Launched		
BRD-A61221616-001-04-3	BRD-A61221616	medroxyprogesterone-acetate	PSGAAPLEWMOORI	progesterone receptor agonist	ESR1|PGR	broad_id_20170327	Launched		
BRD-A61676498-001-06-6	BRD-A61676498	climbazole	OWEGWHBOCFMBLP	enzyme inducer		broad_id_20170327	Launched		
BRD-A61767428-001-01-9	BRD-A61767428	ursolic-acid	WCGUUGGRBIKTOS	ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor	HSD11B1|PLA2G1B|PTPN1|PYGM	deprecated_broad_id_20180907	Phase 2/Phase 3		
BRD-A61793559-001-15-6	BRD-A61793559	metolazone	AQCHWTWZEMGIFD	carbonic anhydrase inhibitor	SLC12A3	broad_id_20170327	Launched		
BRD-A62025033-001-01-8	BRD-A62025033								
BRD-A62035778-004-03-6	BRD-A62035778	scopolamine	STECJAGHUSJQJN	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|SI	broad_id_20170327	Launched		
BRD-A62071884-001-04-6	BRD-A62071884	siguazodan	NUHPODZZKHQQET	phosphodiesterase inhibitor	PDE3A	broad_id_20170327	Phase 1		
BRD-A62525898-001-05-2	BRD-A62525898	prednisone	XOFYZVNMUHMLCC	glucocorticoid receptor agonist	HSD11B1|NR3C1	broad_id_20170327	Launched		
BRD-A62879835-001-04-2	BRD-A62879835	rifaximin	NZCRJKRKKOLAOJ	RNA synthesis inhibitor		broad_id_20170327	Launched		
BRD-A63236097-001-01-3	BRD-A63236097	andrographolide	BOJKULTULYSRAS	tumor necrosis factor production inhibitor	IL1B|IL6|NFKB1|NFKB2|TNF	broad_id_20170327	Phase 2		
BRD-A63310107-001-04-8	BRD-A63310107	miglitol	IBAQFPQHRJAVAV	glucosidase inhibitor	GAA|GANAB|GANC|MGAM	broad_id_20170327	Launched		
BRD-A63675168-001-01-6	BRD-A63675168	brivudine	ODZBBRURCPAEIQ	DNA directed DNA polymerase inhibitor		broad_id_20170327	Launched		
BRD-A63752151-001-01-2	BRD-A63752151	fidarestat	WAAPEIZFCHNLKK	aldose reductase inhibitor	AKR1B1	broad_id_20170327	Phase 3		
BRD-A64406146-001-01-2	BRD-A64406146	timofibrate	QSNOWCXXECLALL	cholesterol inhibitor|lipase clearing factor inhibitor	LPL	broad_id_20170327	Phase 2		
BRD-A64485570-001-11-0	BRD-A64485570	trifluridine	VSQQQLOSPVPRAZ	DNA directed DNA polymerase inhibitor|thymidylate synthase inhibitor	TYMS	broad_id_20170327	Launched		
BRD-A64553394-001-04-4	BRD-A64553394	DPI-201106	BYBYHCOEAFHGJL	sodium channel activator	ADRB2	broad_id_20170327	Phase 2		
BRD-A64977602-001-15-9	BRD-A64977602	mirtazapine	RONZAEMNMFQXRA	adrenergic receptor antagonist|serotonin receptor antagonist	ADRA2A|ADRA2B|ADRA2C|HTR2A|HTR2C	broad_id_20170327	Launched		
BRD-A65013509-003-24-4	BRD-A65013509	oxybutynin	XIQVNETUBQGFHX	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3	broad_id_20170327	Launched		
BRD-A65051990-001-12-9	BRD-A65051990	acenocoumarol	VABCILAOYCMVPS	vitamin K antagonist	VKORC1	broad_id_20170327	Launched		
BRD-A65248799-001-01-7	BRD-A65248799	EMD-53998	IZLRMTJLQCLMKF	phosphodiesterase inhibitor	TNNC1	broad_id_20170327	Phase 1		
BRD-A65280694-003-13-7	BRD-A65280694	molindone	KLPWJLBORRMFGK	dopamine receptor antagonist	DRD2|HRH1|HTR2A	broad_id_20170327	Launched		
BRD-A66155091-001-01-8	BRD-A66155091	trilostane	RLQVKDVIBJCQGE	3beta-hydroxy-delta5-steroid dehydrogenase inhibitor		broad_id_20170327	Launched		
BRD-A66419424-001-02-4	BRD-A66419424	ixazomib-citrate	YTXSYWAKVMZICI	proteasome inhibitor		broad_id_20170327	Launched		
BRD-A67097164-001-18-7	BRD-A67097164	ifosfamide	HOMGKSMUEGBAAB	DNA alkylating agent	CYP2A6|CYP2B6|CYP2C18|CYP2C19|CYP2C8|CYP2C9|CYP3A4|CYP3A5|CYP3A7|PTGS1	broad_id_20170327	Launched		
BRD-A67373739-001-02-2	BRD-A67373739								
BRD-A67479912-001-03-4	BRD-A67479912	progesterone	RJKFOVLPORLFTN	progesterone receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|CYP17A1|ESR1|NR3C2|OPRK1|PGR|TRPC5	broad_id_20170327	Launched		
BRD-A67516570-001-02-8	BRD-A67516570	lafutidine	KMZQAVXSMUKBPD	histamine receptor antagonist	HRH2	broad_id_20170327	Launched		
BRD-A67616246-001-07-9	BRD-A67616246	levomequitazine	HOKDBMAJZXIPGC	histamine receptor antagonist	HRH1	broad_id_20170327	Phase 2		
BRD-A67862938-034-14-9	BRD-A67862938	naftidrofuryl	KBAFPSLPKGSANY	adrenergic receptor antagonist		broad_id_20170327	Launched		
BRD-A68009927-003-03-7	BRD-A68009927	daunorubicin	STQGQHZAVUOBTE	RNA synthesis inhibitor|topoisomerase inhibitor	TOP2A|TOP2B	broad_id_20170327	Launched		
BRD-A68281735-001-18-6	BRD-A68281735	REV-5901	JRLOEMCOOZSCQP	leukotriene receptor antagonist|lipoxygenase inhibitor	ALOX5	broad_id_20170327	Phase 2		
BRD-A68304895-003-02-2	BRD-A68304895	BTS-54505	WQSACWZKKZPCHN	dopamine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Withdrawn		
BRD-A68464583-001-02-5	BRD-A68464583		ZPXSCAKFGYXMGA			broad_id_20170327			
BRD-A68493689-001-01-9	BRD-A68493689	simeprevir	JTZZSQYMACOLNN	HCV inhibitor	CYP1A2|CYP3A4	broad_id_20170327	Launched		
BRD-A68888262-003-15-1	BRD-A68888262	azelastine	MBUVEWMHONZEQD	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-A68942014-003-01-7	BRD-A68942014	amitifadine	BSMNRYCSBFHEMQ	serotonin transporter (SERT) inhibitor	SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Phase 3		
BRD-A69275535-001-01-5	BRD-A69275535	pinitol	DSCFFEYYQKSRSV	gamma secretase inhibitor		broad_id_20170327	Phase 2		
BRD-A69636825-003-04-7	BRD-A69636825	diltiazem	HSUGRBWQSSZJOP	calcium channel blocker	CACNA1C|CACNA1S|CACNA2D1|CACNG1|HTR3A|KCNA5	broad_id_20170327	Launched		
BRD-A69815203-001-07-6	BRD-A69815203	cyclosporin-A	PMATZTZNYRCHOR	calcineurin inhibitor	ABCB11|CAMLG|FPR1|PPIA|PPIF|PPP3CA|PPP3R2|SLC10A1|SLCO1B1|SLCO1B3	broad_id_20170327	Launched		
BRD-A69951442-001-01-3	BRD-A69951442								
BRD-A70083328-001-23-5	BRD-A70083328	secnidazole	KPQZUUQMTUIKBP	acetylcholinesterase inhibitor|microtubule inhibitor		broad_id_20170327	Launched		
BRD-A70858459-001-01-7	BRD-A70858459	estramustine	FRPJXPJMRWBBIH	DNA alkylating agent	ESR1|ESR2|MAP1A|MAP2	broad_id_20170327	Launched		
BRD-A70998768-004-01-1	BRD-A70998768	pinaverium	DDHUTBKXLWCZCO	T-type calcium channel blocker	CACNA1C	broad_id_20170327	Launched		
BRD-A72066420-001-04-5	BRD-A72066420	mifobate	VQHUQHAPWMNBLP	PPAR receptor antagonist	PPARG	broad_id_20170327	Phase 2		
BRD-A72309220-001-04-1	BRD-A72309220	metergoline	WZHJKEUHNJHDLS	dopamine receptor agonist|serotonin receptor antagonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR6|HTR7	broad_id_20170327	Launched		
BRD-A72390365-001-15-2	BRD-A72390365	choline-alfoscerate	SUHOQUVVVLNYQR	acetylcholine precursor		broad_id_20170327	Launched		
BRD-A72711497-236-03-8	BRD-A72711497	lasalocid	BBMULGJBVDDDNI	bacterial permeability inducer		broad_id_20170327	Launched		
BRD-A73368467-003-17-6	BRD-A73368467	fexofenadine	RWTNPBWLLIMQHL	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-A73556557-001-06-4	BRD-A73556557	tagatose	BJHIKXHVCXFQLS	phosphorylase inhibitor	PYGL	broad_id_20170327	Launched		
BRD-A73741725-001-02-8	BRD-A73741725	exemestane	BFYIZQONLCFLEV	aromatase inhibitor	CYP19A1	broad_id_20170327	Launched		
BRD-A73908300-001-06-7	BRD-A73908300	EX-527	FUZYTVDVLBBXDL	SIRT inhibitor	SIRT1	broad_id_20170327	Phase 2		
BRD-A74391928-051-01-3	BRD-A74391928	ibutilide	ALOBUEHUHMBRLE	potassium channel blocker	CACNA1C|KCNH2	broad_id_20170327	Launched		
BRD-A74667430-001-23-6	BRD-A74667430	etodolac	NNYBQONXHNTVIJ	cyclooxygenase inhibitor	PTGS2	broad_id_20170327	Launched		
BRD-A74914197-001-02-9	BRD-A74914197	pralatrexate	OGSBUKJUDHAQEA	dihydrofolate reductase inhibitor	DHFR	broad_id_20170327	Launched		
BRD-A74980173-001-11-9	BRD-A74980173	gatifloxacin	XUBOMFCQGDBHNK	bacterial DNA gyrase inhibitor		broad_id_20170327	Withdrawn		
BRD-A75172220-001-04-0	BRD-A75172220	hydrocortisone	JYGXADMDTFJGBT	glucocorticoid receptor agonist	ANXA1|NOS2|NR3C1|NR3C2	broad_id_20170327	Launched		
BRD-A75305484-001-01-3	BRD-A75305484	anidulafungin	JHVAMHSQVVQIOT	fungal 1,3-beta-D-glucan synthase inhibitor		broad_id_20170327	Launched		
BRD-A75479906-001-02-4	BRD-A75479906	rimantadine	UBCHPRBFMUDMNC	antiviral|RNA synthesis inhibitor		broad_id_20170327	Launched		
BRD-A75726477-003-21-3	BRD-A75726477	clenbuterol	STJMRWALKKWQGH	adrenergic receptor agonist	ABCC8|ADRB2|KCNJ11	broad_id_20170327	Launched		
BRD-A76747559-001-03-1	BRD-A76747559	rutin	IKGXIBQEEMLURG	antioxidant|capillary stabilizing agent|nitric oxide scavenger	AKR1C3	broad_id_20170327	Launched		
BRD-A77216878-001-01-4	BRD-A77216878								
BRD-A78195072-001-06-2	BRD-A78195072	imexon	BIXBBIPTYBJTRY	apoptosis stimulant|ribonucleotide reductase inhibitor		broad_id_20170327	Phase 2		
BRD-A78341343-001-01-6	BRD-A78341343	regadenoson	LZPZPHGJDAGEJZ	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3	broad_id_20170327	Launched		
BRD-A78723049-001-01-2	BRD-A78723049	cefotetan	SRZNHPXWXCNNDU	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-A78877355-001-03-0	BRD-A78877355	nefopam	RGPDEAGGEXEMMM	cyclooxygenase inhibitor		broad_id_20170327	Launched		
BRD-A79431551-001-01-1	BRD-A79431551	3-deazaadenosine	DBZQFUNLCALWDY	adenosylhomocysteinase inhibitor	AHCY	broad_id_20170327	Phase 2		
BRD-A79768653-001-12-0	BRD-A79768653	sirolimus	QFJCIRLUMZQUOT	mTOR inhibitor	FKBP1A|MTOR	broad_id_20170327	Launched		
BRD-A79981887-003-16-4	BRD-A79981887	midodrine	PTKSEFOSCHHMPD	adrenergic receptor agonist		broad_id_20170327	Launched		
BRD-A80017228-001-25-7	BRD-A80017228	bendroflumethiazide	HDWIHXWEUNVBIY	sodium/potassium/chloride transporter inhibitor	SLC12A1|SLC12A3	broad_id_20170327	Launched		
BRD-A80151636-066-04-8	BRD-A80151636	bromocriptine	OZVBMTJYIDMWIL	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR6|HTR7	broad_id_20170327	Launched		
BRD-A81233518-004-16-1	BRD-A81233518	glycopyrrolate	ANGKOCUUWGHLCE	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-A82035391-001-02-7	BRD-A82035391	tolvaptan	GYHCTFXIZSNGJT	vasopressin receptor antagonist	AVPR1A|AVPR2	broad_id_20170327	Launched		
BRD-A82156122-001-01-9	BRD-A82156122	saxagliptin	QGJUIPDUBHWZPV	dipeptidyl peptidase inhibitor	DPP4	broad_id_20170327	Launched		
BRD-A82395837-001-01-9	BRD-A82395837	ginkgolide-B	SQOJOAFXDQDRGF	platelet activating factor receptor antagonist	GLRA1|GLRA2|GLRA3|GLRB|HTR3A|HTR3B	broad_id_20170327	Phase 3		
BRD-A82396632-008-29-0	BRD-A82396632	miconazole	BYBLEWFAAKGYCD	bacterial cell wall synthesis inhibitor	TRPM2|TRPV5	broad_id_20170327	Launched		
BRD-A82522119-001-01-7	BRD-A82522119	tibolone	WZDGZWOAQTVYBX	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	ESR1	broad_id_20170327	Launched		
BRD-A82772293-001-03-2	BRD-A82772293	mepazine	CBHCDHNUZWWAPP	MALT1 inhibitor (JH)	MALT1	broad_id_20170327	Phase 2		
BRD-A83081521-001-02-3	BRD-A83081521	finasteride	DBEPLOCGEIEOCV	5 alpha reductase inhibitor	AKR1D1|SRD5A1|SRD5A2	broad_id_20170327	Launched		
BRD-A84045418-001-03-1	BRD-A84045418								
BRD-A84174393-236-07-1	BRD-A84174393		ZAHQBPYQBHTECE			broad_id_20170327			
BRD-A84481105-003-20-6	BRD-A84481105	thioridazine	KLBQZWRITKRQQV	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7	broad_id_20170327	Withdrawn		
BRD-A84575140-001-02-4	BRD-A84575140	pimobendan	GLBJJMFZWDBELO	calcium sensitizer|phosphodiesterase inhibitor	PDE3A	broad_id_20170327	Launched		
BRD-A85439007-001-01-6	BRD-A85439007	idoxuridine	XQFRJNBWHJMXHO	DNA directed DNA polymerase inhibitor|DNA synthesis inhibitor		broad_id_20170327	Launched		
BRD-A85548292-001-01-8	BRD-A85548292	piketoprofen	ASFKKFRSMGBFRO	cyclooxygenase inhibitor		broad_id_20170327	Launched		
BRD-A86216746-046-02-6	BRD-A86216746	varenicline	JQSHBVHOMNKWFT	acetylcholine receptor agonist	CHRNA3|CHRNA4|CHRNA6|CHRNA7	broad_id_20170327	Launched		
BRD-A86248581-001-01-4	BRD-A86248581	tetrahydrouridine	UCKYOOZPSJFJIZ	cytidine deaminase inhibitor	CDA	broad_id_20170327	Phase 2		
BRD-A86871940-001-01-9	BRD-A86871940	nicaraven	KTXBOOWDLPUROC	free radical scavenger		broad_id_20170327	Phase 3		
BRD-A87130939-001-07-9	BRD-A87130939	masoprocol	HCZKYJDFEPMADG	lipoxygenase inhibitor	ALOX5	broad_id_20170327	Launched		
BRD-A87435144-001-01-6	BRD-A87435144	AZD7545	DTDZLJHKVNTQGZ	pyruvate dehydrogenase kinase inhibitor	PDK1	broad_id_20170327	Phase 1		
BRD-A87479750-001-02-7	BRD-A87479750	tenidap	IGPDWKCUDHIIRL	cyclooxygenase inhibitor	KCNJ4|PTGS1	broad_id_20170327	Phase 3		
BRD-A87983072-001-01-1	BRD-A87983072	benzotript	QJERBBQXOMUURJ	CCK receptor antagonist	CCKAR|CCKBR	broad_id_20170327	Phase 1		
BRD-A88138582-001-04-8	BRD-A88138582	halcinonide	MUQNGPZZQDCDFT	glucocorticoid receptor agonist	NR3C1	broad_id_20170327	Launched		
BRD-A89164055-001-03-3	BRD-A89164055	sorbinil	LXANPKRCLVQAOG	aldose reductase inhibitor	AKR1B1	broad_id_20170327	Phase 3		
BRD-A89175223-051-14-8	BRD-A89175223	bisoprolol	VHYCDWMUTMEGQY	adrenergic receptor antagonist	ADRB1	broad_id_20170327	Launched		
BRD-A89585551-003-16-6	BRD-A89585551	mefloquine	XEEQGYMUWCZPDN	adenosine receptor antagonist|hemoglobin antagonist		broad_id_20170327	Launched		
BRD-A90547603-001-02-5	BRD-A90547603	eptifibatide	CZKPOZZJODAYPZ	platelet aggregation inhibitor	ITGA2B|ITGB3	broad_id_20170327	Launched		
BRD-A90625545-001-02-0	BRD-A90625545	clinofibrate	BMOVQUBVGICXQN	lipase clearing factor inhibitor	LPL	broad_id_20170327	Launched		
BRD-A90799790-001-19-9	BRD-A90799790	isradipine	HMJIYCCIJYRONP	calcium channel blocker	CACNA1D|CACNA1F|CACNA2D1	broad_id_20170327	Launched		
BRD-A91699651-316-10-9	BRD-A91699651	chloroquine	WHTVZRBIWZFKQO	antimalarial agent	MRGPRX1	broad_id_20170327	Launched		
BRD-A91877226-001-01-4	BRD-A91877226	capecitabine	GAGWJHPBXLXJQN	DNA synthesis inhibitor|thymidylate synthase inhibitor	TYMS	broad_id_20170327	Launched		
BRD-A92537424-001-04-7	BRD-A92537424	danazol	POZRVZJJTULAOH	estrogen receptor antagonist|progesterone receptor agonist	AR|CCL2|ESR1|GNRHR|GNRHR2|PGR	broad_id_20170327	Launched		
BRD-A92630576-050-24-1	BRD-A92630576	trimebutine	LORDFXWUHHSAQU	opioid receptor agonist	OPRD1|OPRK1|OPRM1	broad_id_20170327	Launched		
BRD-A92826379-001-01-5	BRD-A92826379	lupanine	JYIJIIVLEOETIQ	sodium channel blocker	INS	broad_id_20170327	Phase 1		
BRD-A93000692-001-08-1	BRD-A93000692	ciglitazone	YZFWTZACSRHJQD	PPAR receptor agonist	PPARG	broad_id_20170327	Phase 2		
BRD-A93093700-001-02-9	BRD-A93093700		SEQDDYPDSLOBDC			broad_id_20170327			
BRD-A93255169-001-28-3	BRD-A93255169	thalidomide	UEJJHQNACJXSKW	tumor necrosis factor production inhibitor	TNF	broad_id_20170327	Launched		
BRD-A93353767-008-02-2	BRD-A93353767	isoconazole	MPIPASJGOJYODL	fungal lanosterol demethylase inhibitor	CYP17A1	broad_id_20170327	Launched		
BRD-A93424738-001-04-8	BRD-A93424738	betamethasone-acetate	AKUJBENLRBOFTD	glucocorticoid receptor agonist	NR3C1	broad_id_20170327	Launched	glucocorticoid receptor agonist	nan
BRD-A93964801-003-03-3	BRD-A93964801	clinafloxacin	QGPKADBNRMWEQR	bacterial DNA gyrase inhibitor		broad_id_20170327	Phase 3		
BRD-A94276798-001-01-4	BRD-A94276798	talinolol	MXFWWQICDIZSOA	adrenergic receptor antagonist	ADRB1	broad_id_20170327	Launched		
BRD-A94543220-001-24-7	BRD-A94543220	bifonazole	OCAPBUJLXMYKEJ	sterol demethylase inhibitor		broad_id_20170327	Launched		
BRD-A94756469-001-04-7	BRD-A94756469	digoxin	LTMHDMANZUZIPE	ATPase inhibitor	ATP1A1	broad_id_20170327	Launched		
BRD-A95032015-065-01-2	BRD-A95032015	abacavir	MCGSCOLBFJQGHM	nucleoside reverse transcriptase inhibitor		broad_id_20170327	Launched		
BRD-A95696066-003-13-8	BRD-A95696066	nisoxetine	ITJNARMNRKSWTA	norepinephrine reuptake inhibitor	SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Phase 1		
BRD-A95869247-001-26-9	BRD-A95869247	indapamide	NDDAHWYSQHTHNT	thiazide diuretic	CA2|HTR3A|KCNQ1	broad_id_20170327	Launched		
BRD-A95939040-001-01-2	BRD-A95939040	sertaconazole	JLGKQTAYUIMGRK	sterol demethylase inhibitor		broad_id_20170327	Launched		
BRD-A96060515-004-01-6	BRD-A96060515	ipratropium	OEXHQOGQTVQTAT	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-A96292436-003-16-1	BRD-A96292436	eflornithine	VLCYCQAOQCDTCN	ornithine decarboxylase inhibitor	ARG2|ODC1	broad_id_20170327	Launched		
BRD-A96456596-001-02-2	BRD-A96456596	FPL-55712	LMQBMWHHGVZWMR	leukotriene receptor antagonist		broad_id_20170327	Phase 1		
BRD-A96754982-001-01-4	BRD-A96754982	tacrolimus	QJJXYPPXXYFBGM	calcineurin inhibitor	FKBP1A	broad_id_20170327	Launched		
BRD-A97104540-004-15-0	BRD-A97104540	fenoterol	LSLYOANBFKQKPT	adrenergic receptor agonist	ADRB2	broad_id_20170327	Withdrawn		
BRD-A97437073-050-14-5	BRD-A97437073	rosiglitazone	YASAKCUCGLMORW	insulin sensitizer|PPAR receptor agonist	FFAR1|PPARG|TRPC5|TRPM3	broad_id_20170327	Withdrawn		
BRD-A97479839-003-13-3	BRD-A97479839	piperidolate	KTHVBAZBLKXIHZ	acetylcholine receptor antagonist	CHRM1	broad_id_20170327	Launched		
BRD-A97502381-001-01-3	BRD-A97502381		FMCRMSOQAVOHRD			broad_id_20170327			
BRD-A97674275-001-11-8	BRD-A97674275	ranolazine	XKLMZUWKNUAPSZ	sodium channel blocker	SCN10A|SCN9A	broad_id_20170327	Launched		
BRD-A97701745-001-16-0	BRD-A97701745	pindolol	JZQKKSLKJUAGIC	adrenergic receptor antagonist	ADRB1|ADRB2|HTR1A|HTR2A|HTR2B	broad_id_20170327	Launched	adrenergic receptor antagonist|serotonin receptor antagonist	HTR1A
BRD-A97739905-001-26-5	BRD-A97739905	ketoprofen	DKYWVDODHFEZIM	cyclooxygenase inhibitor	PTGS1|PTGS2|SLC5A8	broad_id_20170327	Launched		
BRD-A97808748-001-03-8	BRD-A97808748	spironolactone	LXMSZDCAJNLERA	mineralocorticoid receptor antagonist	AR|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CYP11B2|NR3C1|NR3C2|PGR|SHBG	broad_id_20170327	Launched		
BRD-A98702003-304-04-8	BRD-A98702003	carbenoxolone	OBZHEBDUNPOCJG	11-beta hydroxysteroid dehydrogenase inhibitor	GJA1|GJA10|GJA3|GJA4|GJA5|GJA8|GJA9|GJB1|GJB2|GJB3|GJB4|GJB5|GJB6|GJB7|GJC1|GJC2|GJC3|GJD2|GJD3|GJD4|GJE1|HSD11B1|PANX1|PANX2|PANX3	broad_id_20170327	Launched		
BRD-A98845662-036-03-7	BRD-A98845662	desvenlafaxine	KYYIDSXMWOZKMP	serotoninânorepinephrine reuptake inhibitor (SNRI)	SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-A98990573-003-01-3	BRD-A98990573	epinastine	WHWZLSFABNNENI	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-A99939097-001-24-2	BRD-A99939097		OFZCIYFFPZCNJE			broad_id_20170327			
BRD-K00077635-304-01-2	BRD-K00077635	estramustine-phosphate	ADFOJJHRTBFFOF	DNA synthesis inhibitor|microtubule inhibitor	ESR1|ESR2|MAP1A|MAP2	broad_id_20170327	Launched		
BRD-K00152668-001-01-5	BRD-K00152668	adarotene	QAWBIEIZDDIEMW	retinoid receptor agonist	RARB|RARG	broad_id_20170327	Phase 1		
BRD-K00259736-001-16-4	BRD-K00259736	colchicine	IAKHMKGGTNLKSZ	microtubule inhibitor	GLRA1|GLRA2|TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8	broad_id_20170327	Launched		
BRD-K00494077-066-01-9	BRD-K00494077	trovafloxacin	WVPSKSLAZQPAKQ	bacterial DNA gyrase inhibitor	TOP2A	broad_id_20170327	Withdrawn		
BRD-K00521308-019-01-9	BRD-K00521308	ATN-161	MMHDBUJXLOFTLC	integrin antagonist	ITGA5|ITGAV|ITGB1|ITGB3	broad_id_20170327	Phase 2		
BRD-K00603606-003-24-0	BRD-K00603606	ticlopidine	PHWBOXQYWZNQIN	purinergic receptor antagonist	P2RY12	broad_id_20170327	Launched		
BRD-K00610438-003-02-5	BRD-K00610438	altanserin	SMYALUSCZJXWHG	serotonin receptor antagonist	HTR2A	broad_id_20170327	Phase 2		
BRD-K00662280-001-09-4	BRD-K00662280	CL-218872	GUOQUXNJZHGPQF	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2	broad_id_20170327	Phase 1		
BRD-K00673382-001-18-9	BRD-K00673382	famotidine	XUFQPHANEAPEMJ	histamine receptor antagonist	HRH2	broad_id_20170327	Launched		
BRD-K00674894-001-01-4	BRD-K00674894	orteronel	OZPFIJIOIVJZMN	androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor	CYP17A1	broad_id_20170327	Phase 3		
BRD-K00911143-001-01-9	BRD-K00911143	brexpiprazole	ZKIAIYBUSXZPLP	dopamine receptor partial agonist	DRD2	broad_id_20170327	Launched		
BRD-K01029106-001-01-4	BRD-K01029106	chromium-picolinate	CBDQOLKNTOMMTL	insulin sensitizer		broad_id_20170327	Launched		
BRD-K01039503-001-01-2	BRD-K01039503	sofalcone	GFWRVVCDTLRWPK	mucus protecting agent	CBR1	broad_id_20170327	Launched		
BRD-K01174345-001-01-9	BRD-K01174345	anamorelin	VQPFSIRUEPQQPP	growth hormone secretagogue receptor agonist	GHSR	broad_id_20170327	Phase 3		
BRD-K01192156-001-02-7	BRD-K01192156								
BRD-K01292756-001-25-0	BRD-K01292756	pimozide	YVUQSNJEYSNKRX	dopamine receptor antagonist	CACNA1I|CALM1|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR2A|KCNA10|KCNH2	broad_id_20170327	Launched		
BRD-K01577834-001-15-1	BRD-K01577834	adenosine	OIRDTQYFTABQOQ	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4	broad_id_20170327	Launched	antiviral	ADA
BRD-K01621533-001-01-1	BRD-K01621533	acarbose	XUFXOAAUWZOOIT	glucosidase inhibitor	AMY2A|MGAM	broad_id_20170327	Launched		
BRD-K01638814-051-10-1	BRD-K01638814	rilmenidine	CQXADFVORZEARL	adrenergic receptor agonist|imidazoline receptor agonist	ADRA2A	broad_id_20170327	Launched		
BRD-K01663662-003-20-2	BRD-K01663662	diphenidol	OGAKLTJNUQRZJU	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4	broad_id_20170327	Launched		
BRD-K01674964-300-06-3	BRD-K01674964	histamine	NTYJJOPFIAHURM	histamine receptor agonist	HRH1|HRH2|HRH3|HRH4	broad_id_20170327	Launched		
BRD-K01815685-001-15-5	BRD-K01815685	indole-3-carbinol	IVYPNXXAYMYVSP	aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor	AHR	broad_id_20170327	Phase 2/Phase 3		
BRD-K01824921-001-18-5	BRD-K01824921	DPCPX	FFBDFADSZUINTG	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3	broad_id_20170327	Phase 1		
BRD-K02079473-001-01-3	BRD-K02079473	oxatomide	BAINIUMDFURPJM	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K02113016-001-15-4	BRD-K02113016	olaparib	FDLYAMZZIXQODN	PARP inhibitor	PARP1|PARP2	broad_id_20170327	Launched		
BRD-K02123250-001-06-7	BRD-K02123250	JNJ-38877605	JRWCBEOAFGHNNU	tyrosine kinase inhibitor	MET	broad_id_20170327	Phase 1		
BRD-K02265150-001-26-5	BRD-K02265150	amoxapine	QWGDMFLQWFTERH	norepinephrine reputake inhibitor	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH4|HTR1A|HTR1B|HTR2A|HTR2B|HTR2C|HTR3A|HTR6|HTR7|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-K02292852-001-02-1	BRD-K02292852	cefoperazone	GCFBRXLSHGKWDP	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-K02314383-001-01-3	BRD-K02314383	epitiostanol	OBMLHUPNRURLOK	androgen receptor agonist	AR	broad_id_20170327	Launched		
BRD-K02389548-001-02-5	BRD-K02389548	RG2833	VOPDXHFYDJAYNS	HDAC inhibitor	HDAC1|HDAC3	broad_id_20170327	Phase 1		
BRD-K02404261-001-16-7	BRD-K02404261	caffeine	RYYVLZVUVIJVGH	adenosine receptor antagonist|phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADORA3|ATM|ITPR1|ITPR2|ITPR3|PDE10A|PDE11A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|PIK3CA|PIK3CB|PIK3CD|PRKDC|RYR1|RYR2|RYR3	broad_id_20170327	Launched		
BRD-K02501528-001-01-1	BRD-K02501528	S18986	MNTIJYGEITVWHU	glutamate receptor modulator	GRIA1|GRIA2|GRIA3|GRIA4	broad_id_20170327	Phase 2		
BRD-K02637541-001-18-0	BRD-K02637541	celecoxib	RZEKVGVHFLEQIL	cyclooxygenase inhibitor	CA12|PDPK1|PTGS2	broad_id_20170327	Launched		
BRD-K02867583-300-08-9	BRD-K02867583	minaprine	LDMWSLGGVTVJPG	serotonin reuptake inhibitor	ACHE|CHRM1|DRD1|DRD2|HTR2A|HTR2B|HTR2C|MAOA|SLC6A4	broad_id_20170327	Withdrawn		
BRD-K02900412-001-11-3	BRD-K02900412	clofoctol	HQVZOORKDNCGCK	protein synthesis inhibitor		broad_id_20170327	Launched		
BRD-K02943813-001-01-9	BRD-K02943813	dasabuvir	NBRBXGKOEOGLOI	HCV inhibitor		broad_id_20170327	Launched		
BRD-K02950022-001-02-9	BRD-K02950022	BMS-299897	IZAOBRWCUGOKNH	gamma secretase inhibitor		broad_id_20170327	Phase 1		
BRD-K02992638-001-11-8	BRD-K02992638	lamivudine	JTEGQNOMFQHVDC	nucleoside reverse transcriptase inhibitor		broad_id_20170327	Launched		
BRD-K03095347-001-06-1	BRD-K03095347	levosimendan	WHXMKTBCFHIYNQ	calcium sensitizer	KCNJ11|KCNJ8|PDE3A|TNNC1	broad_id_20170327	Launched		
BRD-K03194791-001-04-8	BRD-K03194791	roflumilast	MNDBXUUTURYVHR	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D	broad_id_20170327	Launched		
BRD-K03289534-001-01-4	BRD-K03289534	lersivirine	MCPUZZJBAHRIPO	non-nucleoside reverse transcriptase inhibitor		broad_id_20170327	Phase 2		
BRD-K03353589-236-01-4	BRD-K03353589	ecabet	IWCWQNVIUXZOMJ	gastrin inhibitor|urease inhibitor	NOXO1	broad_id_20170327	Launched		
BRD-K03384561-001-02-7	BRD-K03384561	roquinimex	SGOOQMRIPALTEL	angiogenesis inhibitor|tumor necrosis factor production inhibitor		broad_id_20170327	Phase 3		
BRD-K03390685-001-01-7	BRD-K03390685	cobimetinib	BSMCAPRUBJMWDF	MEK inhibitor	MAP2K1	broad_id_20170327	Launched		
BRD-K03449891-001-08-6	BRD-K03449891	foretinib	CXQHYVUVSFXTMY	VEGFR inhibitor	FLT1|FLT4|KDR|MET	broad_id_20170327	Phase 2		
BRD-K03601870-001-01-2	BRD-K03601870	ixabepilone	FABUFPQFXZVHFB	microtubule stabilizing agent	TUBB	broad_id_20170327	Launched		
BRD-K03816923-001-05-4	BRD-K03816923								
BRD-K03842655-001-02-1	BRD-K03842655								
BRD-K04111260-001-10-0	BRD-K04111260	raclopride	WAOQONBSWFLFPE	dopamine receptor antagonist	DRD2|DRD3|HTR1A	broad_id_20170327	Launched		
BRD-K04112579-001-07-0	BRD-K04112579	nepafenac	QEFAQIPZVLVERP	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K04185004-003-11-9	BRD-K04185004	oxybuprocaine	CMHHMUWAYWTMGS	local anesthetic	SCN10A	broad_id_20170327	Launched		
BRD-K04264130-001-01-4	BRD-K04264130	favipiravir	ZCGNOVWYSGBHAU	RNA polymerase inhibitor		broad_id_20170327	Phase 3		
BRD-K04691817-001-01-8	BRD-K04691817	AGI-6780	CCAWRGNYALGPQH	isocitrate dehydrogenase inhibitor	IDH2	broad_id_20170327	Preclinical		
BRD-K04704168-003-14-3	BRD-K04704168	clemizole	CJXAEXPPLWQRFR	HCV inhibitor		broad_id_20170327	Launched		
BRD-K04804440-001-09-5	BRD-K04804440	ciprofloxacin	MYSWGUAQZAJSOK	bacterial DNA gyrase inhibitor	TOP2A	broad_id_20170327	Launched		
BRD-K04887706-375-01-4	BRD-K04887706								
BRD-K04956647-003-02-5	BRD-K04956647	nebivolol	KOHIRBRYDXPAMZ	adrenergic receptor antagonist	ADRB1	broad_id_20170327	Launched		
BRD-K04993719-001-01-7	BRD-K04993719	LY2334737	MEOYFIHNRBNEPI	antitumor agent|ribonucleotide reductase inhibitor		broad_id_20170327	Phase 1		
BRD-K05104363-001-10-0	BRD-K05104363	PD-184352	GFMMXOIFOQCCGU	MEK inhibitor	MAP2K1|MAP3K1|MAP3K2	broad_id_20170327	Phase 2		
BRD-K05236810-001-19-0	BRD-K05236810	luteolin	IQPNAANSBPBGFQ	glucosidase inhibitor	TOP1	broad_id_20170327	Phase 2		
BRD-K05395900-322-05-4	BRD-K05395900	nicotine	SNICXCGAKADSCV	acetylcholine receptor agonist	CHAT|CHRNA10|CHRNA2|CHRNA3|CHRNA4|CHRNA5|CHRNA6|CHRNA7|CHRNA9|CHRNB2|CHRNB3|CHRNB4|CYP19A1|TBXAS1|TRPA1	broad_id_20170327	Launched		
BRD-K05446112-001-01-8	BRD-K05446112	ledipasvir	VRTWBAAJJOHBQU	HCV inhibitor		broad_id_20170327	Launched		
BRD-K05524748-003-04-4	BRD-K05524748	dronedarone	ZQTNQVWKHCQYLQ	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|CACNA1C|CACNA1D|CACNA1F|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|KCNA5|KCNH2|KCNK2|SCN1A	broad_id_20170327	Launched		
BRD-K05658747-001-02-9	BRD-K05658747	raltegravir	CZFFBEXEKNGXKS	HIV integrase inhibitor		broad_id_20170327	Launched		
BRD-K05673000-236-12-1	BRD-K05673000	dicloxacillin	YFAGHNZHGGCZAX	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-K05674516-001-02-5	BRD-K05674516	PSI-7976	TTZHDVOVKQGIBA	HCV inhibitor		broad_id_20170327	Preclinical		
BRD-K05804044-001-06-0	BRD-K05804044	AZ-628	ZGBGPEDJXCYQPH	RAF inhibitor	BRAF|RAF1	broad_id_20170327	Preclinical		
BRD-K05977355-001-19-0	BRD-K05977355	fluconazole	RFHAOTPXVQNOHP	sterol demethylase inhibitor	CYP51A1	broad_id_20170327	Launched		
BRD-K06240250-001-01-6	BRD-K06240250	rilpivirine	YIBOMRUWOWDFLG	non-nucleoside reverse transcriptase inhibitor	NR1I2|SCN10A	broad_id_20170327	Launched		
BRD-K06294530-001-01-5	BRD-K06294530	UK-383367	ARJCBSRIPGJMAD	procollagen C-endopeptidase inhibitor	BMP1	broad_id_20170327	Phase 1		
BRD-K06335600-003-20-7	BRD-K06335600	tizanidine	XFYDIVBRZNQMJC	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C|NISCH	broad_id_20170327	Launched		
BRD-K06388322-312-02-6	BRD-K06388322	pramipexole	FASDKYOPVNHBLU	dopamine receptor agonist	ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C	broad_id_20170327	Launched		
BRD-K06557128-001-07-0	BRD-K06557128	voriconazole	BCEHBSKCWLPMDN	cytochrome P450 inhibitor	CYP2C19|CYP2C9|CYP3A4|CYP3A5|PTGS1	broad_id_20170327	Launched		
BRD-K06674495-334-03-2	BRD-K06674495	nafamostat	MQQNFDZXWVTQEH	serine protease inhibitor	ASIC1|ASIC2|ASIC3|C1R|PRSS1|TPSAB1|TRPM7	broad_id_20170327	Launched		
BRD-K06762493-001-08-1	BRD-K06762493	isbufylline	WHUWQSQEVISUMC	phosphodiesterase inhibitor		broad_id_20170327	Phase 2		
BRD-K06858286-001-01-3	BRD-K06858286	cabazitaxel	BMQGVNUXMIRLCK	microtubule inhibitor	TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3D|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8	broad_id_20170327	Launched		
BRD-K06878038-001-18-6	BRD-K06878038	deferiprone	TZXKOCQBRNJULO	chelating agent	UGT1A6	broad_id_20170327	Launched		
BRD-K06900071-001-01-2	BRD-K06900071	tebipenem	SNUDIPVBUUXCDG	bacterial cell wall synthesis inhibitor	CNR1	broad_id_20170327	Launched		
BRD-K06902185-003-01-7	BRD-K06902185	minoxidil	ZFMITUMMTDLWHR	KATP activator|Kir6 channel (KATP) activator|vasodilator	ABCC9|KCNJ1|KCNJ10|KCNJ11|KCNJ8|PTGS1	broad_id_20170327	Launched		
BRD-K07106112-003-03-8	BRD-K07106112	BMS-599626	LUJZZYWHBDHDQX	EGFR inhibitor|protein tyrosine kinase inhibitor	EGFR|ERBB2|ERBB4	broad_id_20170327	Phase 1		
BRD-K07160047-001-01-3	BRD-K07160047	fiacitabine	GIMSJJHKKXRFGV	DNA synthesis inhibitor		broad_id_20170327	Phase 2		
BRD-K07208025-001-29-7	BRD-K07208025	trimethoprim	IEDVJHCEMCRBQM	dihydrofolate reductase inhibitor	DHFR|TYMS	broad_id_20170327	Launched		
BRD-K07220430-001-18-4	BRD-K07220430	cinnarazine	DERZBLKQOCDDDZ	calcium channel blocker		broad_id_20170327	Launched		
BRD-K07237224-001-19-6	BRD-K07237224	moclobemide	YHXISWVBGDMDLQ	monoamine oxidase inhibitor	MAOA|MAOB	broad_id_20170327	Launched		
BRD-K07310275-001-02-5	BRD-K07310275	PF-04691502	XDLYKKIQACFMJG	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA	broad_id_20170327	Phase 2		
BRD-K07572174-001-17-0	BRD-K07572174	curcumin	ZIUSSTSXXLLKKK	cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor	APP|CA1|CA12|CA14|CA2|CA4|CA6|CA9|CHRM3|CYP3A4|DNMT3B|EP300|MMP13|MMP9|NOS2|PTGS1|PTGS2|XDH	broad_id_20200324	Launched		
BRD-K07609981-001-01-7	BRD-K07609981	dexloxiglumide	QNQZBKQEIFTHFZ	CCK receptor antagonist	CCKAR	broad_id_20170327	Phase 3		
BRD-K07691486-001-15-5	BRD-K07691486	roscovitine	BTIHMVBBUGXLCJ	CDK inhibitor	CDK2|CDK9	broad_id_20170327	Phase 2		
BRD-K07753030-003-17-6	BRD-K07753030	acecainide	KEECCEWTUVWFCV	polarization inhibitor	SCN5A	broad_id_20170327	Phase 3		
BRD-K07798980-001-01-9	BRD-K07798980	PSI-6130	NYPIRLYMDJMKGW	RNA polymerase inhibitor		broad_id_20170327	Phase 1		
BRD-K07857022-002-01-1	BRD-K07857022	alvimopan	UPNUIXSCZBYVBB	opioid receptor antagonist	OPRD1|OPRK1|OPRM1	broad_id_20170327	Launched		
BRD-K07881437-001-03-8	BRD-K07881437	danusertib	XKFTZKGMDDZMJI	Aurora kinase inhibitor|growth factor receptor inhibitor	AURKA|AURKB|AURKC|FGFR1|NTRK1|RET|SLK	broad_id_20170327	Phase 2		
BRD-K07954936-001-01-3	BRD-K07954936	2-iminobiotin	WWVANQJRLPIHNS	nitric oxide synthase inhibitor	NOS1|NOS2	broad_id_20170327	Phase 2		
BRD-K08037784-001-12-6	BRD-K08037784	arbutin	BJRNKVDFDLYUGJ	melanin inhibitor	TYR	broad_id_20170327	Phase 2/Phase 3		
BRD-K08109215-001-06-4	BRD-K08109215	I-BET-762	AAAQFGUYHFJNHI	bromodomain inhibitor	BRD2|BRD3|BRD4	broad_id_20170327	Phase 2		
BRD-K08206212-002-01-0	BRD-K08206212	entecavir	QDGZDCVAUDNJFG	DNA replication inhibitor|nucleoside reverse transcriptase inhibitor		broad_id_20170327	Launched		
BRD-K08248804-001-01-8	BRD-K08248804	LCL-161	UFPFGVNKHCLJJO	XIAP inhibitor	BIRC2|XIAP	broad_id_20170327	Phase 2		
BRD-K08252256-236-33-8	BRD-K08252256	diclofenac	DCOPUUMXTXDBNB	cyclooxygenase inhibitor	AKR1C3|ALOX5|ASIC1|ASIC3|KCNQ2|KCNQ3|PLA2G2A|PPARG|PTGS1|PTGS2|SCN4A	broad_id_20170327	Launched		
BRD-K08547377-394-03-5	BRD-K08547377	irinotecan	UWKQSNNFCGGAFS	topoisomerase inhibitor	TOP1|TOP1MT	broad_id_20170327	Launched		
BRD-K08586861-001-01-1	BRD-K08586861	ramatroban	LDXDSHIEDAPSSA	prostanoid receptor antagonist	PTGDR2|TBXA2R	broad_id_20170327	Launched		
BRD-K08703257-001-12-1	BRD-K08703257	3-amino-benzamide	GSCPDZHWVNUUFI	PARP inhibitor	PARP1	broad_id_20170327	Phase 2		
BRD-K08799216-001-05-3	BRD-K08799216	pelitinib	WVUNYSQLFKLYNI	EGFR inhibitor	EGFR	broad_id_20170327	Phase 2		
BRD-K08832567-001-11-5	BRD-K08832567	naringenin	FTVWIRXFELQLPI	aromatase inhibitor|TRPV antagonist	CYP19A1|CYP1B1|ESR2|GLO1|HSD17B1	broad_id_20170327	Phase 1		
BRD-K08859203-001-01-9	BRD-K08859203	DU-728	NNRFRJQMBSBXGO	structural glycoprotein antagonist	ITGA2B|ITGB3	broad_id_20170327	Phase 1		
BRD-K08924299-003-06-1	BRD-K08924299	palonosetron	CPZBLNMUGSZIPR	serotonin receptor antagonist	HTR3A	broad_id_20170327	Launched		
BRD-K08976401-001-18-5	BRD-K08976401	azelaic-acid	BDJRBEYXGGNYIS	tyrosinase inhibitor	AKR1D1|SRD5A2|TYR	broad_id_20170327	Launched		
BRD-K09078998-001-01-4	BRD-K09078998	deforolimus	BUROJSBIWGDYCN	mTOR inhibitor	MTOR	broad_id_20170327	Phase 3		
BRD-K09090949-001-01-9	BRD-K09090949	CP-945,598	UNAZAADNBYXMIV	cannabinoid receptor antagonist	CNR1	broad_id_20170327	Phase 3		
BRD-K09132007-001-07-5	BRD-K09132007	D-4476	DPDZHVCKYBCJHW	TGF beta receptor inhibitor	CSNK1A1|CSNK1D|TGFB1	broad_id_20170327	Preclinical		
BRD-K09255212-001-16-6	BRD-K09255212	clioquinol	QCDFBFJGMNKBDO	chelating agent	OPRK1	broad_id_20170327	Withdrawn		
BRD-K09372874-001-01-0	BRD-K09372874	merimepodib	JBPUGFODGPKTDW	inosine monophosphate dehydrogenase inhibitor	IMPDH1	broad_id_20170327	Phase 2		
BRD-K09397065-003-06-1	BRD-K09397065	SR-57227A	WPVVMKYQOMJPIN	serotonin receptor agonist	HTR3A	broad_id_20170327	Phase 2		
BRD-K09426783-300-01-0	BRD-K09426783	TAS-103	ROWSTIYZUWEOMM	topoisomerase inhibitor	TOP1	broad_id_20170327	Phase 1		
BRD-K09471561-001-18-2	BRD-K09471561	levofloxacin	GSDSWSVVBLHKDQ	bacterial DNA gyrase inhibitor	TOP2A	broad_id_20170327	Launched	bacterial DNA gyrase inhibitor	nan
BRD-K09549677-300-03-4	BRD-K09549677	mibefradil	HBNPJJILLOYFJU	T-type calcium channel blocker	ANO1|CACNA1C|CACNA1D|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNB1|CACNB2|CACNB3|CACNB4|CATSPER1|CATSPER2|CATSPER3|CATSPER4	broad_id_20170327	Withdrawn		
BRD-K09602097-001-13-6	BRD-K09602097	colforsin	OHCQJHSOBUTRHG	adenylyl cyclase activator	ADCY2|ADCY5	broad_id_20170327	Phase 2	adenylyl cyclase activator	ADCY2|ADCY5|GNAS
BRD-K09711437-001-04-3	BRD-K09711437	varespladib	BHLXTPHDSZUFHR	secretory phospholipase inhibitor	PLA2G2A	broad_id_20170327	Phase 3		
BRD-K09951645-001-06-8	BRD-K09951645	dabrafenib	BFSMGDJOXZAERB	RAF inhibitor	BRAF|LIMK1|NEK11|RAF1|SIK1	broad_id_20170327	Launched		
BRD-K10670311-001-15-5	BRD-K10670311	sulfasalazine	NCEXYHBECQHGNR	cyclooxygenase inhibitor	ACAT1|ALOX5|CHUK|IKBKB|PLA2G1B|PPARG|PTGS1|PTGS2|SLC46A1|SLC7A11|TBXAS1	broad_id_20170327	Launched		
BRD-K10843433-001-22-7	BRD-K10843433	phenylbutazone	VYMDGNCVAMGZFE	cyclooxygenase inhibitor|prostanoid receptor antagonist	PTGIS|PTGS1|PTGS2	broad_id_20170327	Withdrawn		
BRD-K10845183-304-01-6	BRD-K10845183	tiludronate	DKJJVAGXPKPDRL	bone resorption inhibitor|osteoclast inhibitor	ATP6V1A|MMP2|PTPN1	broad_id_20170327	Launched		
BRD-K10852020-001-04-5	BRD-K10852020	tolcapone	MIQPIUSUKVNLNT	catechol O methyltransferase inhibitor	COMT	broad_id_20170327	Withdrawn		
BRD-K10859802-001-01-0	BRD-K10859802	APD668	XTRUQJBVQBUKSQ	glucose dependent insulinotropic receptor agonist	GPR119	broad_id_20170327	Phase 1		
BRD-K10961822-001-05-1	BRD-K10961822	latanoprost	GGXICVAJURFBLW	prostanoid receptor agonist	PTGFR	broad_id_20170327	Launched		
BRD-K11071038-001-01-7	BRD-K11071038	ICI-162846	ALCSGJCIESECFD	histamine receptor antagonist	HRH2	broad_id_20170327	Phase 1		
BRD-K11073688-001-01-6	BRD-K11073688	CPI-1189	DJKNRCWSXSZACF	tumor necrosis factor release inhibitor	TNF	broad_id_20170327	Phase 2		
BRD-K11129031-001-27-5	BRD-K11129031	gemfibrozil	HEMJJKBWTPKOJG	lipoprotein lipase activator	LPL|PPARA|SLCO1B1|SLCO1B3|SLCO2B1	broad_id_20170327	Launched		
BRD-K11153516-001-05-5	BRD-K11153516	iniparib	MDOJTZQKHMAPBK	PARP inhibitor	PARP1	broad_id_20170327	Phase 3		
BRD-K11196887-001-21-2	BRD-K11196887	norfloxacin	OGJPXUAPXNRGGI	bacterial DNA gyrase inhibitor	TOP2A	broad_id_20170327	Launched		
BRD-K11267252-001-04-4	BRD-K11267252	alectinib	KDGFLJKFZUIJMX	ALK tyrosine kinase receptor inhibitor	ALK|MET	broad_id_20170327	Launched		
BRD-K11399644-003-11-3	BRD-K11399644	phenformin	ICFJFFQQTFMIBG	AMPK activator	KCNJ8|PRKAA1	broad_id_20170327	Withdrawn		
BRD-K11433652-001-17-0	BRD-K11433652	aspirin	BSYNRYMUTXBXSQ	cyclooxygenase inhibitor	AKR1C1|ASIC3|EDNRA|HSPA5|IKBKB|NFKB1|NFKB2|NFKBIA|PRKAA1|PRKAA2|PRKAB1|PRKAB2|PRKAG1|PRKAG2|PRKAG3|PTGS1|PTGS2|RPS6KA3|TP53	broad_id_20170327	Launched		
BRD-K11717138-001-30-3	BRD-K11717138	benzbromarone	WHQCHUCQKNIQEC	chloride channel blocker	ABCC1	broad_id_20170327	Launched		
BRD-K11973162-003-01-8	BRD-K11973162	tipiracil	QQHMKNYGKVVGCZ	thymidine phosphorylase inhibitor		broad_id_20170327	Launched		
BRD-K12184916-001-15-4	BRD-K12184916	NVP-BEZ235	JOGKUKXHTYWRGZ	mTOR inhibitor|PI3K inhibitor	ATR|MTOR|PIK3CA|PIK3CD|PIK3CG	broad_id_20170327	Phase 3		
BRD-K12219985-001-26-1	BRD-K12219985	glipizide	ZJJXGWJIGJFDTL	sulfonylurea	ABCC8|KCNJ10|KCNJ11|PPARG	broad_id_20170327	Launched		
BRD-K12423485-001-01-7	BRD-K12423485	griseofulvin	DDUHZTYCFQRHIY	tubulin polymerization inhibitor	KRT12	broad_id_20170327	Launched		
BRD-K12539416-001-01-4	BRD-K12539416	sulbutiamine	CKHJPWQVLKHBIH	acetylcholine receptor antagonist		broad_id_20170327	Launched		
BRD-K12609457-001-03-1	BRD-K12609457	exalamide	CKSJXOVLXUMMFF	membrane permeability inhibitor		broad_id_20170327	Launched		
BRD-K12735121-001-01-4	BRD-K12735121	TG-100801	JMGXJHWTVBGOKG	SRC inhibitor|VEGFR inhibitor	CSK|FGFR1|FLT1|FLT4|KDR|SRC	broad_id_20170327	Phase 2		
BRD-K12737986-001-01-4	BRD-K12737986	veliparib	JNAHVYVRKWKWKQ	PARP inhibitor	PARP1|PARP2	broad_id_20170327	Phase 3		
BRD-K12787259-001-04-3	BRD-K12787259	CX-5461	XGPBJCHFROADCK	RNA polymerase inhibitor		broad_id_20170327	Phase 1		
BRD-K12867552-001-04-7	BRD-K12867552	PCI-24781	MAUCONCHVWBMHK	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC6	broad_id_20170327	Phase 3		
BRD-K12885236-001-02-7	BRD-K12885236	dapivirine	ILAYIAGXTHKHNT	non-nucleoside reverse transcriptase inhibitor	CYP3A4|CYP3A5	broad_id_20170327	Phase 3		
BRD-K12932420-001-02-3	BRD-K12932420	YM-976	MNHXYNNKDDXKNP	phosphodiesterase inhibitor	PDE4A	broad_id_20170327	Phase 1		
BRD-K12994359-001-18-4	BRD-K12994359	valdecoxib	LNPDTQAFDNKSHK	cyclooxygenase inhibitor	CA12|PTGS2	broad_id_20170327	Withdrawn		
BRD-K13050541-001-01-9	BRD-K13050541	acivicin	QAWIHIJWNYOLBE	gamma glutamyltransferase inhibitor	CTPS1	broad_id_20170327	Phase 2		
BRD-K13154216-001-01-3	BRD-K13154216	everolimus	HKVAMNSJSFKALM	mTOR inhibitor	MTOR	broad_id_20170327	Launched		
BRD-K13183738-317-10-2	BRD-K13183738	pentamidine	XDRYMKDFEDOLFX	anti-pneumocystis agent	TRDMT1	broad_id_20170327	Launched		
BRD-K13296708-001-05-8	BRD-K13296708	rimonabant	JZCPYUJPEARBJL	cannabinoid receptor antagonist	CNR1|GPR55	broad_id_20170327	Withdrawn		
BRD-K13356952-001-25-1	BRD-K13356952	methazolamide	FLOSMHQXBMRNHR	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA7	broad_id_20170327	Launched		
BRD-K13390322-001-06-3	BRD-K13390322	AT-7519	OVPNQJVDAFNBDN	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK6|CDK9	broad_id_20170327	Phase 2		
BRD-K13646352-001-03-8	BRD-K13646352	midostaurin	BMGQWWVMWDBQGC	FLT3 inhibitor|KIT inhibitor|PKC inhibitor	FLT3|PRKCG	broad_id_20170327	Launched		
BRD-K13662825-001-07-5	BRD-K13662825	dinaciclib	PIMQWRZWLQKKBJ	CDK inhibitor	CDK1|CDK2|CDK5|CDK9	broad_id_20170327	Phase 3		
BRD-K13756951-001-01-4	BRD-K13756951	bitopertin	YUUGYIUSCYNSQR	glycine transporter inhibitor	SLC6A5|SLC6A9	broad_id_20170327	Phase 3		
BRD-K13819402-003-10-2	BRD-K13819402	desoxypeganine	WUFQLZTXIWKION	acetylcholinesterase inhibitor|monoamine oxidase inhibitor	ACHE	broad_id_20170327	Phase 1		
BRD-K13926615-003-03-3	BRD-K13926615	vardenafil	SECKRCOLJRRGGV	phosphodiesterase inhibitor	PDE5A|PDE6G|PDE6H	broad_id_20170327	Launched		
BRD-K14175878-001-01-6	BRD-K14175878	MK-0812	MTMDXAIUENDNDL	CC chemokine receptor antagonist	CCR2	broad_id_20170327	Phase 2		
BRD-K14529030-001-01-9	BRD-K14529030	meisoindigo	QNOCRUSVMMAKSC	STAT inhibitor	STAT3	broad_id_20170327	Phase 3		
BRD-K14619660-001-01-5	BRD-K14619660	altrenogest	VWAUPFMBXBWEQY	progestogen hormone	PGR	broad_id_20170327	Launched		
BRD-K14653796-001-01-1	BRD-K14653796	tasquinimod	ONDYALNGTUAJDX	angiogenesis inhibitor|S100A9 inhibitor	HDAC4	broad_id_20170327	Phase 3		
BRD-K14704277-001-22-6	BRD-K14704277	cinoxacin	VDUWPHTZYNWKRN	topoisomerase inhibitor		broad_id_20170327	Launched		
BRD-K14796088-003-26-8	BRD-K14796088	berberine	YBHILYKTIRIUTE	LDL receptor activator	LDLR	broad_id_20170327	Launched		
BRD-K14870255-001-02-3	BRD-K14870255	R-428	KXMZDGSRSGHMMK	AXL kinase inhibitor	AXL	broad_id_20170327	Phase 2		
BRD-K14993104-001-05-9	BRD-K14993104	bemegride	ORRZGUBHBVWWOP	chemoreceptor agonist	GABRA1	broad_id_20170327	Launched		
BRD-K15010214-364-02-7	BRD-K15010214	emedastine	KBUZBQVCBVDWKX	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K15108141-001-06-6	BRD-K15108141	gemcitabine	SDUQYLNIPVEERB	ribonucleotide reductase inhibitor	CMPK1|RRM1|RRM2|TYMS	broad_id_20170327	Launched		
BRD-K15170068-001-03-2	BRD-K15170068	swainsonine	FXUAIOOAOAVCGD	alpha mannosidase inhibitor	MAN2A1	broad_id_20170327	Phase 2		
BRD-K15179879-001-03-2	BRD-K15179879	carfilzomib	BLMPQMFVWMYDKT	proteasome inhibitor	PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9	broad_id_20170327	Launched		
BRD-K15318383-201-01-5	BRD-K15318383	ammonium-glycyrrhizinate	LPLVUJXQOOQHMX	thrombin inhibitor	HSD11B1|HSD11B2|SLCO1B1|SLCO1B3	broad_id_20170327	Launched		
BRD-K15409150-001-05-8	BRD-K15409150	penfluridol	MDLAAYDRRZXJIF	T-type calcium channel blocker	CACNA1G	broad_id_20170327	Launched		
BRD-K15426076-001-01-2	BRD-K15426076	iguratimod	ANMATWQYLIFGOK	cyclooxygenase inhibitor|NFkB pathway inhibitor	PTGS2	broad_id_20170327	Launched		
BRD-K15502390-001-20-9	BRD-K15502390	nevirapine	NQDJXKOVJZTUJA	non-nucleoside reverse transcriptase inhibitor	CYP1A2|CYP2A6|CYP2B6|CYP2C9|CYP2D6|CYP3A4|CYP3A5	broad_id_20170327	Launched		
BRD-K15507868-001-03-7	BRD-K15507868	tesaglitazar	CXGTZJYQWSUFET	insulin sensitizer|PPAR receptor agonist	PPARA|PPARG	broad_id_20170327	Phase 3		
BRD-K15567136-003-27-2	BRD-K15567136	papaverine	XQYZDYMELSJDRZ	phosphodiesterase inhibitor	PDE10A|PDE4B|PDE5A	broad_id_20170327	Launched		
BRD-K15766189-001-09-8	BRD-K15766189	cefdinir	RTXOFQZKPXMALH	bacterial cell wall synthesis inhibitor	MPO	broad_id_20170327	Launched		
BRD-K15916496-001-27-9	BRD-K15916496	clotrimazole	VNFPBHJOKIVQEB	cytochrome P450 inhibitor|imidazoline receptor ligand	CYP3A4|KCNN4|NR1I2|NR1I3|TRPM2|TRPM4|TRPM8	broad_id_20170327	Launched		
BRD-K15933101-003-06-1	BRD-K15933101	ropinirole	UHSKFQJFRQCDBE	dopamine receptor agonist	ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C	broad_id_20170327	Launched		
BRD-K15976406-001-03-3	BRD-K15976406	telbivudine	IQFYYKKMVGJFEH	DNA polymerase inhibitor		broad_id_20170327	Launched		
BRD-K16037980-001-01-1	BRD-K16037980	Z160	VCPMZDWBEWTGNW	N-type calcium channel blocker	CACNA2D1	broad_id_20170327	Phase 2		
BRD-K16077845-001-06-1	BRD-K16077845	fentiazac	JIEKMACRVQTPRC	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K16133773-001-01-9	BRD-K16133773	abiraterone-acetate	UVIQSJCZCSLXRZ	androgen biosynthesis inhibitor	CYP17A1	broad_id_20170327	Launched		
BRD-K16195444-003-26-0	BRD-K16195444	oxymetazoline	WYWIFABBXFUGLM	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR2C	broad_id_20170327	Launched		
BRD-K16295392-003-01-3	BRD-K16295392	atrasentan	MOTJMGVDPWRKOC	endothelin receptor antagonist	EDNRA	broad_id_20170327	Phase 3		
BRD-K16444452-001-09-1	BRD-K16444452	ibudilast	ZJVFLBOZORBYFE	leukotriene receptor antagonist|phosphodiesterase inhibitor	IL1B|IL6|PDE3A|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A	broad_id_20170327	Launched		
BRD-K16508793-001-05-9	BRD-K16508793		AAOVKJBEBIDNHE			broad_id_20170327			
BRD-K16542329-001-13-5	BRD-K16542329	zaprinast	REZGGXNDEMKIQB	phosphodiesterase inhibitor	GPR35|PDE1A|PDE4D|PDE5A|PDE9A	broad_id_20170327	Phase 2		
BRD-K16730910-001-07-3	BRD-K16730910	regorafenib	FNHKPVJBJVTLMP	FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	ABL1|BRAF|DDR2|EPHA2|FGFR1|FGFR2|FLT1|FLT4|FRK|KDR|KIT|MAPK11|NTRK1|PDGFRA|PDGFRB|RAF1|RET|TEK	broad_id_20170327	Launched		
BRD-K16732600-001-01-7	BRD-K16732600	MK-0893	DNTVJEMGHBIUMW	glucagon receptor antagonist	GCGR	broad_id_20170327	Phase 2		
BRD-K16757695-050-02-5	BRD-K16757695	PRX-08066	IENZFHBNCRQMNP	serotonin receptor antagonist	HTR2B	broad_id_20170327	Phase 2		
BRD-K16761703-001-03-8	BRD-K16761703	sotrastaurin	OAVGBZOFDPFGPJ	PKC inhibitor	PRKCA|PRKCB|PRKCD|PRKCE|PRKCH|PRKCQ	broad_id_20170327	Phase 2		
BRD-K16762525-001-01-6	BRD-K16762525	clarithromycin	AGOYDEPGAOXOCK	bacterial 50S ribosomal subunit inhibitor	CYP3A4	broad_id_20170327	Launched		
BRD-K16803204-001-01-6	BRD-K16803204	filgotinib	RIJLVEAXPNLDTC	JAK inhibitor	JAK1|JAK2|JAK3|TYK2	broad_id_20170327	Phase 3		
BRD-K16898998-001-01-6	BRD-K16898998	bevirimat-dimeglumine	YJEJKUQEXFSVCJ	HIV capsid assembly inhibitor		broad_id_20170327	Phase 2		
BRD-K17026858-001-01-2	BRD-K17026858	pibenzimol	INAAIJLSXJJHOZ	DNA inhibitor		broad_id_20170327	Phase 2		
BRD-K17068645-003-04-2	BRD-K17068645	bendamustine	YTKUWDBFDASYHO	DNA inhibitor		broad_id_20170327	Launched		
BRD-K17075857-001-17-6	BRD-K17075857	chloroxine	WDFKMLRRRCGAKS	opioid receptor antagonist	OPRK1	broad_id_20170327	Launched		
BRD-K17203476-001-01-9	BRD-K17203476	LY2874455	GKJCVYLDJWTWQU	FGFR antagonist	FGFR1|FGFR2|FGFR3|FGFR4|KDR	broad_id_20170327	Phase 1		
BRD-K17498618-344-02-6	BRD-K17498618	atracurium	YXSLJKQTIDHPOT	acetylcholine receptor antagonist		broad_id_20170327	Launched	acetylcholine receptor antagonist	CHRNA2
BRD-K17500877-001-02-1	BRD-K17500877	bropirimine	CIUUIPMOFZIWIZ	interferon inducer		broad_id_20170327	Phase 3		
BRD-K17513304-001-01-9	BRD-K17513304	firategrast	YLFZHHDVRSYTKT	integrin antagonist	ITGA4	broad_id_20170327	Phase 2		
BRD-K17555800-003-01-5	BRD-K17555800	talmapimod	ZMELOYOKMZBMRB	p38 MAPK inhibitor	IL1B|MAPK11|MAPK14|MT-CO2|TNF	broad_id_20170327	Phase 2		
BRD-K17561142-003-32-5	BRD-K17561142	amiodarone	IYIKLHRQXLHMJQ	potassium channel blocker	ADRB1|CACNA1H|CACNA2D2|KCNA7|KCNH2	broad_id_20170327	Launched		
BRD-K17705806-003-04-4	BRD-K17705806	JTC-801	VTGBZWHPJFMTKS	opioid receptor antagonist	OPRL1	broad_id_20170327	Phase 2		
BRD-K17743125-001-08-4	BRD-K17743125	belinostat	NCNRHFGMJRPRSK	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9	broad_id_20170327	Launched		
BRD-K17849083-001-31-1	BRD-K17849083	tranilast	NZHGWWWHIYHZNX	angiogenesis inhibitor	HPGDS|HRH1	broad_id_20170327	Launched		
BRD-K17894950-001-14-3	BRD-K17894950	indirubin	CRDNMYFJWFXOCH	CDK inhibitor|glycogen synthase kinase inhibitor	CDK1|CDK5|GSK3A	broad_id_20170327	Phase 2/Phase 3		
BRD-K17930269-001-01-8	BRD-K17930269	retapamulin	STZYTFJPGGDRJD	protein synthesis inhibitor		broad_id_20170327	Launched		
BRD-K17944737-001-02-1	BRD-K17944737	artesunate	FIHJKUPKCHIPAT	DNA synthesis inhibitor		broad_id_20170327	Launched		
BRD-K17953908-001-01-7	BRD-K17953908	LY2886721	NIDRNVHMMDAAIK	beta-secretase inhibitor	BACE1	broad_id_20170327	Phase 1/Phase 2		
BRD-K18157228-001-01-7	BRD-K18157228	fdcyd	IDYKCXHJJGMAEV	DNA methyltransferase inhibitor		broad_id_20170327	Phase 2		
BRD-K18194590-065-08-0	BRD-K18194590	mephentermine	RXQCGGRTAILOIN	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3	broad_id_20170327	Launched		
BRD-K18324993-001-01-6	BRD-K18324993	budipine	QIHLUZAFSSMXHQ	glutamate receptor antagonist	GRIN1	broad_id_20170327	Launched		
BRD-K18673820-001-15-5	BRD-K18673820	folic-acid	OVBPIULPVIDEAO	folate receptor ligand	FOLR2|FOLR3|SLC19A1|SLC46A1	broad_id_20170327	Launched		
BRD-K18678457-003-02-8	BRD-K18678457	ZD-7288	JABSKGQQWUDVRU	HCN channel blocker	HCN1|HCN2|HCN3|HCN4	broad_id_20170327	Phase 2		
BRD-K18779551-003-07-8	BRD-K18779551	bifemelane	QSQQPMHPCBLLGX	acetylcholine release enhancer	MAOA|MAOB	broad_id_20170327	Launched		
BRD-K18850819-001-04-6	BRD-K18850819	MK-0752	XCGJIFAKUZNNOR	gamma secretase inhibitor		broad_id_20170327	Phase 1/Phase 2		
BRD-K18895904-001-16-1	BRD-K18895904	olanzapine	KVWDHTXUZHCGIO	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K18922609-004-23-1	BRD-K18922609	neostigmine	ALWKGYPQUAPLQC	acetylcholinesterase inhibitor	ACHE	broad_id_20170327	Launched		
BRD-K18961567-001-01-1	BRD-K18961567	LY2801653	QHADVLVFMKEIIP	MET inhibitor	MET	broad_id_20170327	Phase 2		
BRD-K19061412-001-02-4	BRD-K19061412	mubritinib	ZTFBIUXIQYRUNT	protein tyrosine kinase inhibitor	EGFR|ERBB2	broad_id_20170327	Phase 1		
BRD-K19085898-001-01-8	BRD-K19085898	darapladib	WDPFJWLDPVQCAJ	phospholipase inhibitor	PLA2G7	broad_id_20170327	Phase 3		
BRD-K19111024-001-20-9	BRD-K19111024	clofibric-acid	TXCGAZHTZHNUAI	PPAR receptor agonist	PPARA	broad_id_20170327	Launched		
BRD-K19284129-001-02-6	BRD-K19284129	salvinorin-A	OBSYBRPAKCASQB	opioid receptor agonist	OPRD1|OPRK1|OPRM1	broad_id_20170327	Phase 1		
BRD-K19352500-070-12-4	BRD-K19352500	prochlorperazine	WIKYUJGCLQQFNW	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4	broad_id_20170327	Launched		
BRD-K19388745-003-01-7	BRD-K19388745	colforsin-daproate	RSOZZQTUMVBTMR	adenylyl cyclase activator		broad_id_20170327	Launched		
BRD-K19412355-001-01-0	BRD-K19412355	SB-242235	PDTYLGXVBIWRIM	p38 MAPK inhibitor	HSPB1|MAPK14	broad_id_20170327	Phase 1		
BRD-K19416115-001-05-3	BRD-K19416115	sitagliptin	MFFMDFFZMYYVKS	dipeptidyl peptidase inhibitor	DPP4	broad_id_20170327	Launched		
BRD-K19438463-001-05-5	BRD-K19438463	CNQX	RPXVIAFEQBNEAX	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4	broad_id_20170327	Phase 1		
BRD-K19456237-001-27-6	BRD-K19456237	piracetam	GMZVRMREEHBGGF	acetylcholine receptor agonist	GRIA1|GRIA2|GRIA3|GRIA4	broad_id_20170327	Launched		
BRD-K19462402-003-24-6	BRD-K19462402	buflomedil	OWYLAEYXIQKAOL	adrenergic receptor antagonist|calcium channel blocker	ADRA1A	broad_id_20170327	Launched		
BRD-K19477839-001-07-6	BRD-K19477839	SGX523	BCZUAADEACICHN	hepatocyte growth factor receptor inhibitor	MET	broad_id_20170327	Phase 1		
BRD-K19540840-001-09-4	BRD-K19540840	saracatinib	OUKYUETWWIPKQR	SRC inhibitor	ABL1|LCK|SRC|YES1	broad_id_20170327	Phase 2/Phase 3		
BRD-K19687926-379-07-4	BRD-K19687926	lapatinib	BCFGMOOMADDAQU	EGFR inhibitor	EGFR|ERBB2	broad_id_20170327	Launched		
BRD-K19741547-003-01-7	BRD-K19741547	vernakalant	VBHQKCBVWWUUKN	potassium channel blocker	KCNA5	broad_id_20170327	Launched		
BRD-K19761926-001-02-8	BRD-K19761926	eplerenone	JUKPWJGBANNWMW	cytochrome P450 inhibitor	NR3C2	broad_id_20170327	Launched		
BRD-K19939891-001-05-4	BRD-K19939891	TIC10	RSAQARAFWMUYLL	AKT inhibitor|TRAIL modulator	AKT1|MAPK1	broad_id_20170327	Phase 2		
BRD-K20001883-001-02-7	BRD-K20001883	apabetalone	NETXMUIMUZJUTB	apolipoprotein expression enhancer	BRD3	broad_id_20170327	Phase 3		
BRD-K20008181-001-01-3	BRD-K20008181	LCQ908	GXALXAKNHIROPE	diacylglycerol O acyltransferase inhibitor	DGAT1	broad_id_20170327	Phase 3		
BRD-K20079257-001-09-6	BRD-K20079257	rufinamide	POGQSBRIGCQNEG	voltage-gated sodium channel blocker	GRM5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K20141153-003-13-7	BRD-K20141153	atomoxetine	VHGCDTVCOLNTBX	norepinephrine transporter inhibitor	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-K20285085-001-07-1	BRD-K20285085	R406	NHHQJBCNYHBUSI	SYK inhibitor	RET|SYK	broad_id_20170327	Phase 1		
BRD-K20722021-001-02-1	BRD-K20722021	CEP-32496	DKNUPRMJNUQNHR	RAF inhibitor	BRAF|RAF1	broad_id_20170327	Phase 1/Phase 2		
BRD-K20738689-001-01-2	BRD-K20738689	dazmegrel	DEQLGSOHGTZKFB	thromboxane synthase inhibitor	TBXAS1	broad_id_20170327	Phase 2		
BRD-K20745393-003-01-0	BRD-K20745393	olprinone	JPAWFIIYTJQOKW	phosphodiesterase inhibitor	PDE3A	broad_id_20170327	Launched		
BRD-K20897876-001-10-0	BRD-K20897876	castanospermine	JDVVGAQPNNXQDW	glucosidase inhibitor	GAA|GBA	broad_id_20170327	Phase 2		
BRD-K20920669-304-09-1	BRD-K20920669	cromoglicic-acid	IMZMKUWMOSJXDT	immunosuppressant	KCNMA1|S100P	broad_id_20170327	Launched		
BRD-K20958582-001-01-4	BRD-K20958582	TH-302	UGJWRPJDTDGERK	DNA alkylating agent		broad_id_20170327	Phase 3		
BRD-K21071223-001-02-8	BRD-K21071223	VP-20629	GOLXRNDWAUTYKT	beta amyloid antagonist	PLA2G2E|SLC36A1	broad_id_20170327	Phase 1		
BRD-K21283037-001-21-5	BRD-K21283037	riluzole	FTALBRSUTCGOEG	glutamate inhibitor	KCNK10|KCNK2|KCNK4|KCNN4|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A|SLC7A11	broad_id_20170327	Launched		
BRD-K21295289-001-01-6	BRD-K21295289	senicapoc	SCTZUZTYRMOMKT	intermediate conductance potassium channel blocker	KCNN4	broad_id_20170327	Phase 3		
BRD-K21361524-001-01-1	BRD-K21361524	selinexor	DEVSOMFAQLZNKR	exportin antagonist	XPO1	broad_id_20170327	Launched		
BRD-K21396683-001-04-8	BRD-K21396683	marimastat	OCSMOTCMPXTDND	matrix metalloprotease inhibitor	MMP1|MMP10|MMP11|MMP12|MMP13|MMP14|MMP15|MMP16|MMP17|MMP19|MMP2|MMP20|MMP21|MMP23A|MMP24|MMP25|MMP26|MMP27|MMP28|MMP3|MMP7|MMP8|MMP9	broad_id_20170327	Phase 3		
BRD-K21450440-001-14-6	BRD-K21450440	benzthiazide	MQMCZGVMQZPYQA	carbonic anhydrase inhibitor	CA2	broad_id_20200324	Launched		
BRD-K21547160-001-01-4	BRD-K21547160		GGCSSNBKKAUURC			broad_id_20170327			
BRD-K21548250-003-19-1	BRD-K21548250	moracizine	FUBVWMNBEHXPSU	sodium channel blocker	SCN5A	broad_id_20170327	Withdrawn		
BRD-K21670884-001-01-9	BRD-K21670884	cariporide	IWXNYAIICFKCTM	sodium/hydrogen exchanger inhibitor	SLC9A1	broad_id_20170327	Phase 3		
BRD-K21680192-300-14-4	BRD-K21680192	mitoxantrone	KKZJGLLVHKMTCM	topoisomerase inhibitor	TOP2A	broad_id_20170327	Launched		
BRD-K21718444-001-06-8	BRD-K21718444	KW-2449	YYLKKYCXAOBSRM	Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor	ABL1|AURKA|AURKB|FLT3	broad_id_20170327	Phase 1		
BRD-K21884483-001-03-7	BRD-K21884483	mizolastine	PVLJETXTTWAYEW	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K21908111-001-01-8	BRD-K21908111	AZD1208	MCUJKPPARUPFJM	Pim kinase inhibitor	PIM1|PIM2|PIM3	broad_id_20170327	Phase 1		
BRD-K22024824-001-03-7	BRD-K22024824	RG4733	OJPLJFIFUQPSJR	gamma secretase inhibitor	PSEN1	broad_id_20170327	Phase 2		
BRD-K22031190-001-23-6	BRD-K22031190	diflunisal	HUPFGZXOMWLGNK	prostanoid receptor antagonist	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K22097830-001-01-9	BRD-K22097830	OCO-1112	ODLDHXPJRGNTPC	cholesterol inhibitor		broad_id_20170327	Phase 2		
BRD-K22134346-001-22-3	BRD-K22134346	simvastatin	RYMZZMVNJRMUDD	HMGCR inhibitor	HMGCR|ITGB2	broad_id_20170327	Launched		
BRD-K22482860-001-21-4	BRD-K22482860	dalfampridine	NUKYPUAOHBNCPY	potassium channel blocker	KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNJ13|KCNJ5|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2	broad_id_20170327	Launched		
BRD-K22662435-001-18-3	BRD-K22662435	ganciclovir	IRSCQMHQWWYFCW	DNA polymerase inhibitor		broad_id_20170327	Launched		
BRD-K22749967-046-02-3	BRD-K22749967	ABT-239	KFHYZKCRXNRKRC	histamine receptor antagonist	HRH1|HRH2|HRH3	broad_id_20170327	Phase 1		
BRD-K22822991-001-02-3	BRD-K22822991	odanacatib	FWIVDMJALNEADT	cathepsin inhibitor	CTSK	broad_id_20170327	Phase 3		
BRD-K22848513-001-01-9	BRD-K22848513	bardoxolone-methyl	WPTTVJLTNAWYAO	nuclear factor erythroid derived|like (NRF2) activator	PPARG|STAT3	broad_id_20170327	Phase 3		
BRD-K22861715-001-17-4	BRD-K22861715	chrysin	RTIXKCRFFJGDFG	breast cancer resistance protein inhibitor	AKR1B1|CDK6|CYP19A1|CYP1B1	broad_id_20170327	Phase 1		
BRD-K22936972-003-23-6	BRD-K22936972	diphenylpyraline	OWQUZNMMYNAXSL	dopamine reuptake inhibitor	HRH1|SLC6A3	broad_id_20170327	Launched		
BRD-K22969690-001-04-2	BRD-K22969690	chloramphenicol	WIIZWVCIJKGZOK	bacterial 50S ribosomal subunit inhibitor	CD55	broad_id_20170327	Launched		
BRD-K23082237-003-01-5	BRD-K23082237	butaclamol	ZZJYIKPMDIWRSN	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A	broad_id_20170327	Phase 2		
BRD-K23190681-001-01-1	BRD-K23190681	AV-412	ZAJXXUDARPGGOC	protein tyrosine kinase inhibitor	EGFR|ERBB2	broad_id_20170327	Phase 1		
BRD-K23204545-001-16-4	BRD-K23204545	busulfan	COVZYZSDYWQREU	DNA inhibitor		broad_id_20170327	Launched		
BRD-K23228615-001-02-8	BRD-K23228615	GDC-0980	YOVVNQKCSKSHKT	mTOR inhibitor|PI3K inhibitor	FGR|MAP3K9|MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|SYK	broad_id_20170327	Phase 2		
BRD-K23248433-001-01-8	BRD-K23248433	camicinal	RZKDEGZIFSJVNA	motilin receptor agonist	MLNR	broad_id_20170327	Phase 2		
BRD-K23363278-001-02-1	BRD-K23363278	CYT-997	MTJHLONVHHPNSI	tubulin polymerization inhibitor	TUBB	broad_id_20170327	Phase 2		
BRD-K23499943-003-01-6	BRD-K23499943	alvespimycin	KUFRQPKVAWMTJO	HSP inhibitor	HSP90AA1	broad_id_20170327	Phase 2		
BRD-K23672206-001-01-4	BRD-K23672206	BCI-540	PSPGQHXMUKWNDI	glutamate receptor agonist		broad_id_20170327	Phase 2		
BRD-K23677682-003-01-2	BRD-K23677682	voreloxin	XZAFZXJXZHRNAQ	topoisomerase inhibitor	TOP2A	broad_id_20170327	Phase 3		
BRD-K23728141-001-01-2	BRD-K23728141	tafamidis-meglumine	TXEIIPDJKFWEEC	transthyretin amyloid inhibitor	TTR	broad_id_20170327	Launched		
BRD-K23875128-001-04-2	BRD-K23875128								
BRD-K23976833-001-01-0	BRD-K23976833	travoprost	MKPLKVHSHYCHOC	prostanoid receptor agonist	PTGFR	broad_id_20170327	Launched		
BRD-K23984367-075-15-2	BRD-K23984367	sorafenib	MLDQJTXFUGDVEO	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	BRAF|DDR2|FGFR1|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RAF1|RET	broad_id_20170327	Launched		
BRD-K24219278-001-01-6	BRD-K24219278	amineptine	ONNOFKFOZAJDHT	dopamine receptor agonist	SLC6A2|SLC6A4	broad_id_20170327	Withdrawn		
BRD-K24576554-001-04-8	BRD-K24576554	AT-9283	LOLPPWBBNUVNQZ	Aurora kinase inhibitor|JAK inhibitor	AURKA|AURKB|JAK2|JAK3|RPS6KA6|STK17A	broad_id_20170327	Phase 2		
BRD-K24616672-003-20-1	BRD-K24616672	procaine	MFDFERRIHVXMIY	HMGCR inhibitor	CHRNA2|GRIN3A|HTR3A|KCNMA1|KCNMB1|KCNMB2|KCNMB3|KCNMB4|KCNN1|KCNN2|KCNN3|KCNN4|MAOA|MAOB|RYR1|RYR2|SCN10A|SLC6A3	broad_id_20170327	Launched		
BRD-K24723746-036-02-5	BRD-K24723746	solifenacin-succinate	FBOUYBDGKBSUES	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-K24771047-001-01-6	BRD-K24771047	ampalex	ANDGGVOPIJEHOF	glutamate receptor agonist	GRIA1|GRIA2|GRIA3|GRIA4	broad_id_20170327	Phase 2		
BRD-K24844714-001-24-5	BRD-K24844714	5-fluorouracil	GHASVSINZRGABV	thymidylate synthase inhibitor	DPYD|TYMS	broad_id_20170327	Launched		
BRD-K24943235-001-01-3	BRD-K24943235	grazoprevir	OBMNJSNZOWALQB	HCV inhibitor		broad_id_20170327	Launched		
BRD-K24968862-001-01-0	BRD-K24968862	SB-683698	DRSJLVGDSNWQBI	integrin antagonist	ITGA4|ITGAV|ITGB1|ITGB7	broad_id_20170327	Phase 1		
BRD-K25114078-003-08-1	BRD-K25114078	aminoguanidine	HAMNKKUPIHEESI	nitric oxide synthase inhibitor	AKR1B1|NOS2|TIMP3	broad_id_20170327	Phase 3		
BRD-K25140590-001-03-0	BRD-K25140590	CX-516	BXBNADAPIHHXJQ	glutamate receptor modulator		broad_id_20170327	Phase 2/Phase 3		
BRD-K25204779-001-01-1	BRD-K25204779	pritelivir	IVZKZONQVYTCKC	helicase primase inhibitor		broad_id_20170327	Phase 2		
BRD-K25361343-001-01-6	BRD-K25361343	batimastat	XFILPEOLDIKJHX	matrix metalloprotease inhibitor	ADAM28|ADAMTS5|MMP12|MMP16|MMP2|MMP8	broad_id_20170327	Phase 3		
BRD-K25394294-001-14-9	BRD-K25394294	oxaprozin	OFPXSFXSNFPTHF	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K25412176-001-01-9	BRD-K25412176	GSK2110183	AFJRDFWMXUECEW	AKT inhibitor	AKT1|AKT2|AKT3	broad_id_20170327	Phase 2		
BRD-K25433859-003-25-4	BRD-K25433859	maprotiline	QSLMDECMDJKHMQ	norepinephrine reputake inhibitor|tricyclic antidepressant	SLC6A2	broad_id_20170327	Launched		
BRD-K25630527-001-03-8	BRD-K25630527	LY2784544	SQSZANZGUXWJEA	JAK inhibitor	JAK2|JAK3	broad_id_20170327	Phase 2		
BRD-K25650355-065-02-0	BRD-K25650355	physostigmine	PIJVFDBKTWXHHD	acetylcholinesterase inhibitor|cholinesterase inhibitor	ACHE|BCHE	broad_id_20170327	Launched		
BRD-K25837718-001-03-8	BRD-K25837718		UKNSBNVKSFTZOJ			broad_id_20170327			
BRD-K25943794-001-02-3	BRD-K25943794	blonanserin	XVGOZDAJGBALKS	dopamine receptor antagonist|serotonin receptor antagonist	DRD2|HTR2A	broad_id_20170327	Launched		
BRD-K26011976-001-01-0	BRD-K26011976	licochalcone-A	KAZSKMJFUPEHHW	topoisomerase inhibitor	PTPN1	broad_id_20170327	Phase 3		
BRD-K26325692-003-01-3	BRD-K26325692	API-001	DGPGXHRHNRYVDH	sigma receptor antagonist	SIGMAR1	broad_id_20170327	Phase 2		
BRD-K26341917-001-01-3	BRD-K26341917	L-ergothioneine	SSISHJJTAXXQAX	free radical scavenger		broad_id_20170327	Phase 3		
BRD-K26603252-003-04-9	BRD-K26603252	PD-153035	LSPANGZZENHZNJ	EGFR inhibitor	EGFR|KDR	broad_id_20170327	Phase 1		
BRD-K26619122-001-02-1	BRD-K26619122	thiocolchicoside	LEQAKWQJCITZNK	GABA receptor antagonist	GABRA1|GABRB2|GABRG2|GLRA1|GLRB	broad_id_20170327	Launched		
BRD-K26657438-001-15-2	BRD-K26657438	imiquimod	DOUYETYNHWVLEO	interferon inducer|toll-like receptor agonist	TLR7|TLR8	broad_id_20170327	Launched		
BRD-K26667523-001-02-5	BRD-K26667523	TAK-733	RCLQNICOARASSR	MEK inhibitor	MAP2K1	broad_id_20170327	Phase 1		
BRD-K26701552-001-01-8	BRD-K26701552	tegobuvir	XBEQSQDCBSKCHJ	HCV inhibitor|protease inhibitor		broad_id_20170327	Phase 3		
BRD-K26712974-001-01-5	BRD-K26712974	VX-765	SJDDOCKBXFJEJB	caspase inhibitor	CASP1	broad_id_20170327	Phase 2		
BRD-K26823213-001-02-9	BRD-K26823213	GW-842166	TWQYWUXBZHPIIV	cannabinoid receptor agonist	CNR2	broad_id_20170327	Phase 2		
BRD-K27182532-001-02-3	BRD-K27182532	metatinib	PDYXPCKITKHFOZ	Bcr-Abl kinase inhibitor	ABL1|BCR	broad_id_20170327	Phase 1		
BRD-K27184429-300-01-3	BRD-K27184429	cetirizine	ZKLPARSLTMPFCP	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K27204852-001-01-9	BRD-K27204852	balicatib	LLCRBOWRJOUJAE	cathepsin inhibitor	CTSK	broad_id_20170327	Phase 2		
BRD-K27938825-001-02-4	BRD-K27938825	ASA-404	XGOYIMQSIKSOBS	angiogenesis inhibitor		broad_id_20170327	Phase 3		
BRD-K27955832-001-02-9	BRD-K27955832	lomeguatrib	JUJPKFNFCWJBCX	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT	broad_id_20170327	Phase 2		
BRD-K28115081-001-02-7	BRD-K28115081	apafant	JGPJQFOROWSRRS	platelet activating factor receptor antagonist	PTAFR	broad_id_20170327	Phase 3		
BRD-K28143534-003-25-9	BRD-K28143534	cyproheptadine	JJCFRYNCJDLXIK	histamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|HRH1|HTR2A|HTR2C|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K28183345-003-11-4	BRD-K28183345	proguanil	SSOLNOMRVKKSON	dihydrofolate reductase inhibitor	DHFR	broad_id_20170327	Launched		
BRD-K28217197-001-01-4	BRD-K28217197	ganaxolone	PGTVWKLGGCQMBR	GABA receptor modulator	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6	broad_id_20170327	Phase 3		
BRD-K28307902-001-21-7	BRD-K28307902	flutamide	MKXKFYHWDHIYRV	androgen receptor antagonist	AHR|AR	broad_id_20170327	Launched		
BRD-K28392481-001-05-1	BRD-K28392481	AZD4547	VRQMAABPASPXMW	FGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|IGF1R|KDR	broad_id_20170327	Phase 2/Phase 3		
BRD-K28428262-001-04-1	BRD-K28428262	brivanib	WCWUXEGQKLTGDX	FGFR inhibitor|VEGFR inhibitor	CYP3A4|FGFR1|FLT1|KCNH2|KDR	broad_id_20170327	Phase 3		
BRD-K28456624-001-01-1	BRD-K28456624	seocalcitol	LVLLALCJVJNGQQ	vitamin D receptor agonist	VDR	broad_id_20170327	Phase 3		
BRD-K28470988-001-02-0	BRD-K28470988	L-690330	JKOCAAWWDVHWKB	inositol monophosphatase inhibitor	IMPA1	broad_id_20170327	Preclinical		
BRD-K28542495-003-13-5	BRD-K28542495	benzydamine	CNBGNNVCVSKAQZ	prostanoid receptor antagonist		broad_id_20170327	Launched		
BRD-K28667793-001-28-1	BRD-K28667793	pyrazinamide	IPEHBUMCGVEMRF	fatty acid synthase inhibitor	FASN	broad_id_20170327	Launched		
BRD-K28731095-001-01-7	BRD-K28731095	calcitriol	GMRQFYUYWCNGIN	vitamin D receptor agonist	VDR	broad_id_20170327	Launched		
BRD-K28761891-001-10-1	BRD-K28761891	ramelteon	YLXDSYKOBKBWJQ	melatonin receptor agonist	MTNR1A|MTNR1B	broad_id_20170327	Launched		
BRD-K28822270-001-01-1	BRD-K28822270	resminostat	FECGNJPYVFEKOD	HDAC inhibitor	HDAC1|HDAC3|HDAC6|HDAC8	broad_id_20170327	Phase 2		
BRD-K28912512-001-23-2	BRD-K28912512	nicotinamide	DFPAKSUCGFBDDF	protein synthesis stimulant	BST1|LDHA|PARP1|SIRT5	broad_id_20170327	Launched		
BRD-K28936863-051-33-0	BRD-K28936863	ketotifen	OVJRNFMIYGGLDL	histamine receptor agonist|leukotriene receptor antagonist|phosphodiesterase inhibitor	HRH1	broad_id_20200324	Launched		
BRD-K28965160-001-01-1	BRD-K28965160	BVD-523	KSERXGMCDHOLSS	MAP kinase inhibitor		broad_id_20170327	Phase 2		
BRD-K28971625-003-01-4	BRD-K28971625	ZD-7114	RVMBDLSFFNKKLG	adrenergic receptor agonist	ADRB3	broad_id_20170327	Phase 1		
BRD-K28984613-001-01-5	BRD-K28984613	dutasteride	JWJOTENAMICLJG	5 alpha reductase inhibitor	SRD5A1|SRD5A2|SRD5A3	broad_id_20170327	Launched		
BRD-K29133151-001-03-2	BRD-K29133151	ICI-185,282	ZWAVGFSZMACJHA	thromboxane receptor antagonist		broad_id_20170327	Phase 1		
BRD-K29322660-001-01-9	BRD-K29322660	edoxaban	HGVDHZBSSITLCT	coagulation factor inhibitor	F10	broad_id_20170327	Launched		
BRD-K29359156-001-30-1	BRD-K29359156	ebselen	DYEFUKCXAQOFHX	cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor	ALB	broad_id_20170327	Phase 2/Phase 3		
BRD-K29458283-001-29-9	BRD-K29458283	chlorambucil	JCKYGMPEJWAADB	DNA inhibitor		broad_id_20170327	Launched		
BRD-K29530284-001-06-2	BRD-K29530284	amlexanox	SGRYPYWGNKJSDL	histamine receptor modulator	FGF1|IL3|PDE4A|PDE4B|PDE4C|PDE4D|S100A12|S100A13	broad_id_20170327	Launched		
BRD-K29582115-066-01-2	BRD-K29582115	ziprasidone	MVWVFYHBGMAFLY	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A4	broad_id_20170327	Launched		
BRD-K29653726-001-13-4	BRD-K29653726	topiramate	KJADKKWYZYXHBB	carbonic anhydrase inhibitor|glutamate receptor antagonist|kainate receptor antagonist	CA1|CA12|CA2|CA4|CA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA1|GRIA2|GRIA3|GRIA4|GRIK1|GRIK2|GRIK3|GRIK4|GRIK5|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K29656036-001-02-5	BRD-K29656036	MK-8245	UJEAABFSXKCSGI	stearoyl-CoA desaturase inhibitor	SCD	broad_id_20170327	Phase 2		
BRD-K29673530-001-05-4	BRD-K29673530	hypericin	BTXNYTINYBABQR	tyrosine kinase inhibitor		broad_id_20170327	Phase 3		
BRD-K29735307-001-02-9	BRD-K29735307	ostarine	JNGVJMBLXIUVRD	androgen receptor modulator	AR	broad_id_20170327	Phase 3		
BRD-K29950728-048-17-4	BRD-K29950728	clomifene	GKIRPKYJQBWNGO	estrogen receptor antagonist	ESR1	broad_id_20170327	Launched		
BRD-K29968218-001-03-2	BRD-K29968218	KX2-391	HUNGUWOZPQBXGX	SRC inhibitor|tubulin polymerization inhibitor	SRC	broad_id_20170327	Phase 3		
BRD-K30020243-051-02-5	BRD-K30020243	aliskiren-hemifumarate	UXOWGYHJODZGMF	renin inhibitor	REN	broad_id_20170327	Launched		
BRD-K30126819-304-02-7	BRD-K30126819	dimesna	BYUKOOOZTSTOOH	tubulin polymerization inhibitor		broad_id_20170327	Phase 3		
BRD-K30331124-001-01-7	BRD-K30331124	ASC-J9	ZMGUKFHHNQMKJI	androgen receptor enhancer	AR	broad_id_20200324	Phase 2		
BRD-K30421593-050-04-9	BRD-K30421593	timolol	BLJRIMJGRPQVNF	adrenergic receptor antagonist	ADRB1|ADRB2	broad_id_20170327	Launched		
BRD-K30466858-001-09-6	BRD-K30466858	ellagic-acid	AFSDNFLWKVMVRB	glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor	CA1|CA12|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9|CSNK2A1|GSK3B|PRKACA|PRKCA|PRKCB|SQLE|SYK	broad_id_20170327	Phase 2		
BRD-K30480208-001-18-5	BRD-K30480208	torasemide	NGBFQHCMQULJNZ	electrolyte reabsorption inhibitor|thromboxane receptor antagonist	SLC12A1	broad_id_20170327	Launched		
BRD-K30550578-001-01-3	BRD-K30550578	PF-04620110	GEVVQZHMFVFGLN	diacylglycerol O acyltransferase inhibitor	DGAT1	broad_id_20170327	Phase 1		
BRD-K30563334-001-02-9	BRD-K30563334		AZFBLLCNOQPJGJ			broad_id_20170327			
BRD-K30685142-001-15-4	BRD-K30685142	levothyroxine	XUIIKFGFIJCVMT	thyroid hormone stimulant	THRA|THRB	broad_id_20170327	Launched		
BRD-K31092604-003-03-5	BRD-K31092604	donitriptan	SOHCKWZVTCTQBG	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR5A|HTR6	broad_id_20170327	Phase 2		
BRD-K31111078-001-04-2	BRD-K31111078	dimethyl-fumarate	LDCRTTXIJACKKU	nuclear factor erythroid derived|like (NRF2) activator	KEAP1	broad_id_20170327	Launched		
BRD-K31135544-001-07-0	BRD-K31135544	IB-MECA	HUJXGQILHAUCCV	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3	broad_id_20170327	Phase 3		
BRD-K31309378-001-01-5	BRD-K31309378	lucitanib	CUDVHEFYRIWYQD	FGFR inhibitor|VEGFR inhibitor	FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET	broad_id_20170327	Phase 2		
BRD-K31339321-001-03-6	BRD-K31339321	lirimilast	YPFLFUJKZDAXRA	phosphodiesterase inhibitor		broad_id_20170327	Phase 2		
BRD-K31342827-001-08-8	BRD-K31342827	GF109203X	QMGUOJYZJKLOLH	PKC inhibitor	PDPK1|PIM1|PRKCI|PRKCZ	broad_id_20170327	Preclinical		
BRD-K31385749-003-01-3	BRD-K31385749	ivabradine	ACRHBAYQBXXRTO	HCN channel blocker|potassium channel blocker|sodium channel blocker	HCN1|HCN3|HCN4	broad_id_20170327	Launched		
BRD-K31447894-236-01-0	BRD-K31447894	pravastatin	TUZYXOIXSAXUGO	HMGCR inhibitor	HMGCR|SLCO1B1	broad_id_20170327	Launched		
BRD-K31476763-001-01-5	BRD-K31476763	AZD9668	QNQZWEGMKJBHEM	elastase inhibitor	ELANE	broad_id_20170327	Phase 2		
BRD-K31495718-001-01-1	BRD-K31495718	AZD7687	YXFNPRHZMOGREC	diacylglycerol O acyltransferase inhibitor	DGAT1	broad_id_20170327	Phase 1		
BRD-K31519811-001-02-2	BRD-K31519811	PF-02545920	AZEXWHKOMMASPA	phosphodiesterase inhibitor	PDE10A	broad_id_20170327	Phase 2		
BRD-K31627533-001-09-5	BRD-K31627533	rimexolone	QTTRZHGPGKRAFB	glucocorticoid receptor agonist	NR3C1|SERPINA6	broad_id_20170327	Launched		
BRD-K31731454-237-02-5	BRD-K31731454	pemirolast	HIANJWSAHKJQTH	mediator release inhibitor	HRH1	broad_id_20170327	Launched		
BRD-K31812033-003-11-0	BRD-K31812033	levobunolol	IXHBTMCLRNMKHZ	adrenergic receptor antagonist	ADRB1|ADRB2|ADRB3	broad_id_20170327	Launched	adrenergic receptor antagonist	nan
BRD-K31841515-001-07-8	BRD-K31841515	oxypurinol	HXNFUBHNUDHIGC	xanthine oxidase inhibitor	XDH	broad_id_20170327	Phase 2/Phase 3		
BRD-K31928526-001-02-1	BRD-K31928526	barasertib	GBJVVSCPOBPEIT	Aurora kinase inhibitor	AURKA|AURKB	broad_id_20170327	Phase 2/Phase 3		
BRD-K32101625-001-01-6	BRD-K32101625	LX1031	XNMUICFMGGQSMZ	tryptophan hydroxylase inhibitor	TPH1	broad_id_20170327	Phase 2		
BRD-K32107296-001-16-9	BRD-K32107296	temozolomide	BPEGJWRSRHCHSN	DNA alkylating agent	MGMT	broad_id_20170327	Launched		
BRD-K32164935-001-30-8	BRD-K32164935	tolazamide	OUDSBRTVNLOZBN	ATP channel blocker	ABCC8|KCNJ1|KCNJ10|KCNJ11	broad_id_20170327	Launched		
BRD-K32218650-001-01-6	BRD-K32218650	MBX-2982	NFTMKHWBOINJGM	glucose dependent insulinotropic receptor agonist	GPR119	broad_id_20170327	Phase 2		
BRD-K32247306-001-29-4	BRD-K32247306	primidone	DQMZLTXERSFNPB	GABA receptor antagonist	CHRNA4|CHRNA7|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIA2|GRIK2|SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K32285926-001-02-1	BRD-K32285926	AMG-208	HEAIZQNMNCHNFD	tyrosine kinase inhibitor	MET	broad_id_20170327	Phase 1		
BRD-K32318651-001-23-7	BRD-K32318651	acyclovir	MKUXAQIIEYXACX	DNA polymerase inhibitor	PNP	broad_id_20170327	Launched		
BRD-K32405725-001-02-8	BRD-K32405725	etomoxir	DZLOHEOHWICNIL	carnitine palmitoyltransferase inhibitor	CPT1A	broad_id_20170327	Phase 2		
BRD-K32501161-300-06-2	BRD-K32501161	vanoxerine	NAUWTFJOPJWYOT	dopamine reuptake inhibitor	SLC6A3	broad_id_20170327	Phase 3		
BRD-K32744045-001-31-2	BRD-K32744045	disulfiram	AUZONCFQVSMFAP	aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist	ALDH2|DBH	broad_id_20170327	Launched		
BRD-K32821942-001-21-3	BRD-K32821942	azathioprine	LMEKQMALGUDUQG	dehydrogenase inhibitor	HPRT1|IMPDH1|PPAT	broad_id_20170327	Launched		
BRD-K32977963-001-05-0	BRD-K32977963	eugenol	RRAFCDWBNXTKKO	androgen receptor antagonist	AR	broad_id_20170327	Launched		
BRD-K33106058-001-16-8	BRD-K33106058	cytarabine	UHDGCWIWMRVCDJ	ribonucleotide reductase inhibitor	POLA1|POLB|POLD1|POLE	broad_id_20170327	Launched		
BRD-K33127281-001-05-6	BRD-K33127281	adapalene	LZCDAPDGXCYOEH	retinoid receptor agonist	RARA|RARB|RARG|RXRA|RXRB|RXRG	broad_id_20170327	Launched		
BRD-K33141550-003-05-7	BRD-K33141550	L-NAME	KCWZGJVSDFYRIX	nitric oxide synthase inhibitor	NOS3	broad_id_20170327	Phase 2/Phase 3		
BRD-K33211335-004-01-7	BRD-K33211335	dextromethorphan	MKXZASYAUGDDCJ	glutamate receptor antagonist|sigma receptor agonist	CHRNA2|CHRNA3|CHRNA4|CHRNA7|CHRNB2|CHRNB4|CYBA|CYBB|GRIN3A|NCF1|NCF2|NCF4|OPRD1|OPRK1|OPRM1|PGRMC1|RAC1|RAC2|SIGMAR1|SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-K33226500-001-01-0	BRD-K33226500	indinavir	CBVCZFGXHXORBI	HIV protease inhibitor	CYP3A4|CYP3A5|CYP3A7	broad_id_20170327	Launched		
BRD-K33251802-001-01-3	BRD-K33251802	miglustat	UQRORFVVSGFNRO	glycosyl transferase inhibitor	UGCG	broad_id_20170327	Launched		
BRD-K33379087-001-07-5	BRD-K33379087	tivantinib	UCEQXRCJXIVODC	tyrosine kinase inhibitor	MET	broad_id_20170327	Phase 3		
BRD-K33453211-003-11-5	BRD-K33453211	levocabastine	ZCGOMHNNNFPNMX	histamine receptor antagonist	HRH1|NTSR2	broad_id_20170327	Launched		
BRD-K33483813-001-10-0	BRD-K33483813	actarit	MROJXXOCABQVEF	interleukin receptor agonist		broad_id_20170327	Launched		
BRD-K33610132-001-02-9	BRD-K33610132	rociletinib	HUFOZJXAKZVRNJ	EGFR inhibitor	EGFR	broad_id_20170327	Phase 3		
BRD-K33732501-004-01-0	BRD-K33732501	methylnaltrexone	JVLBPIPGETUEET	opioid receptor antagonist	OPRD1|OPRK1|OPRM1	broad_id_20170327	Launched		
BRD-K33852358-001-09-9	BRD-K33852358	arofylline	GVTLDPJNRVMCAL	phosphodiesterase inhibitor	PDE4A	broad_id_20170327	Phase 3		
BRD-K33882852-003-02-8	BRD-K33882852	ZK-93423	ALBKMJDFBZVHAK	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA5|GABRB2|GABRG2	broad_id_20170327	Phase 3		
BRD-K34008116-001-01-7	BRD-K34008116	dolasetron	UKTAZPQNNNJVKR	serotonin receptor antagonist	HTR3A	broad_id_20170327	Launched		
BRD-K34022604-001-06-6	BRD-K34022604	clofarabine	WDDPHFBMKLOVOX	ribonucleotide reductase inhibitor	POLA1|POLD1|POLE|RRM1|RRM2|RRM2B	broad_id_20170327	Launched		
BRD-K34154330-003-06-4	BRD-K34154330	tracazolate	PCTRYMLLRKWXGF	GABA receptor modulator	GABRA1	broad_id_20170327	Phase 2		
BRD-K34157611-001-16-0	BRD-K34157611	cimetidine	AQIXAKUUQRKLND	histamine receptor antagonist	HRH2|SLC29A4|SLC47A1|SLC47A2	broad_id_20170327	Launched		
BRD-K34185671-001-02-8	BRD-K34185671	AMG-517	YUTIXVXZQIQWGY	TRPV antagonist	TRPV1	broad_id_20170327	Phase 1		
BRD-K34313798-001-01-6	BRD-K34313798	LY215490	ZXFRFPSZAKNPQQ	glutamate receptor antagonist	GRIA1|GRIA2|GRIA3|GRIA4|GRIK1	broad_id_20170327	Phase 1		
BRD-K34328244-001-01-4	BRD-K34328244	MF-101	FURUXTVZLHCCNA	estrogen receptor agonist	CYP19A1|XDH	broad_id_20170327	Phase 3		
BRD-K34341643-001-01-4	BRD-K34341643	glasdegib	SFNSLLSYNZWZQG	hedgehog pathway inhibitor	SMO	broad_id_20170327	Launched		
BRD-K34415467-003-13-0	BRD-K34415467	trimethobenzamide	FEZBIKUBAYAZIU	histamine receptor antagonist	DRD2	broad_id_20170327	Launched		
BRD-K34469523-003-03-0	BRD-K34469523	albuterol	NDAUXUAQIAJITI	adrenergic receptor agonist	ADRB2	broad_id_20170327	Launched		
BRD-K34713073-001-01-3	BRD-K34713073	PD-123319	YSTVFDAKLDMYCR	angiotensin antagonist	AGTR2	broad_id_20170327	Phase 1		
BRD-K34776109-001-16-6	BRD-K34776109	glimepiride	WIGIZIANZCJQQY	insulin secretagogue	ABCC8|KCNJ1|KCNJ11	broad_id_20170327	Launched		
BRD-K34870043-001-01-8	BRD-K34870043	adoprazine	IUVSEUFHPNITEQ	dopamine receptor antagonist|serotonin receptor agonist	DRD2|HTR1A	broad_id_20170327	Phase 2		
BRD-K34888156-213-01-4	BRD-K34888156	theobromine	YAPQBXQYLJRXSA	phosphodiesterase inhibitor	ADORA1|ADORA2A|PDE4B	broad_id_20170327	Launched		
BRD-K35007173-001-07-5	BRD-K35007173	enprofylline	SIQPXVQCUCHWDI	phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADORA3|PDE4A|PDE4B	broad_id_20170327	Phase 3		
BRD-K35169477-001-01-9	BRD-K35169477	taranabant	QLYKJCMUNUWAGO	cannabinoid receptor inverse agonist	CNR1	broad_id_20170327	Phase 3		
BRD-K35189033-001-26-1	BRD-K35189033	levonorgestrel	WWYNJERNGUHSAO	estrogen receptor agonist|glucocorticoid receptor antagonist|progesterone receptor agonist|progesterone receptor antagonist	PGR	broad_id_20170327	Launched	progesterone receptor agonist	AR|ESR1|PGR|SRD5A1
BRD-K35245662-001-01-2	BRD-K35245662	ciclesonide	LUKZNWIVRBCLON	glucocorticoid receptor agonist	NR3C1|SERPINA6	broad_id_20170327	Launched		
BRD-K35520305-001-17-7	BRD-K35520305	dacarbazine	FDKXTQMXEQVLRF	DNA alkylating agent	PGD|POLA2	broad_id_20170327	Launched		
BRD-K35586044-003-15-4	BRD-K35586044	rauwolscine	BLGXFZZNTVWLAY	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C|HTR1B|HTR1D|HTR1E|HTR2B	broad_id_20170327	Preclinical	adrenergic receptor antagonist	ADRA2A|ADRA2B|ADRA2C|DRD2|DRD3|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|KCNJ1|KCNJ10|KCNJ11|KCNJ12|KCNJ14|KCNJ15|KCNJ8
BRD-K35589454-003-01-1	BRD-K35589454	danegaptide	BIZKIHUJGMSVFD	gap junction modulator		broad_id_20170327	Phase 2		
BRD-K35629949-001-02-0	BRD-K35629949	SR-27897	ILNRQFBVVQUOLP	CCK receptor antagonist	CCKAR	broad_id_20170327	Phase 2		
BRD-K35687421-001-02-5	BRD-K35687421	gimeracil	ZPLQIPFOCGIIHV	dihydropyrimidine dehydrogenase inhibitor	DPYD	broad_id_20170327	Launched		
BRD-K35719256-001-02-6	BRD-K35719256	rotundine	AEQDJSLRWYMAQI	serotonin receptor agonist	DRD1|DRD2|DRD3|HTR1A	broad_id_20170327	Launched		
BRD-K35775715-001-03-1	BRD-K35775715	liranaftate	VPHPQNGOVQYUMG	fungal squalene epoxidase inhibitor		broad_id_20170327	Launched		
BRD-K35960502-001-20-0	BRD-K35960502	niclosamide	RJMUSRYZPJIFPJ	DNA replication inhibitor|STAT inhibitor	STAT3	broad_id_20170327	Launched		
BRD-K36269323-300-02-6	BRD-K36269323	asymmetrical-dimethylarginine	YDGMGEXADBMOMJ	nitric oxide synthase inhibitor	NOS2|NOS3	broad_id_20170327	Phase 1		
BRD-K36270037-001-01-7	BRD-K36270037	esculin	XHCADAYNFIFUHF	antioxidant		broad_id_20170327	Phase 1		
BRD-K36280065-048-01-2	BRD-K36280065	tofacitinib	UJLAWZDWDVHWOW	JAK inhibitor	JAK1|JAK2|JAK3	broad_id_20170327	Launched		
BRD-K36324071-363-01-3	BRD-K36324071								
BRD-K36386086-001-01-1	BRD-K36386086	dolutegravir	RHWKPHLQXYSBKR	HIV integrase inhibitor	CYP3A4|CYP3A5|CYP3A7|POU2F2|UGT1A1	broad_id_20170327	Launched		
BRD-K36467523-001-02-8	BRD-K36467523	bindarit	MTHORRSSURHQPZ	NFkB pathway inhibitor	CCL2|CCL7|CCL8	broad_id_20170327	Phase 2		
BRD-K36627727-001-05-4	BRD-K36627727	tamibarotene	MUTNCGKQJGXKEM	retinoid receptor agonist	RARA|RARB	broad_id_20170327	Launched		
BRD-K36680103-001-01-6	BRD-K36680103	omecamtiv-mecarbil	RFUBTTPMWSKEIW	cardiac myosin activator	MYBPC3	broad_id_20170327	Phase 3		
BRD-K36732695-001-01-9	BRD-K36732695	setiptiline	GVPIXRLYKVFFMK	adrenergic receptor antagonist	HRH1|HTR2A|HTR2C	broad_id_20170327	Launched		
BRD-K36740062-001-06-6	BRD-K36740062	GSK1070916	QTBWCSQGBMPECM	Aurora kinase inhibitor	AURKA|AURKB|AURKC|CYP2D6|CYP3A4	broad_id_20170327	Phase 1		
BRD-K36862742-001-25-6	BRD-K36862742	hydroflumethiazide	DMDGGSIALPNSEE	sodium/potassium/chloride transporter inhibitor	ATP1A1|CA1|CA12|CA2|CA4|CA9|KCNMA1|SLC12A1|SLC12A3	broad_id_20170327	Launched		
BRD-K36927236-001-32-6	BRD-K36927236	glyburide	ZNNLBTZKUZBEKO	ATP channel blocker|insulin secretagogue|sulfonylurea	ABCA1|ABCB11|ABCC8|ABCC9|CFTR|CPT1A|KCNJ1|KCNJ11|KCNJ5|KCNJ8|SLCO2B1	broad_id_20170327	Launched		
BRD-K36970462-001-01-6	BRD-K36970462	tonabersat	XLIIRNOPGJTBJD	gap junction modulator|nitric oxide production inhibitor		broad_id_20170327	Phase 2		
BRD-K37111771-300-02-6	BRD-K37111771	trientine	VILCJCGEZXAXTO	chelating agent	CA14	broad_id_20170327	Launched		
BRD-K37289225-001-36-4	BRD-K37289225	clozapine	QZUDBNBUXVUHMW	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALY|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2B|HTR2C|HTR3A|HTR5A|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K37355418-236-01-6	BRD-K37355418	efaproxiral	BNFRJXLZYUTIII	hemoglobin oxygen release stimulant	HBA1|HBB	broad_id_20170327	Phase 3		
BRD-K37385792-003-02-1	BRD-K37385792	conivaptan	IKENVDNFQMCRTR	vasopressin receptor antagonist	AVPR1A|AVPR2	broad_id_20170327	Launched		
BRD-K37516142-001-10-5	BRD-K37516142	idebenone	JGPMMRGNQUBGND	calcium channel modulator		broad_id_20170327	Launched		
BRD-K37561857-001-15-5	BRD-K37561857	zardaverine	HJMQDJPMQIHLPB	phosphodiesterase inhibitor	PDE4D	broad_id_20170327	Phase 2		
BRD-K37590257-001-02-8	BRD-K37590257	GSK256066	JFHROPTYMMSOLG	phosphodiesterase inhibitor	PDE4A	broad_id_20170327	Phase 2		
BRD-K37687095-001-06-9	BRD-K37687095	AZD8330	RWEVIPRMPFNTLO	MEK inhibitor	MAP3K1	broad_id_20170327	Phase 1		
BRD-K37694030-003-12-7	BRD-K37694030	doxepin	ODQWQRRAPPTVAG	histamine receptor antagonist	HRH1|SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-K37714784-305-02-1	BRD-K37714784	ABT-724	FRPJGTNLZNXQEX	dopamine receptor agonist	DRD4	broad_id_20170327	Phase 2		
BRD-K37764012-001-04-1	BRD-K37764012	PF-03758309	AYCPARAPKDAOEN	p21 activated kinase inhibitor	PAK4	broad_id_20170327	Phase 1		
BRD-K37846922-001-09-4	BRD-K37846922	3,3'-diindolylmethane	VFTRKSBEFQDZKX	CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor	AR|HIF1A|IFNG|PI3	broad_id_20170327	Phase 3		
BRD-K37872686-003-01-9	BRD-K37872686	tirofiban	COKMIXFXJJXBQG	platelet aggregation inhibitor|structural glycoprotein antagonist	ITGA2B|ITGB3	broad_id_20170327	Launched		
BRD-K37890730-001-15-1	BRD-K37890730	camptothecin	VSJKWCGYPAHWDS	topoisomerase inhibitor	TOP1	broad_id_20170327	Phase 3		
BRD-K37991163-003-13-4	BRD-K37991163	paroxetine	AHOUBRCZNHFOSL	selective serotonin reuptake inhibitor (SSRI)	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HTR2A|SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-K38183498-001-02-0	BRD-K38183498		DGBIGWXXNGSACT			broad_id_20170327			
BRD-K38197229-001-29-9	BRD-K38197229	bumetanide	MAEIEVLCKWDQJH	solute carrier family member inhibitor	CFTR|GPR35|SLC12A1|SLC12A2|SLC12A4|SLC12A5	broad_id_20170327	Launched		
BRD-K38287497-001-01-2	BRD-K38287497	narlaprevir	RICZEKWVNZFTNZ	HCV inhibitor		broad_id_20170327	Phase 3		
BRD-K38436528-003-26-1	BRD-K38436528	imipramine	BCGWQEUPMDMJNV	norepinephrine reputake inhibitor|serotonin reuptake inhibitor	ADRA1A|ADRA1B|ADRA1D|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD5|HRH1|HTR1A|HTR2A|HTR2C|HTR6|HTR7|KCND2|KCND3|KCNH1|KCNH2|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-K38473998-001-02-0	BRD-K38473998	cilomilast	CFBUZOUXXHZCFB	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4D	broad_id_20170327	Phase 3		
BRD-K38744518-001-01-7	BRD-K38744518	betulinic-acid	QGJZLNKBHJESQX	apoptosis stimulant|NFkB pathway inhibitor	GPBAR1	broad_id_20170327	Phase 1/Phase 2		
BRD-K38852836-001-02-1	BRD-K38852836	ganetespib	RVAQIUULWULRNW	HSP inhibitor	HSP90AA1	broad_id_20170327	Phase 3		
BRD-K38868394-001-01-3	BRD-K38868394	MK-0773	GBEUKTWTUSPHEE	androgen receptor modulator	AR	broad_id_20170327	Phase 2		
BRD-K39252998-003-01-5	BRD-K39252998	atipamezole	HSWPZIDYAHLZDD	adrenergic receptor antagonist		broad_id_20170327	Launched		
BRD-K39339537-001-21-0	BRD-K39339537	epirizole	RHAXSHUQNIEUEY	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K39503511-001-03-9	BRD-K39503511	quiflapon	NZOONKHCNQFYCI	leukotriene synthesis inhibitor	ALOX5|ALOX5AP	broad_id_20170327	Phase 2		
BRD-K39974922-001-04-3	BRD-K39974922	lenvatinib	WOSKHXYHFSIKNG	FGFR inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	FLT4|KDR	broad_id_20170327	Launched		
BRD-K40175214-001-11-6	BRD-K40175214	torin-1	AKCRNFFTGXBONI	mTOR inhibitor	MTOR	broad_id_20170327	Preclinical		
BRD-K40227168-001-12-9	BRD-K40227168	vinburnine	WYJAPUKIYAZSEM	adrenergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4	broad_id_20170327	Launched		
BRD-K40718343-001-02-6	BRD-K40718343	AEE788	OONFNUWBHFSNBT	EGFR inhibitor|VEGFR inhibitor	EGFR|ERBB2|ERBB4|FGFR2|FGFR3|KDR	broad_id_20170327	Phase 1/Phase 2		
BRD-K40738845-001-05-0	BRD-K40738845	BMS-777607	VNBRGSXVFBYQNN	AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor	AXL|MERTK|MET|MST1R|TYRO3	broad_id_20170327	Phase 1/Phase 2		
BRD-K40758068-001-08-2	BRD-K40758068	efavirenz	XPOQHMRABVBWPR	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C9|CYP2D6|CYP3A4	broad_id_20170327	Launched		
BRD-K40797222-001-01-8	BRD-K40797222	SC-12267	XPRDUGXOWVXZLL	dihydroorotate dehydrogenase inhibitor	IL17A	broad_id_20170327	Phase 2		
BRD-K40870905-001-01-7	BRD-K40870905	CT-7758	KYHVWHYLKOHLKA	integrin antagonist	ITGA4	broad_id_20170327	Phase 2		
BRD-K41160163-001-06-8	BRD-K41160163	fenobam	DWPQODZAOSWNHB	glutamate receptor antagonist	GRM5	broad_id_20170327	Phase 2		
BRD-K41170226-001-13-8	BRD-K41170226	deoxycholic-acid	KXGVEGMKQFWNSR	biliverdin reductase A activator|G protein-coupled receptor agonist	FPR1|GPBAR1	broad_id_20170327	Launched		
BRD-K41185545-001-02-3	BRD-K41185545	ambrisentan	OUJTZYPIHDYQMC	endothelin receptor antagonist	EDNRA|EDNRB	broad_id_20170327	Launched		
BRD-K41213548-001-02-0	BRD-K41213548	KW-2478	VFUXSYAXEKYYMB	HSP inhibitor		broad_id_20170327	Phase 1/Phase 2		
BRD-K41260949-236-16-8	BRD-K41260949	valproic-acid	NIJJYAXOARWZEE	benzodiazepine receptor agonist|HDAC inhibitor	ABAT|ACADSB|ALDH5A1|HDAC1|HDAC2|HDAC9|OGDH|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K41410256-304-02-2	BRD-K41410256	balsalazide	IPOKCKJONYRRHP	cyclooxygenase inhibitor	ALOX5|PPARG|PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K41434598-003-01-9	BRD-K41434598	ORG-9768	JOLKQWPKJFRPOU	adrenergic receptor antagonist	ADRA2A	broad_id_20170327	Phase 1		
BRD-K41438959-001-01-7	BRD-K41438959		PRMWGUBFXWROHD			broad_id_20170327			
BRD-K41524689-001-23-5	BRD-K41524689	paracetamol	RZVAJINKPMORJF	cyclooxygenase inhibitor	FAAH|PTGS1|PTGS2|TRPV1	broad_id_20170327	Launched		
BRD-K41599323-001-02-3	BRD-K41599323	lonafarnib	DHMTURDWPRKSOA	farnesyltransferase inhibitor	FNTA|HRAS|KRAS|NRAS	broad_id_20170327	Phase 3		
BRD-K41708980-001-01-6	BRD-K41708980	triamcinolone-acetonide	YNDXUCZADRHECN	glucocorticoid receptor agonist|immunosuppressant	NR3C1|SERPINA6	broad_id_20170327	Launched		
BRD-K41731458-001-15-1	BRD-K41731458	triclosan	XEFQLINVKFYRCS	antibacterial agent	DNMT1	broad_id_20170327	Launched		
BRD-K41772907-001-01-2	BRD-K41772907	tolimidone	HJQILFPVRNHTIG	SRC activator	LYN|SRC	broad_id_20170327	Phase 2		
BRD-K41783120-001-02-8	BRD-K41783120	STA-5326	HSKAZIJJKRAJAV	interleukin synthesis inhibitor	IL12A	broad_id_20170327	Phase 2		
BRD-K41895714-001-01-4	BRD-K41895714								
BRD-K41996876-001-06-3	BRD-K41996876								
BRD-K42098891-003-20-5	BRD-K42098891	protriptyline	BWPIARFWQZKAIA	tricyclic antidepressant	SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-K42191735-001-05-3	BRD-K42191735	buparlisib	CWHUFRVAEUJCEF	PI3K inhibitor	PIK3CA|PIK3CG	broad_id_20170327	Phase 3		
BRD-K42348709-003-13-1	BRD-K42348709	cyclobenzaprine	JURKNVYFZMSNLP	adrenergic receptor agonist|serotonin receptor agonist	HTR2A	broad_id_20170327	Launched		
BRD-K42352790-001-05-3	BRD-K42352790	anandamide	LGEQQWMQCRIYKG	cannabinoid receptor agonist	CACNA1G|CACNA1H|CACNA1I|CNR1|CNR2|GLRA1|GPR18|GPR55|KCNA2|KCNK3|KCNK9|TRPM8|TRPV1	broad_id_20170327	Phase 2		
BRD-K42417338-045-01-9	BRD-K42417338		IFKLAQQSCNILHL			broad_id_20170327			
BRD-K42495768-001-01-7	BRD-K42495768	tasisulam	WWONFUQGBVOKOF	apoptosis stimulant		broad_id_20170327	Phase 3		
BRD-K42679050-001-02-1	BRD-K42679050	Y-27152	RHFUXPCCELGMFC	potassium channel activator	KCNJ8	broad_id_20170327	Phase 1		
BRD-K42805893-001-04-9	BRD-K42805893	osimertinib	DUYJMQONPNNFPI	EGFR inhibitor	EGFR	broad_id_20170327	Launched		
BRD-K42898655-001-01-8	BRD-K42898655	temsirolimus	CBPNZQVSJQDFBE	mTOR inhibitor	MTOR	broad_id_20170327	Launched		
BRD-K42948882-305-01-1	BRD-K42948882	AMD11070	WVLHHLRVNDMIAR	CC chemokine receptor antagonist	CCR5|CXCR4	broad_id_20170327	Phase 3		
BRD-K42981054-001-01-9	BRD-K42981054	mibampator	ULRDYYKSPCRXAJ	glutamate receptor modulator	GRIA1	broad_id_20170327	Phase 2		
BRD-K43002771-034-01-6	BRD-K43002771	SR-33805	GCVFQRRBTCHIPK	calcium channel blocker		broad_id_20170327	Phase 1		
BRD-K43164539-001-11-5	BRD-K43164539	cholic-acid	BHQCQFFYRZLCQQ	bile acid	ADH1C|CES1|COX4I1|COX5A|COX5B|COX6A2|COX6B1|COX6C|COX7A1|COX7B|COX7C|COX8A|ESRRG|FABP6|FECH|GPBAR1|MT-CO1|MT-CO2|MT-CO3|PLA2G1B	broad_id_20170327	Launched		
BRD-K43410529-001-02-3	BRD-K43410529	MLN2480	VWMJHAFYPMOMGF	RAF inhibitor		broad_id_20170327	Phase 1/Phase 2		
BRD-K43457670-001-27-8	BRD-K43457670	acetazolamide	BZKPWHYZMXOIDC	carbonic anhydrase inhibitor	AQP1|CA1|CA12|CA14|CA2|CA3|CA4|CA7	broad_id_20170327	Launched		
BRD-K43578482-001-01-4	BRD-K43578482	defactinib	FWLMVFUGMHIOAA	focal adhesion kinase inhibitor	PTK2	broad_id_20170327	Phase 2		
BRD-K43586850-001-02-9	BRD-K43586850	lacidipine	GKQPCPXONLDCMU	calcium channel blocker	CACNA1C	broad_id_20170327	Launched		
BRD-K43723251-001-01-5	BRD-K43723251	chenodeoxycholic-acid	RUDATBOHQWOJDD	11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist	HSD11B1|NR1H4	broad_id_20170327	Launched	nuclear factor erythroid derived|like (NRF2) activator	AKR1C2|NR1H4
BRD-K43797669-001-30-4	BRD-K43797669	genistein	TZBJGXHYKVUXJN	tyrosine kinase inhibitor	CFTR|ESR1|ESR2|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5	broad_id_20170327	Phase 2/Phase 3		
BRD-K43802723-340-01-9	BRD-K43802723	AMG-837	ZOPNBMMVVZRSGH	free fatty acid receptor agonist	FFAR1	broad_id_20170327	Phase 1		
BRD-K43806473-066-02-1	BRD-K43806473	camostat-mesilate	XASIMHXSUQUHLV	protease inhibitor	PRSS1	broad_id_20170327	Launched		
BRD-K43887077-003-26-3	BRD-K43887077	dopamine	VYFYYTLLBUKUHU	dopamine receptor agonist	DBH|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR7|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-K43966364-237-04-8	BRD-K43966364	penicillin-v-potassium	BPLBGHOLXOTWMN	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-K44273375-001-25-0	BRD-K44273375	tolnaftate	FUSNMLFNXJSCDI	fungal squalene epoxidase inhibitor		broad_id_20170327	Launched		
BRD-K44309363-003-02-1	BRD-K44309363	dexniguldipine	SVJMLYUFVDMUHP	calmodulin antagonist	ADORA3	broad_id_20170327	Phase 2	adrenergic receptor antagonist	ADRA1A
BRD-K44353683-001-08-3	BRD-K44353683	nateglinide	OELFLUMRDSZNSF	insulin secretagogue	ABCC8|KCNJ10|KCNJ11|PPARG	broad_id_20170327	Launched		
BRD-K44366189-001-01-9	BRD-K44366189	anacetrapib	MZZLGJHLQGUVPN	cholesteryl ester transfer protein inhibitor	CETP	broad_id_20170327	Phase 3		
BRD-K44408410-001-17-6	BRD-K44408410	2-methoxyestradiol	CQOQDQWUFQDJMK	hypoxia inducible factor inhibitor	COMT|CYP19A1|CYP1A1|CYP1B1|HIF1A|TUBB	broad_id_20170327	Phase 2		
BRD-K44442813-001-12-9	BRD-K44442813	pidotimod	UUTKICFRNVKFRG	interferon receptor agonist|interleukin receptor agonist		broad_id_20170327	Launched		
BRD-K44771174-066-01-0	BRD-K44771174	ibutamoren	UMUPQWIGCOZEOY	growth hormone secretagogue receptor agonist	GHR|GHSR	broad_id_20170327	Phase 2		
BRD-K44827188-001-06-0	BRD-K44827188	vismodegib	BPQMGSKTAYIVFO	hedgehog pathway inhibitor|smoothened receptor antagonist	SMO	broad_id_20170327	Launched		
BRD-K44844162-001-01-6	BRD-K44844162	taselisib	BEUQXVWXFDOSAQ	PI3K inhibitor	PIK3CA	broad_id_20170327	Phase 3		
BRD-K44876623-001-03-7	BRD-K44876623		ZAFYATHCZYHLPB			broad_id_20170327			
BRD-K44942188-001-09-1	BRD-K44942188	fomocaine	CVHGCWVMTZWGAY	voltage-gated sodium channel modulator		broad_id_20170327	Launched		
BRD-K44974079-001-01-3	BRD-K44974079	ticagrelor	OEKWJQXRCDYSHL	purinergic receptor antagonist	P2RY12	broad_id_20170327	Launched		
BRD-K45033733-001-12-2	BRD-K45033733	famciclovir	GGXKWVWZWMLJEH	DNA polymerase inhibitor		broad_id_20170327	Launched		
BRD-K45071273-003-25-6	BRD-K45071273	tetracaine	GKCBAIGFKIBETG	membrane integrity inhibitor	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K45117373-001-02-9	BRD-K45117373	Y-26763	IWTCFIIOUXJOOV	potassium channel activator	KCNJ8	broad_id_20170327	Phase 1		
BRD-K45152786-001-08-4	BRD-K45152786	merbarone	GFYRZTLCYQQVHZ	topoisomerase inhibitor	TOP2A	broad_id_20200324	Phase 2		
BRD-K45158365-001-11-4	BRD-K45158365	valsartan	ACWBQPMHZXGDFX	angiotensin receptor antagonist	AGTR1	broad_id_20170327	Launched		
BRD-K45168550-001-01-9	BRD-K45168550	SB-756050	GJUFPAZNBPFNRI	G protein-coupled receptor agonist	GPBAR1	broad_id_20170327	Phase 1		
BRD-K45245728-335-01-4	BRD-K45245728	ursodeoxycholyltaurine	BHTRKEVKTKCXOH	cholesterol inhibitor		broad_id_20170327	Phase 3		
BRD-K45252063-001-13-6	BRD-K45252063	clofibrate	KNHUKKLJHYUCFP	PPAR receptor agonist	LPL|PPARA	broad_id_20170327	Launched		
BRD-K45275534-001-01-3	BRD-K45275534	betrixaban	XHOLNRLADUSQLD	coagulation factor inhibitor	KCNH2	broad_id_20170327	Launched		
BRD-K45330754-001-21-7	BRD-K45330754	diethylstilbestrol	RGLYKWWBQGJZGM	estrogen receptor agonist	ESR1|ESR2|ESRRB|ESRRG	broad_id_20170327	Withdrawn		
BRD-K45503887-001-01-1	BRD-K45503887	delivert	CZGUSIXMZVURDU	angiotensin receptor agonist	AGTR1|AGTR2	broad_id_20170327	Launched		
BRD-K45542189-048-22-1	BRD-K45542189	diethylcarbamazine	RCKMWOKWVGPNJF	lipoxygenase inhibitor	ALOX5|PTGS1	broad_id_20170327	Launched		
BRD-K45746021-003-01-9	BRD-K45746021	CC-401	XDJCLCLBSGGNKS	JNK inhibitor	MAPK8	broad_id_20170327	Phase 1		
BRD-K45875383-001-01-2	BRD-K45875383	XBD173	NBMBIEOUVBHEBM	benzodiazepine receptor ligand	TSPO	broad_id_20170327	Phase 2		
BRD-K45924332-001-16-8	BRD-K45924332	amrinone	RNLQIBCLLYYYFJ	phosphodiesterase inhibitor	PDE3A|PDE3B|PDE4B|TNF	broad_id_20170327	Launched		
BRD-K46018455-001-27-6	BRD-K46018455	bezafibrate	IIBYAHWJQTYFKB	PPAR receptor agonist	PPARA|PPARD|PPARG	broad_id_20170327	Launched		
BRD-K46133855-304-03-8	BRD-K46133855	NXY-059	OVTCHWSLKGENKP	free radical scavenger		broad_id_20170327	Phase 3		
BRD-K46290096-001-01-1	BRD-K46290096	preladenant	DTYWJKSSUANMHD	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3	broad_id_20170327	Phase 3		
BRD-K46386702-001-02-1	BRD-K46386702	ARRY-334543	UWXSAYUXVSFDBQ	EGFR inhibitor	ERBB2	broad_id_20170327	Phase 2/Phase 3		
BRD-K46424862-001-14-1	BRD-K46424862	hymecromone	HSHNITRMYYLLCV	monoamine oxidase inhibitor	MAOA|MAOB	broad_id_20170327	Phase 2		
BRD-K46604138-001-01-3	BRD-K46604138	dapagliflozin	JVHXJTBJCFBINQ	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2	broad_id_20170327	Launched		
BRD-K46654563-238-01-0	BRD-K46654563	zofenopril-calcium	IAIDUHCBNLFXEF	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Launched		
BRD-K46692793-004-01-8	BRD-K46692793	umeclidinium	FVTWTVQXNAJTQP	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3	broad_id_20170327	Launched		
BRD-K46839850-050-04-2	BRD-K46839850	cinepazide	RCUDFXMNPQNBDU	calcium channel activator		broad_id_20170327	Withdrawn		
BRD-K46937689-001-15-0	BRD-K46937689	phenazone	VEQOALNAAJBPNY	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K46970505-003-01-9	BRD-K46970505	cefozopran	QDUIJCOKQCCXQY	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-K47000838-001-01-6	BRD-K47000838	cytochalasin-B	GBOGMAARMMDZGR	microtubule inhibitor	ACTB	broad_id_20170327	Phase 2		
BRD-K47095176-001-01-6	BRD-K47095176	talnetant	BIAVGWDGIJKWRM	tachykinin antagonist	TACR2|TACR3	broad_id_20170327	Phase 2		
BRD-K47539947-001-03-7	BRD-K47539947	tetradecylthioacetic-acid	IPBCWPPBAWQYOO	lipid peroxidase inhibitor		broad_id_20170327	Phase 2		
BRD-K47554101-001-01-2	BRD-K47554101	eperezolid	SIMWTRCFFSTNMG	bacterial 30S ribosomal subunit inhibitor		broad_id_20170327	Phase 1		
BRD-K47639036-003-06-6	BRD-K47639036	flavoxate	SPIUTQOUKAMGCX	acetylcholine receptor antagonist	CHRM1|CHRM2	broad_id_20170327	Launched		
BRD-K47642186-001-01-3	BRD-K47642186	piclamilast	RRRUXBQSQLKHEL	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D	broad_id_20170327	Phase 2		
BRD-K47780086-001-07-9	BRD-K47780086	penciclovir	JNTOCHDNEULJHD	DNA directed DNA polymerase inhibitor		broad_id_20170327	Launched		
BRD-K47869605-001-32-0	BRD-K47869605	podophyllotoxin	YJGVMLPVUAXIQN	microtubule inhibitor|tubulin polymerization inhibitor	IGF1R|TOP2A|TUBA4A|TUBB	broad_id_20170327	Launched		
BRD-K47936004-003-11-4	BRD-K47936004	piribedil	OQDPVLVUJFGPGQ	dopamine receptor agonist	ADRA1A|ADRA2A|ADRA2C|DRD2|DRD3|DRD4|HTR1A|HTR2B	broad_id_20170327	Launched		
BRD-K47976015-001-01-2	BRD-K47976015	balapiravir	VKXWOLCNTHXCLF	RNA polymerase inhibitor		broad_id_20170327	Phase 2		
BRD-K48068743-001-01-6	BRD-K48068743	teneligliptin	WGRQANOPCQRCME	dipeptidyl peptidase inhibitor	DPP4	broad_id_20170327	Launched		
BRD-K48168960-001-19-2	BRD-K48168960	propylthiouracil	KNAHARQHSZJURB	thyroid peroxidase inhibitor	DIO1|TPO	broad_id_20170327	Launched		
BRD-K48195801-001-01-6	BRD-K48195801	tecastemizole	SFOVDSLXFUGAIV	histamine receptor antagonist	KCNH2	broad_id_20170327	Phase 3		
BRD-K48213016-001-01-8	BRD-K48213016	CC-930	IBGLGMOPHJQDJB	JNK inhibitor		broad_id_20170327	Phase 2		
BRD-K48300629-001-14-5	BRD-K48300629	zonisamide	UBQNRHZMVUUOMG	sodium channel blocker|T-type calcium channel blocker	CA1|CA10|CA11|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA8|CA9|CACNA1G|CACNA1H|CACNA1I|MAOA|MAOB|SCN10A|SCN11A|SCN1A|SCN1B|SCN2A|SCN2B|SCN3A|SCN3B|SCN4A|SCN4B|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K48367671-001-05-9	BRD-K48367671	febuxostat	BQSJTQLCZDPROO	xanthine oxidase inhibitor	XDH	broad_id_20170327	Launched		
BRD-K48461310-234-01-3	BRD-K48461310	fosfomycin	YMDXZJFXQJVXBF	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-K48578705-001-16-8	BRD-K48578705	methyldopa	CJCSPKMFHVPWAR	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C|DDC	broad_id_20170327	Launched		
BRD-K48722258-300-10-2	BRD-K48722258	dilazep	QVZCXCJXTMIDME	adenosine reuptake inhibitor	SLC29A1	broad_id_20170327	Launched		
BRD-K48812570-001-02-3	BRD-K48812570	macitentan	JGCMEBMXRHSZKX	endothelin receptor antagonist	EDNRA|EDNRB	broad_id_20170327	Launched		
BRD-K48892307-001-04-1	BRD-K48892307	sasapyrine	WVYADZUPLLSGPU	NFkB pathway inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K48894757-001-01-8	BRD-K48894757	laropiprant	NXFFJDQHYLNEJK	prostanoid receptor antagonist	PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGFR|PTGIR|TBXA2R	broad_id_20170327	Launched		
BRD-K49075727-001-08-5	BRD-K49075727	nintedanib	XZXHXSATPCNXJR	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FGFR4|FLT1|FLT4|KDR|PDGFRA|PDGFRB	broad_id_20170327	Launched		
BRD-K49111258-003-29-7	BRD-K49111258	prazosin	IENZQIKPVFGBNW	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|KCNH2|KCNH6|KCNH7	broad_id_20170327	Launched		
BRD-K49215523-001-04-2	BRD-K49215523	GSK2636771	XTKLTGBKIDQGQL	PI3K inhibitor	PIK3CB	broad_id_20170327	Phase 2		
BRD-K49328571-001-15-0	BRD-K49328571	dasatinib	ZBNZXTGUTAYRHI	Bcr-Abl kinase inhibitor|ephrin inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor|tyrosine kinase inhibitor	ABL1|ABL2|BLK|EPHA2|FGR|FRK|FYN|HCK|KIT|LCK|LYN|PDGFRB|SRC|SRMS|STAT5B|YES1	broad_id_20170327	Launched		
BRD-K49350383-001-13-7	BRD-K49350383	thioguanine	WYWHKKSPHMUBEB	purine antagonist	IMPDH1|IMPDH2	broad_id_20170327	Launched		
BRD-K49404994-001-10-9	BRD-K49404994	levetiracetam	HPHUVLMMVZITSG	calcium channel blocker	CACNA1B|SCN1A|SV2A	broad_id_20170327	Launched		
BRD-K49456274-001-01-9	BRD-K49456274	pilaralisib	QINPEPAQOBZPOF	PI3K inhibitor		broad_id_20170327	Phase 2		
BRD-K49504902-001-01-6	BRD-K49504902	SEP-227900	MMAIBGHDBYQYDI	D-amino acid oxidase Inhibitor	DAO	broad_id_20170327	Phase 1		
BRD-K49555808-001-03-9	BRD-K49555808	BMS-707035	VNIWZCGZPBJWBI	HIV integrase inhibitor		broad_id_20170327	Phase 2		
BRD-K49671696-045-08-5	BRD-K49671696	ketanserin	FPCCSQOGAWCVBH	serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD1|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A|HTR7|SLC18A1|SLC18A2	broad_id_20170327	Launched		
BRD-K49685476-001-15-9	BRD-K49685476	TTNPB	FOIVPCKZDPCJJY	retinoid receptor agonist	RARA|RARB|RARG	broad_id_20170327	Phase 1		
BRD-K49807096-003-15-5	BRD-K49807096	benazepril	XPCFTKFZXHTYIP	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Launched		
BRD-K49840922-001-05-1	BRD-K49840922	etofylline-clofibrate	KYAKGJDISSNVPZ	platelet aggregation inhibitor	PPARA	broad_id_20170327	Launched		
BRD-K49865102-001-08-4	BRD-K49865102	PD-0325901	SUDAHWBOROXANE	MEK inhibitor	MAP2K1	broad_id_20170327	Phase 2		
BRD-K50031829-001-01-6	BRD-K50031829	PF-04447943	IWXUVYOOUMLUTQ	phosphodiesterase inhibitor	PDE9A	broad_id_20170327	Phase 2		
BRD-K50133271-001-18-7	BRD-K50133271	tolfenamic-acid	YEZNLOUZAIOMLT	cyclooxygenase inhibitor|prostanoid receptor antagonist		broad_id_20170327	Launched		
BRD-K50163129-001-01-4	BRD-K50163129	acrivastine	PWACSDKDOHSSQD	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K50168500-001-07-9	BRD-K50168500	canertinib	OMZCMEYTWSXEPZ	EGFR inhibitor	AKT1|EGFR|ERBB2|ERBB4	broad_id_20170327	Phase 3		
BRD-K50398167-236-22-7	BRD-K50398167	meclofenamic-acid	SBDNJUWAMKYJOX	cyclooxygenase inhibitor|prostanoid receptor antagonist	ALOX5|CNR1|KCNQ2|KCNQ3|PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K50422030-001-05-3	BRD-K50422030	clomethiazole	PCLITLDOTJTVDJ	GABA receptor antagonist|GABA receptor modulator	GABRA1	broad_id_20170327	Launched		
BRD-K50498985-001-03-3	BRD-K50498985	taladegib	SZBGQDXLNMELTB	smoothened receptor antagonist	DHH|IHH|SMO	broad_id_20170327	Phase 2		
BRD-K50564936-001-01-6	BRD-K50564936	E-2012	PUOAETJYKQITMO	gamma secretase modulator	APH1A|APH1B|PSENEN	broad_id_20170327	Phase 1		
BRD-K50590187-001-19-9	BRD-K50590187	capsaicin	YKPUWZUDDOIDPM	TRPV agonist	CFTR|TRPV1	broad_id_20170327	Launched		
BRD-K50691590-001-02-2	BRD-K50691590	bortezomib	GXJABQQUPOEUTA	NFkB pathway inhibitor|proteasome inhibitor	PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA	deprecated_broad_id_20180907	Launched		
BRD-K50859149-001-19-5	BRD-K50859149	sulfafurazole	NHUHCSRWZMLRLA	bacterial antifolate		broad_id_20170327	Launched		
BRD-K50938287-036-13-8	BRD-K50938287	sumatriptan	KQKPFRSPSRPDEB	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR5A|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K51033547-003-02-6	BRD-K51033547		TVYLLZQTGLZFBW			broad_id_20170327			
BRD-K51040301-001-02-1	BRD-K51040301	cobicistat	ZCIGNRJZKPOIKD	cytochrome P450 inhibitor	CYP3A4|CYP3A43|CYP3A5|CYP3A7	broad_id_20170327	Launched		
BRD-K51087630-001-01-6	BRD-K51087630	tirasemtiv	RSQGZEAXODVTOL	troponin activator		broad_id_20170327	Phase 2		
BRD-K51143828-003-03-1	BRD-K51143828	lurasidone	PQXKDMSYBGKCJA	dopamine receptor antagonist|serotonin receptor antagonist	ADRA2A|ADRA2C|DRD2|HTR1A|HTR2A|HTR7	broad_id_20170327	Launched		
BRD-K51263939-001-08-6	BRD-K51263939	sarcosine	FSYKKLYZXJSNPZ	glycine transporter inhibitor	SLC6A9	broad_id_20170327	Phase 2		
BRD-K51313569-003-03-3	BRD-K51313569	palbociclib	AHJRHEGDXFFMBM	CDK inhibitor	CDK4|CDK6	broad_id_20170327	Launched		
BRD-K51324732-001-01-0	BRD-K51324732	meglitinide	SWLAMJPTOQZTAE	potassium channel blocker	CCR2	broad_id_20170327	Phase 2		
BRD-K51333959-003-01-3	BRD-K51333959	siramesine	XWAONOGAGZNUSF	sigma receptor antagonist	ADRA1A|ADRA1B|ADRA1D	broad_id_20170327	Phase 2		
BRD-K51350053-048-16-5	BRD-K51350053	toremifene	XFCLJVABOIYOMF	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	ESR1	broad_id_20170327	Launched		
BRD-K51485625-001-08-4	BRD-K51485625	ritonavir	NCDNCNXCDXHOMX	HIV protease inhibitor	CYP1A2|CYP2B6|CYP2C19|CYP2C8|CYP2C9|CYP2D6|CYP2E1|CYP3A4|CYP3A5|CYP3A7	broad_id_20170327	Launched		
BRD-K51544265-001-04-2	BRD-K51544265	cabozantinib	ONIQOQHATWINJY	RET tyrosine kinase inhibitor|VEGFR inhibitor	KDR|MET|RET	broad_id_20170327	Launched		
BRD-K51662849-001-05-4	BRD-K51662849	ilomastat	NITYDPDXAAFEIT	matrix metalloprotease inhibitor	ACAN|ADAM28|MMP1|MMP12|MMP13|MMP14|MMP2|MMP3|MMP8|MMP9	broad_id_20170327	Phase 3		
BRD-K51677086-001-12-0	BRD-K51677086	erythromycin-ethylsuccinate	NSYZCCDSJNWWJL	cytochrome P450 inhibitor|protein synthesis inhibitor	ABCB1|ALB|CYP3A4|CYP51A1|KCNH2|MLNR|SLC47A1	broad_id_20170327	Launched		
BRD-K51747290-001-13-1	BRD-K51747290	hydroxyurea	VSNHCAURESNICA	ribonucleotide reductase inhibitor	RRM1|RRM2|RRM2B	broad_id_20170327	Launched		
BRD-K51967704-001-03-6	BRD-K51967704	BIIB021	QULDDKSCVCJTPV	HSP inhibitor	HSP90AA1	broad_id_20170327	Phase 2		
BRD-K52020312-001-26-8	BRD-K52020312	metronidazole	VAOCPAMSLUNLGC	DNA inhibitor	CYP2C9|CYP3A4	broad_id_20170327	Launched		
BRD-K52080565-001-09-2	BRD-K52080565		NPAGDVCDWIYMMC			broad_id_20170327			
BRD-K52172416-001-11-4	BRD-K52172416	anastrozole	YBBLVLTVTVSKRW	aromatase inhibitor	CYP19A1	broad_id_20170327	Launched		
BRD-K52183142-001-01-3	BRD-K52183142	pregnenolone	ORNBQBCIOKFOEO	glutamate receptor modulator	SULT2B1	broad_id_20170327	Launched		
BRD-K52233191-001-02-4	BRD-K52233191	R547	JRNJNYBQQYBCLE	CDK inhibitor	CDK1|CDK2|CDK4|CDK7	broad_id_20170327	Phase 1		
BRD-K52313696-001-12-3	BRD-K52313696	tacedinaline	VAZAPHZUAVEOMC	HDAC inhibitor	HDAC1	broad_id_20170327	Phase 3		
BRD-K52618540-001-09-9	BRD-K52618540	inositol	CDAISMWEOUEBRE	insulin sensitizer	CDIPT	broad_id_20170327	Launched		
BRD-K52662033-003-21-2	BRD-K52662033	lidocaine	NNJVILVZKWQKPM	histamine receptor agonist	EGFR|SCN10A|SCN5A|SCN9A	broad_id_20170327	Launched		
BRD-K52751261-001-06-1	BRD-K52751261	TAK-715	HEKAIDKUDLCBRU	p38 MAPK inhibitor	MAPK14	broad_id_20170327	Phase 2		
BRD-K52818472-001-02-2	BRD-K52818472	ivacaftor	PURKAOJPTOLRMP	CFTR channel potentiator	CFTR	broad_id_20170327	Launched		
BRD-K52911425-001-09-8	BRD-K52911425	GDC-0941	LHNIIDJUOCFXAP	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG	broad_id_20170327	Phase 2		
BRD-K52959329-238-01-9	BRD-K52959329	mitiglinide	WPGGHFDDFPHPOB	insulin secretagogue	ABCC8|KCNJ10|PPARG	broad_id_20170327	Launched		
BRD-K52989797-003-26-4	BRD-K52989797	clomipramine	GDLIGKIOYRNHDA	serotonin transporter (SERT) inhibitor	GSTP1|HTR2A|HTR2B|HTR2C|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-K53061490-003-13-9	BRD-K53061490	ozagrel	SHZKQBHERIJWAO	thromboxane synthase inhibitor	TBXAS1	broad_id_20170327	Launched		
BRD-K53097745-001-01-5	BRD-K53097745	pterostilbene	VLEUZFDZJKSGMX	cyclooxygenase inhibitor|PPAR receptor agonist	PTGS2	broad_id_20170327	Phase 2/Phase 3		
BRD-K53318339-001-24-9	BRD-K53318339	vinpocetine	DDNCQMVWWZOMLN	phosphodiesterase inhibitor|sodium channel blocker	PDE1A|PDE1C	broad_id_20170327	Launched		
BRD-K53414658-001-08-2	BRD-K53414658	tivozanib	SPMVMDHWKHCIDT	VEGFR inhibitor	FLT1|FLT4|KDR|KIT|PDGFRA|PDGFRB	broad_id_20170327	Launched		
BRD-K53417444-003-03-1	BRD-K53417444	OTS167	DKZYXHCYPUVGAF	maternal embryonic leucine zipper kinase inhibitor	MELK	broad_id_20170327	Phase 1/Phase 2		
BRD-K53508936-001-01-0	BRD-K53508936	CTS-1027	ROSNVSQTEGHUKU	metalloproteinase inhibitor	MMP1|MMP13|MMP2|MMP3|MMP9	broad_id_20170327	Phase 2		
BRD-K53517854-051-01-4	BRD-K53517854	fluvoxamine	CJOFXWAVKWHTFT	selective serotonin reuptake inhibitor (SSRI)	SLC6A4	broad_id_20170327	Launched		
BRD-K53581288-001-02-9	BRD-K53581288	baricitinib	XUZMWHLSFXCVMG	JAK inhibitor	JAK1|JAK2	broad_id_20170327	Launched		
BRD-K53665955-001-03-0	BRD-K53665955	MK-5108	LCVIRAZGMYMNNT	Aurora kinase inhibitor	AURKA|AURKB|AURKC	broad_id_20170327	Phase 1		
BRD-K53737926-003-27-8	BRD-K53737926	amitriptyline	KRMDCWKBEZIMAB	norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninânorepinephrine reuptake inhibitor (SNRI)	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|HRH2|HRH4|HTR1A|HTR1B|HTR1D|HTR2A|HTR2C|HTR6|HTR7|KCNA1|KCND2|KCND3|KCNQ2|KCNQ3|NTRK1|NTRK2|OPRD1|OPRK1|OPRM1|SIGMAR1|SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-K53765467-001-02-1	BRD-K53765467	empagliflozin	OBWASQILIWPZMG	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2	broad_id_20170327	Launched		
BRD-K53814070-310-01-3	BRD-K53814070	ripasudil	QSKQVZWVLOIIEV	rho associated kinase inhibitor	ROCK1|ROCK2	broad_id_20170327	Launched		
BRD-K53857191-001-22-7	BRD-K53857191	risperidone	RAPZEAPATHNIPO	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|DRD1|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K53963539-004-02-0	BRD-K53963539	vortioxetine	YQNWZWMKLDQSAC	serotonin receptor agonist|serotonin receptor antagonist	HTR1A|HTR1B|HTR2A|HTR2C|HTR3A|HTR5A|HTR6|HTR7|SLC6A4	broad_id_20170327	Launched		
BRD-K53972329-001-07-0	BRD-K53972329	ruxolitinib	HFNKQEVNSGCOJV	JAK inhibitor	JAK1|JAK2|JAK3|TYK2	broad_id_20170327	Launched	JAK inhibitor	JAK1|JAK2
BRD-K53979406-003-02-8	BRD-K53979406	ALX-5407	FDORQEIHOKEJNX	glycine transporter inhibitor	SLC6A9	broad_id_20170327	Phase 1		
BRD-K54006094-051-01-7	BRD-K54006094	formoterol	BPZSYCZIITTYBL	adrenergic receptor agonist	ADRB2	broad_id_20170327	Launched		
BRD-K54028654-001-02-6	BRD-K54028654	cabaletta	HDTRYLNUVZCQOY	pharmacological chaperone		broad_id_20170327	Phase 2		
BRD-K54256913-001-08-7	BRD-K54256913	MK-1775	BKWJAKQVGHWELA	WEE1 kinase inhibitor	WEE1	broad_id_20170327	Phase 2		
BRD-K54416256-001-19-9	BRD-K54416256	methimazole	PMRYVIKBURPHAH	antithyroid agent	TPO	broad_id_20170327	Launched		
BRD-K54472332-001-03-4	BRD-K54472332	elvitegravir	JUZYLCPPVHEVSV	HIV integrase inhibitor		broad_id_20170327	Launched		
BRD-K54520417-001-01-2	BRD-K54520417	LXR-623	KYWWJENKIMRJBI	LXR agonist	AR|NR1H2|NR1H3|NR1I2|NR3C1	broad_id_20170327	Phase 1		
BRD-K54640016-001-04-7	BRD-K54640016	WAY-362450	INASOKQDNHHMRE	FXR agonist	NR1H4	broad_id_20170327	Phase 1		
BRD-K54759182-003-08-0	BRD-K54759182	dosulepin	PHTUQLWOUWZIMZ	norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|HRH1|SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-K54770957-001-04-3	BRD-K54770957	etoricoxib	MNJVRJDLRVPLFE	cyclooxygenase inhibitor	PTGS2	broad_id_20170327	Launched		
BRD-K54847683-001-03-2	BRD-K54847683	equol	ADFCQWZHKCXPAJ	estrogen receptor agonist	ESR1|ESR2	broad_id_20170327	Launched		
BRD-K54936858-001-01-6	BRD-K54936858	DMP-777	ZSDCIRYNTCVTMF	elastase inhibitor	MPO	broad_id_20170327	Phase 2		
BRD-K55013654-003-02-3	BRD-K55013654		XTTZERNUQAFMOF			broad_id_20170327			
BRD-K55026842-001-01-4	BRD-K55026842	azacitidine	NMUSYJAQQFHJEW	DNA methyltransferase inhibitor	DNMT1|DNMT3A	broad_id_20170327	Launched		
BRD-K55127134-300-11-2	BRD-K55127134	fluphenazine	PLDUPXSUYLZYBN	dopamine receptor antagonist	CALM1|DRD1|DRD2|DRD5|HRH1|HTR2A|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K55191674-237-18-3	BRD-K55191674	benzylpenicillin	JGSARLDLIJGVTE	penicillin binding protein inhibitor		broad_id_20170327	Launched		
BRD-K55250441-001-13-0	BRD-K55250441	sulfadoxine	PJSFRIWCGOHTNF	dihydropteroate synthase inhibitor		broad_id_20170327	Launched		
BRD-K55512740-001-01-6	BRD-K55512740	MK-8033	VMJFTOSOFDEKTM	c-Met inhibitor	MET	broad_id_20170327	Phase 1		
BRD-K55748775-001-02-2	BRD-K55748775	SCH-28080	PYKJFEPAUKAXNN	ATPase inhibitor	ATP4A	broad_id_20170327	Phase 1		
BRD-K55781385-001-01-7	BRD-K55781385	rimegepant	KRNAOFGYEFKHPB	calcitonin antagonist	CALCA	broad_id_20170327	Launched		
BRD-K55847762-304-01-7	BRD-K55847762	lobenzarit	UGDPYGKWIHHBMB	immunosuppressant		broad_id_20170327	Launched		
BRD-K55930204-236-24-3	BRD-K55930204	phenytoin	CXOFVDLJLONNDW	hydantoin antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K55966568-001-05-4	BRD-K55966568	orantinib	NHFDRBXTEDBWCZ	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	AURKA|AURKB|EGFR|FGFR1|FGFR2|KDR|PDGFRA|PDGFRB	broad_id_20170327	Phase 3		
BRD-K56032964-001-02-1	BRD-K56032964	AP26113	OVDSPTSBIQCAIN	ALK tyrosine kinase receptor inhibitor	ALK|EGFR	broad_id_20170327	Phase 2		
BRD-K56104152-008-04-1	BRD-K56104152	oxiconazole	QRJJEGAJXVEBNE	bacterial cell wall synthesis inhibitor		broad_id_20170327	Launched		
BRD-K56195681-001-01-0	BRD-K56195681	losmapimod	KKYABQBFGDZVNQ	p38 MAPK inhibitor	MAPK14	broad_id_20170327	Phase 3		
BRD-K56291712-001-01-0	BRD-K56291712	voxtalisib	RGHYDLZMTYDBDT	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA	broad_id_20170327	Phase 2		
BRD-K56301217-001-07-4	BRD-K56301217	ABT-737	HPLNQCPCUACXLM	BCL inhibitor	BCL2|BCL2L1|BCL2L2	broad_id_20170327	Phase 1/Phase 2		
BRD-K56334280-001-05-1	BRD-K56334280	amonafide	UPALIKSFLSVKIS	topoisomerase inhibitor	TOP2A|TOP2B	broad_id_20170327	Phase 3		
BRD-K56343971-001-10-6	BRD-K56343971	vemurafenib	GPXBXXGIAQBQNI	RAF inhibitor	BRAF|RAF1	broad_id_20170327	Launched		
BRD-K56405753-001-02-4	BRD-K56405753	MK-2461	JGEBLDKNWBUGRZ	FGFR inhibitor|VEGFR inhibitor	FGFR1|FGFR2|FGFR3|FLT1|FLT3|FLT4|KDR|MERTK|MET|MST1R|NTRK1|NTRK2|PDGFRB	broad_id_20170327	Phase 1/Phase 2		
BRD-K56558538-003-11-9	BRD-K56558538	ambroxol	JBDGDEWWOUBZPM	sodium channel blocker	CYP3A4	broad_id_20170327	Launched		
BRD-K56614220-001-19-0	BRD-K56614220	clofazimine	WDQPAMHFFCXSNU	GK0582 inhibitor		broad_id_20170327	Launched		
BRD-K56751279-300-01-4	BRD-K56751279	Y-39983	JTVBXQAYBIJXRP	rho associated kinase inhibitor	ROCK1|ROCK2	broad_id_20170327	Phase 2		
BRD-K56800335-015-04-9	BRD-K56800335	guanaben-acetate	WDZVGELJXXEGPV	adrenergic receptor agonist	ADRA2A|ADRA2B|ADRA2C	broad_id_20170327	Launched		
BRD-K56810756-001-03-0	BRD-K56810756	fomepizole	RIKMMFOAQPJVMX	alcohol dehydrogenase inhibitor	ADH1A|ADH1B|ADH1C|AKR1A1|CAT	broad_id_20170327	Launched		
BRD-K56844688-003-01-2	BRD-K56844688	doxorubicin	AOJJSUZBOXZQNB	topoisomerase inhibitor	TOP2A	broad_id_20170327	Launched	topoisomerase inhibitor	CHD1|TOP2A
BRD-K56851771-001-06-8	BRD-K56851771	enzalutamide	WXCXUHSOUPDCQV	androgen receptor antagonist	AR	broad_id_20170327	Launched		
BRD-K56957086-001-06-3	BRD-K56957086	dacinostat	BWDQBBCUWLSASG	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9	broad_id_20170327	Phase 1		
BRD-K57041787-001-02-6	BRD-K57041787	dabigatran-etexilate	KSGXQBZTULBEEQ	thrombin inhibitor	F2	broad_id_20170327	Launched		
BRD-K57080016-001-15-9	BRD-K57080016	selumetinib	CYOHGALHFOKKQC	MEK inhibitor	MAP2K1	broad_id_20170327	Phase 3		
BRD-K57169635-001-04-5	BRD-K57169635	dacomitinib	LVXJQMNHJWSHET	EGFR inhibitor	EGFR|ERBB2|ERBB4	broad_id_20170327	Launched		
BRD-K57222227-001-30-1	BRD-K57222227	indomethacin	CGIGDMFJXJATDK	cyclooxygenase inhibitor	GLO1|PLA2G2A|PPARA|PPARG|PTGDR2|PTGR2|PTGS1|PTGS2|SLC46A1	broad_id_20170327	Launched		
BRD-K57252450-001-02-5	BRD-K57252450	cilengitide	AMLYAMJWYAIXIA	integrin antagonist	ITGAV|ITGB3	broad_id_20170327	Phase 3		
BRD-K57371763-001-01-7	BRD-K57371763	fidaxomicin	ZVGNESXIJDCBKN	RNA polymerase inhibitor		broad_id_20170327	Launched		
BRD-K57432881-003-21-8	BRD-K57432881	tiapride	JTVPZMFULRWINT	dopamine receptor antagonist	DRD2|DRD3	broad_id_20170327	Launched		
BRD-K57545991-050-23-1	BRD-K57545991	enalapril	GBXSMTUPTTWBMN	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Launched		
BRD-K57569181-001-27-5	BRD-K57569181	pentoxifylline	BYPFEZZEUUWMEJ	phosphodiesterase inhibitor	ADORA1|ADORA2A|ADORA2B|ADRA2B|NT5E|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|TNF	broad_id_20170327	Launched		
BRD-K57631554-003-06-2	BRD-K57631554	5-aminolevulinic-acid	ZGXJTSGNIOSYLO	oxidizing agent	ALAD	broad_id_20170327	Launched		
BRD-K57764956-001-02-8	BRD-K57764956	cariprazine	KPWSJANDNDDRMB	dopamine receptor antagonist	DRD2|DRD3	broad_id_20170327	Launched		
BRD-K58010567-003-02-2	BRD-K58010567	vilazodone	SGEGOXDYSFKCPT	serotonin reuptake inhibitor	DRD2|DRD3|HRH1|HTR1A|HTR4|SLC6A4	broad_id_20170327	Launched		
BRD-K58114536-001-01-6	BRD-K58114536	rasagiline	RUOKEQAAGRXIBM	monoamine oxidase inhibitor	BCL2|MAOB	broad_id_20170327	Launched		
BRD-K58211978-001-01-5	BRD-K58211978	roxithromycin	RXZBMPWDPOLZGW	bacterial 50S ribosomal subunit inhibitor	MLNR	broad_id_20170327	Launched		
BRD-K58435339-001-03-0	BRD-K58435339	AT13387	IFRGXKKQHBVPCQ	HSP inhibitor	HSP90AA1	broad_id_20170327	Phase 2		
BRD-K58486055-001-02-7	BRD-K58486055	reparixin	KQDRVXQXKZXMHP	CC chemokine receptor antagonist	CXCR1|CXCR2	broad_id_20170327	Phase 3		
BRD-K58501140-002-01-0	BRD-K58501140	TAK-875	BZCALJIHZVNMGJ	insulin secretagogue	FFAR1	broad_id_20170327	Phase 3		
BRD-K58550667-001-08-7	BRD-K58550667	FK-866	KPBNHDGDUADAGP	niacinamide phosphoribosyltransferase inhibitor	NAMPT	broad_id_20170327	Phase 2		
BRD-K58626373-003-07-8	BRD-K58626373		DBGIVFWFUFKIQN			broad_id_20170327			
BRD-K58736316-001-09-5	BRD-K58736316	cianidanol	PFTAWBLQPZVEMU	fatty acid synthase inhibitor	PTGS1	broad_id_20170327	Withdrawn		
BRD-K58951486-004-01-5	BRD-K58951486	rocuronium	YXRDKMPIGHSVRX	acetylcholine receptor antagonist	CHRM2|CHRNA2|HTR3A	broad_id_20170327	Launched		
BRD-K59013864-001-01-1	BRD-K59013864	AM-24	VAPDZNUFNKUROY	lipoxygenase inhibitor	ALOX5	broad_id_20170327	Phase 2		
BRD-K59037100-001-14-7	BRD-K59037100	oxybenzone	DXGLGDHPHMLXJC	lipase inhibitor	LIPE	broad_id_20170327	Launched		
BRD-K59058766-003-21-9	BRD-K59058766	chlorprothixene	WSPOMRSOLSGNFJ	dopamine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|HRH1|HTR2A|HTR2B|HTR2C	broad_id_20170327	Launched		
BRD-K59197931-001-04-5	BRD-K59197931	naproxen	CMWTZPSULFXXJA	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K59227464-334-02-4	BRD-K59227464	LY2228820	XPPBBJCBDOEXDN	p38 MAPK inhibitor	MAPK14	broad_id_20170327	Phase 2		
BRD-K59273480-001-10-6	BRD-K59273480	propentofylline	RBQOQRRFDPXAGN	adenosine reuptake inhibitor|phosphodiesterase inhibitor	PDE1A	broad_id_20170327	Launched		
BRD-K59317601-001-05-5	BRD-K59317601	MLN0128	GYLDXIAOMVERTK	mTOR inhibitor	MTOR|PIK3CA|PIK3CD|PIK3CG	broad_id_20170327	Phase 2		
BRD-K59325863-001-02-8	BRD-K59325863	delanzomib	SJFBTAPEPRWNKH	proteasome inhibitor	CMA1|CTSG|CYP3A4|ELANE	broad_id_20170327	Phase 1/Phase 2		
BRD-K59331299-001-01-2	BRD-K59331299	voglibose	FZNCGRZWXLXZSZ	glucosidase inhibitor	MGAM	broad_id_20170327	Launched		
BRD-K59332007-300-02-7	BRD-K59332007	linopirdine	YEJCDKJIEMIWRQ	potassium channel blocker	KCNQ2|KCNQ3|KCNQ4|KCNQ5	broad_id_20170327	Phase 3		
BRD-K59369769-001-20-3	BRD-K59369769	tozasertib	GCIKSSRWRFVXBI	Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor	AURKA|AURKB|AURKC|LCK	broad_id_20170327	Phase 2		
BRD-K59433843-001-01-7	BRD-K59433843	ICI-192605	WHUIENZXNGAHQI	thromboxane receptor antagonist	TBXA2R	broad_id_20170327	Phase 2		
BRD-K59436580-001-01-7	BRD-K59436580	tedizolid	XFALPSLJIHVRKE	bacterial 50S ribosomal subunit inhibitor		broad_id_20170327	Launched		
BRD-K59506194-015-04-9	BRD-K59506194	targinine	NTNWOCRCBQPEKQ	nitric oxide synthase inhibitor	NOS3	broad_id_20170327	Phase 3		
BRD-K59524082-001-01-3	BRD-K59524082	maribavir	KJFBVJALEQWJBS	cytomegalovirus inhibitor|protein kinase inhibitor	PYGM	broad_id_20170327	Phase 3		
BRD-K59573506-001-01-8	BRD-K59573506	cyproterone-acetate	UWFYSQMTEOIJJG	androgen receptor antagonist	ADORA1|AR	broad_id_20170327	Launched		
BRD-K59574735-001-11-8	BRD-K59574735	ubenimex	VGGGPCQERPFHOB	leukotriene synthesis inhibitor	LTA4H|RNPEP	broad_id_20170327	Launched		
BRD-K59632282-052-03-1	BRD-K59632282	quinidine	LOUPRKONTZGTKE	sodium channel blocker	KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4	broad_id_20170327	Launched	hemozoin biocrystallization inhibitor	GP9|KCNB2|KCNN4|SLC29A4
BRD-K59715032-362-01-4	BRD-K59715032	pasireotide	VMZMNAABQBOLAK	somatostatin receptor agonist	SSTR1|SSTR2|SSTR3|SSTR5	broad_id_20170327	Launched		
BRD-K59875992-001-01-8	BRD-K59875992	FPL-62064	WKLGNFJHVJIZPK	cyclooxygenase inhibitor|lipoxygenase inhibitor		broad_id_20170327	Phase 2		
BRD-K59929863-001-01-9	BRD-K59929863	CB-10-277	GUAZPUYTLMUTMA	DNA synthesis inhibitor		broad_id_20170327	Phase 1		
BRD-K60038276-001-09-0	BRD-K60038276	irbesartan	YOSHYTLCDANDAN	angiotensin receptor antagonist	AGTR1|JUN|SLC10A1	broad_id_20170327	Launched		
BRD-K60160658-003-11-2	BRD-K60160658	tiagabine	PBJUNZJWGZTSKL	GABA uptake inhibitor	SLC6A1	broad_id_20170327	Launched		
BRD-K60230970-001-10-0	BRD-K60230970	MG-132	TZYWCYJVHRLUCT	proteasome inhibitor	PSMB1	broad_id_20170327	Preclinical		
BRD-K60237333-001-27-1	BRD-K60237333	niacin	PVNIIMVLHYAWGP	NAD precursor|vitamin B	DGAT2|HCAR1|HCAR2|HCAR3|NNMT|QPRT	broad_id_20170327	Launched		
BRD-K60240222-001-01-4	BRD-K60240222	carglumic-acid	LCQLHJZYVOQKHU	carbamoyl phosphate synthase activator	CPS1	broad_id_20170327	Launched		
BRD-K60341624-001-02-2	BRD-K60341624	GSK1292263	AYJRTVVIBJSSKN	glucose dependent insulinotropic receptor agonist	GRPR	broad_id_20170327	Phase 2		
BRD-K60585088-001-01-5	BRD-K60585088	paricalcitol	BPKAHTKRCLCHEA	vitamin D receptor agonist	VDR	broad_id_20170327	Launched		
BRD-K60623809-001-02-0	BRD-K60623809								
BRD-K60866521-001-07-1	BRD-K60866521	idelalisib	IFSDAJWBUCMOAH	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG	broad_id_20170327	Launched		
BRD-K60997853-001-02-3	BRD-K60997853	PHA-848125	RXZMYLDMFYNEIM	CDK inhibitor|growth factor receptor inhibitor	CDK2|CDK4|CDK7|NTRK1	broad_id_20170327	Phase 2		
BRD-K61036791-001-01-6	BRD-K61036791	rucinol	CSHZYWUPJWVTMQ	tyrosinase inhibitor	TYR	broad_id_20170327	Phase 1		
BRD-K61195623-001-01-4	BRD-K61195623	combretastatin-A-4	HVXBOLULGPECHP	tubulin polymerization inhibitor		broad_id_20170327	Phase 2		
BRD-K61250553-003-32-2	BRD-K61250553	loperamide	RDOIQAHITMMDAJ	opioid receptor agonist	CACNA1A|CALM1|OPRD1|OPRK1|OPRM1|POMC	broad_id_20170327	Launched		
BRD-K61397605-001-03-4	BRD-K61397605	romidepsin	OHRURASPPZQGQM	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9	broad_id_20170327	Launched		
BRD-K61443650-236-13-1	BRD-K61443650	thiomersal	HXQVQGWHFRNKMS	other antibiotic	OXCT1	broad_id_20170327	Launched		
BRD-K61452026-001-04-6	BRD-K61452026	emtricitabine	XQSPYNMVSIKCOC	nucleoside reverse transcriptase inhibitor		broad_id_20170327	Launched		
BRD-K61567297-001-01-9	BRD-K61567297	resatorvid	LEEIJTHMHDMWLJ	toll-like receptor inhibitor	TLR4	broad_id_20170327	Phase 3		
BRD-K61691541-001-01-1	BRD-K61691541	PF-03084014	VFCRKLWBYMDAED	gamma secretase inhibitor		broad_id_20170327	Phase 3		
BRD-K61693562-300-01-7	BRD-K61693562	pyrazinoylguanidine	WNBSDCKJFDZMHT	diuretic		broad_id_20170327	Phase 1		
BRD-K61988078-001-01-2	BRD-K61988078	moxidectin	YZBLFMPOMVTDJY	chloride channel antagonist		broad_id_20170327	Launched		
BRD-K62196610-001-01-6	BRD-K62196610	AVN-944	GYCPCOJTCINIFZ	inosine monophosphate dehydrogenase inhibitor	IMPDH1|IMPDH2	broad_id_20170327	Phase 2		
BRD-K62200014-003-10-5	BRD-K62200014	anagrelide	OTBXOEAOVRKTNQ	phosphodiesterase inhibitor	PDE3A	broad_id_20170327	Launched		
BRD-K62277907-001-01-6	BRD-K62277907	PYM50028	GMBQZIIUCVWOCD	neurotrophic agent		broad_id_20170327	Phase 2		
BRD-K62310379-001-10-5	BRD-K62310379	fluticasone-propionate	WMWTYOKRWGGJOA	glucocorticoid receptor agonist	NR3C1|NR3C2|PGR|PLA2G4A	broad_id_20170327	Launched		
BRD-K62363391-001-24-9	BRD-K62363391	dapsone	MQJKPEGWNLWLTK	bacterial antifolate	DHFR	broad_id_20170327	Launched		
BRD-K62387885-001-01-9	BRD-K62387885	basimglurant	UPZWINBEAHDTLA	glutamate receptor antagonist	GRM5	broad_id_20170327	Phase 2		
BRD-K62391742-001-03-0	BRD-K62391742	venetoclax	LQBVNQSMGBZMKD	BCL inhibitor	BCL2	broad_id_20170327	Launched		
BRD-K62398570-300-01-2	BRD-K62398570	lerisetron	PWWDCRQZITYKDV	serotonin receptor antagonist	HTR3A	broad_id_20170327	Phase 3		
BRD-K62562723-003-02-7	BRD-K62562723	SR-2640	LMPZHLXYBWGGNT	leukotriene receptor antagonist	CYSLTR1	broad_id_20170327	Phase 2		
BRD-K62627508-001-01-5	BRD-K62627508	idasanutlin	TVTXCJFHQKSQQM	MDM inhibitor	MDM2|TP53	broad_id_20170327	Phase 3		
BRD-K62676709-065-05-5	BRD-K62676709	guanethidine	ACGDKVXYNVEAGU	adrenergic inhibitor	SLC6A2	broad_id_20170327	Launched		
BRD-K62685538-001-01-7	BRD-K62685538	triptorelin	VXKHXGOKWPXYNA	gonadotropin releasing factor hormone receptor agonist	GNRHR	broad_id_20170327	Launched		
BRD-K62734952-001-01-0	BRD-K62734952	arglabin	UVJYAKBJSGRTHA	farnesyltransferase inhibitor	FNTA|NFKB1	broad_id_20170327	Launched		
BRD-K62737565-003-02-6	BRD-K62737565	gabapentin	UGJMXCAKCUNAIE	calcium channel blocker	ADORA1|CACNA1A|CACNA1B|CACNA1C|CACNA1D|CACNA1E|CACNA1F|CACNA1G|CACNA1H|CACNA1I|CACNA1S|CACNA2D1|CACNA2D2|CACNA2D3|CACNA2D4|CACNB1|CACNB2|CACNB3|CACNB4|CACNG1|CACNG2|CACNG3|CACNG4|CACNG5|CACNG6|CACNG7|CACNG8|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B	broad_id_20170327	Launched		
BRD-K62762455-001-01-3	BRD-K62762455	RU-58841	ARBYGDBJECGMGA	androgen receptor antagonist	AR	broad_id_20170327	Phase 2		
BRD-K62858456-001-01-8	BRD-K62858456	lomerizine	JQSAYKKFZOSZGJ	calcium channel blocker	CACNA1B|SCN5A	broad_id_20170327	Launched		
BRD-K62965247-001-04-9	BRD-K62965247	tipifarnib	PLHJCIYEEKOWNM	farnesyltransferase inhibitor	FNTA|FNTB	broad_id_20170327	Phase 3		
BRD-K62996583-001-10-3	BRD-K62996583	lidoflazine	ZBIAKUMOEKILTF	calcium channel blocker	SCN1A|SCN3A|SLC29A1	broad_id_20170327	Launched		
BRD-K63126190-003-01-6	BRD-K63126190	epinephrine	UCTWMZQNUQWSLP	adrenergic receptor agonist|carbonic anhydrase activator|neurotransmitter	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|PAH|TNF	broad_id_20170327	Launched		
BRD-K63150726-001-02-1	BRD-K63150726	JTE-907	GRAJFFFXJYFVOC	cannabinoid receptor inverse agonist	CNR2	broad_id_20170327	Phase 1		
BRD-K63178091-001-01-1	BRD-K63178091	telotristat	NCLGDOBQAWBXRA	tryptophan hydroxylase inhibitor	TPH1	broad_id_20170327	Launched		
BRD-K63343048-001-12-2	BRD-K63343048	orlistat	AHLBNYSZXLDEJQ	lipase inhibitor	CNR1|DAGLA|DAGLB|FASN|LIPF|PNLIP	broad_id_20170327	Launched		
BRD-K63430059-001-17-2	BRD-K63430059	methoxsalen	QXKHYNVANLEOEG	DNA synthesis inhibitor	CYP1A1|CYP1A2|CYP2A13|CYP2A6|CYP3A4	broad_id_20170327	Launched		
BRD-K63504947-001-15-4	BRD-K63504947	semaxanib	WUWDLXZGHZSWQZ	VEGFR inhibitor	FGFR1|FLT1|KDR|KIT|PDGFRA|PDGFRB|RET	broad_id_20170327	Phase 3		
BRD-K63550407-001-12-7	BRD-K63550407	erythromycin	ULGZDMOVFRHVEP	NFkB pathway inhibitor	MLNR	broad_id_20170327	Launched		
BRD-K63630713-001-25-8	BRD-K63630713	etacrynic-acid	AVOLMBLBETYQHX	sodium/potassium/chloride transporter inhibitor	ATP1A1|SLC12A1	broad_id_20170327	Launched		
BRD-K63675182-003-23-6	BRD-K63675182	triflupromazine	XSCGXQMFQXDFCW	dopamine receptor antagonist	CHRM1|CHRM2|DRD1|DRD2|HTR2B	broad_id_20170327	Launched		
BRD-K63712959-001-01-8	BRD-K63712959	temoporfin	JGLSWAGTNWZKQU	radical formation stimulant		broad_id_20200324	Launched		
BRD-K63736853-001-04-8	BRD-K63736853	acipimox	DJQOOSBJCLSSEY	cholesterol inhibitor	HCAR2	broad_id_20170327	Launched		
BRD-K63750851-001-20-7	BRD-K63750851	mycophenolic-acid	HPNSFSBZBAHARI	dehydrogenase inhibitor|inositol monophosphatase inhibitor	IMPDH1|IMPDH2	broad_id_20170327	Launched		
BRD-K63828191-003-32-1	BRD-K63828191	raloxifene	GZUITABIAKMVPG	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	ESR1|ESR2	broad_id_20170327	Launched		
BRD-K63861289-001-19-6	BRD-K63861289	molsidomine	XLFWDASMENKTKL	guanylate cyclase stimulant	GUCY1A3	broad_id_20170327	Launched		
BRD-K64052750-001-17-5	BRD-K64052750	gefitinib	XGALLCVXEZPNRQ	EGFR inhibitor	EGFR	broad_id_20170327	Launched		
BRD-K64338723-001-01-6	BRD-K64338723	milacemide	GJNNXIYZWIZFRH	monoamine oxidase inhibitor	MAOB	broad_id_20170327	Phase 3		
BRD-K64504314-001-01-8	BRD-K64504314	dienogest	AZFLJNIPTRTECV	progesterone receptor agonist	PGR	broad_id_20170327	Launched		
BRD-K64538373-001-01-4	BRD-K64538373	Ro-4987655	FIMYFEGKMOCQKT	MEK inhibitor	MAP2K1	broad_id_20170327	Phase 1		
BRD-K64622987-001-01-4	BRD-K64622987	torcetrapib	CMSGWTNRGKRWGS	cholesteryl ester transfer protein inhibitor	CETP	broad_id_20170327	Phase 3		
BRD-K64755930-003-03-2	BRD-K64755930	etazolate	OPQRBXUBWHDHPQ	phosphodiesterase inhibitor	GABRB3|PDE4A	broad_id_20170327	Phase 2		
BRD-K64785675-001-04-0	BRD-K64785675	TG100-115	UJIAQDJKSXQLIT	PI3K inhibitor	PIK3CA|PIK3CB|PIK3CD|PIK3CG	broad_id_20170327	Phase 1/Phase 2		
BRD-K64800655-001-07-4	BRD-K64800655	PHA-793887	HUXYBQXJVXOMKX	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK7|CDK9	broad_id_20170327	Phase 1		
BRD-K64838454-001-01-0	BRD-K64838454	dipraglurant	LZXMUJCJAWVHPZ	glutamate receptor negative allosteric modulator	GRM5	broad_id_20170327	Phase 2		
BRD-K64874225-001-04-7	BRD-K64874225	NSC-4644	FVWJYYTZTCVBKE	ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor	PYGM	broad_id_20170327	Phase 2		
BRD-K64890080-001-13-8	BRD-K64890080	BI-2536	XQVVPGYIWAGRNI	PLK inhibitor	BRD4|PLK1|PLK2|PLK3	broad_id_20170327	Phase 2		
BRD-K64925568-001-01-8	BRD-K64925568	AMG-232	DRLCSJFKKILATL	MDM inhibitor	MDM2	broad_id_20170327	Phase 2		
BRD-K64931368-003-01-4	BRD-K64931368	aminocaproic-acid	SLXKOJJOQWFEFD	plasminogen activator inhibitor	LPA|PLAT|PLG	broad_id_20170327	Launched		
BRD-K64990520-001-08-4	BRD-K64990520	apocynin	DFYRUELUNQRZTB	NADPH oxidase inhibitor	NOX4	broad_id_20170327	Phase 1		
BRD-K65170927-001-01-6	BRD-K65170927	aprepitant	ATALOFNDEOCMKK	tachykinin antagonist	TACR1	broad_id_20170327	Launched		
BRD-K65428967-001-08-4	BRD-K65428967	cordycepin	OFEZSBMBBKLLBJ	DNA inhibitor		broad_id_20170327	Phase 1/Phase 2		
BRD-K65678996-001-05-5	BRD-K65678996	nefiracetam	NGHTXZCKLWZPGK	acetylcholine receptor agonist|benzodiazepine receptor agonist	CHRM1	broad_id_20170327	Phase 3		
BRD-K65781196-001-03-0	BRD-K65781196	avanafil	WEAJZXNPAWBCOA	phosphodiesterase inhibitor	PDE5A	broad_id_20170327	Launched		
BRD-K65820248-001-01-8	BRD-K65820248	SDZ-NKT-343	PCVSIMQAFWRUEC	tachykinin antagonist	TACR1	broad_id_20170327	Phase 1		
BRD-K65928735-001-04-3	BRD-K65928735	AZD1480	PDOQBOJDRPLBQU	JAK inhibitor	JAK1|JAK2|JAK3	broad_id_20170327	Phase 1		
BRD-K65991129-001-02-9	BRD-K65991129	SB-705498	JYILLRHXRVTRSH	TRPV antagonist	TRPV1	broad_id_20170327	Phase 2		
BRD-K65992024-001-01-5	BRD-K65992024	pirenoxine	OKPNYGAWTYOBFZ	AGE inhibitor		broad_id_20170327	Launched		
BRD-K66035042-001-10-1	BRD-K66035042	mannitol-D	FBPFZTCFMRRESA	diuretic		broad_id_20170327	Launched	mucolytic agent	nan
BRD-K66175015-001-09-0	BRD-K66175015	afatinib	ULXXDDBFHOBEHA	EGFR inhibitor	EGFR|ERBB2|ERBB4	broad_id_20170327	Launched		
BRD-K66404838-310-01-1	BRD-K66404838	nalbuphine	NETZHAKZCGBWSS	opioid receptor agonist|opioid receptor antagonist	OPRD1|OPRK1|OPRM1	broad_id_20170327	Launched		
BRD-K66412701-066-01-6	BRD-K66412701	pazufloxacin	XAGMUUZPGZWTRP	topoisomerase inhibitor		broad_id_20170327	Launched		
BRD-K66538826-001-07-2	BRD-K66538826	amuvatinib	FOFDIMHVKGYHRU	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor	KIT|MET	broad_id_20170327	Phase 2		
BRD-K66615216-003-14-8	BRD-K66615216	moxifloxacin	FABPRXSRWADJSP	bacterial DNA gyrase inhibitor	TOP2A	broad_id_20170327	Launched		
BRD-K66876909-001-12-6	BRD-K66876909	linezolid	TYZROVQLWOKYKF	bacterial 50S ribosomal subunit inhibitor	MAOA|MAOB	broad_id_20170327	Launched		
BRD-K66911501-003-01-2	BRD-K66911501	MK-3207	AZAANWYREOQRFB	calcitonin antagonist	CALCA	broad_id_20170327	Phase 2		
BRD-K66937583-001-01-2	BRD-K66937583	lodoxamide	RVGLGHVJXCETIO	histamine receptor antagonist		broad_id_20170327	Launched		
BRD-K67017579-001-28-1	BRD-K67017579	cilostazol	RRGUKTPIGVIEKM	phosphodiesterase inhibitor	PDE3A|PDE3B	broad_id_20170327	Launched		
BRD-K67043667-001-26-4	BRD-K67043667	altretamine	UUVWYPNAQBNQJQ	DNA synthesis inhibitor		broad_id_20170327	Launched		
BRD-K67068943-001-01-0	BRD-K67068943	ORE1001	NTCCRGGIJNDEAB	angiotensin converting enzyme inhibitor	ACE2	broad_id_20170327	Phase 1/Phase 2		
BRD-K67080878-001-15-4	BRD-K67080878	milrinone	PZRHRDRVRGEVNW	phosphodiesterase inhibitor	PDE2A|PDE3A|PDE3B|PDE5A	broad_id_20170327	Launched		
BRD-K67102207-236-07-7	BRD-K67102207	phenylbutyrate	OBKXEAXTFZPCHS	HDAC inhibitor	HDAC1	broad_id_20170327	Launched		
BRD-K67121414-001-03-3	BRD-K67121414	apixaban	QNZCBYKSOIHPEH	coagulation factor inhibitor	F10	broad_id_20170327	Launched		
BRD-K67174965-001-02-7	BRD-K67174965	acetylcysteine	PWKSKIMOESPYIA	mucolytic agent	ACY1|CHUK|GRIN1|GRIN2A|GRIN2B|GRIN2D|GRIN3A|GSS|IKBKB|RELA|SLC7A11	broad_id_20170327	Launched		
BRD-K67277431-002-10-5	BRD-K67277431	picotamide	KYWCWBXGRWWINE	thromboxane receptor antagonist|thromboxane synthase inhibitor	TBXA2R	broad_id_20170327	Launched		
BRD-K67525671-001-02-5	BRD-K67525671	ZK-200775	WZMQMKNCWDCCMT	kainate receptor antagonist		broad_id_20170327	Phase 2		
BRD-K67680372-003-02-6	BRD-K67680372	CI-966	CMHQDSBIBSKHFP	GAT inhibitor	SLC6A1	broad_id_20170327	Phase 1		
BRD-K67783091-001-26-1	BRD-K67783091	haloperidol	LNEPOXFFQSENCJ	dopamine receptor antagonist	DRD1|DRD2|DRD3|DRD4|DRD5|GRIN2B|HRH1|HTR1A|HTR1D|HTR2A|HTR2B|HTR7|KCNH1	broad_id_20170327	Launched		
BRD-K67789209-001-01-0	BRD-K67789209	adatanserin	HPFLVTSWRFCPCV	serotonin receptor agonist|serotonin receptor antagonist	HTR1A|HTR2A	broad_id_20170327	Phase 2		
BRD-K67844266-003-01-9	BRD-K67844266	pevonedistat	MPUQHZXIXSTTDU	nedd activating enzyme inhibitor	NAE1|UBA3	broad_id_20170327	Phase 3		
BRD-K67868012-001-07-6	BRD-K67868012	PI-103	TUVCWJQQGGETHL	mTOR inhibitor|PI3K inhibitor	MTOR|PIK3CA|PIK3CB|PIK3CD|PIK3CG|PRKDC	broad_id_20170327	Preclinical		
BRD-K67901620-001-02-0	BRD-K67901620	avasimibe	PTQXTEKSNBVPQJ	ACAT inhibitor	CES1	broad_id_20170327	Phase 3		
BRD-K67966701-001-11-6	BRD-K67966701	lisinopril	RLAWWYSOJDYHDC	angiotensin converting enzyme inhibitor	ACE|ACE2	broad_id_20170327	Launched		
BRD-K68065987-300-09-1	BRD-K68065987	MK-2206	ULDXWLCXEDXJGE	AKT inhibitor	AKT1|AKT2|AKT3	broad_id_20170327	Phase 2		
BRD-K68095457-001-10-1	BRD-K68095457	palmitoylethanolamide	HXYVTAGFYLMHSO	cannabinoid receptor agonist	CNR2|GPR119|GPR55	broad_id_20170327	Launched		
BRD-K68103045-001-02-9	BRD-K68103045	CGS-20625	UBLXQFIFWUEVGJ	benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6	broad_id_20200324	Phase 1		
BRD-K68132782-003-13-8	BRD-K68132782	terbinafine	DOMXUEMWDBAQBQ	fungal squalene epoxidase inhibitor	SQLE	broad_id_20170327	Launched		
BRD-K68164687-001-01-6	BRD-K68164687	epothilone-B	QXRSDHAAWVKZLJ	microtubule stabilizing agent|tubulin polymerization inhibitor	TUBB	broad_id_20170327	Phase 3		
BRD-K68232413-001-01-2	BRD-K68232413	etizolam	VMZUTJCNQWMAGF	benzodiazepine receptor agonist	GABRA1	broad_id_20170327	Launched		
BRD-K68232650-001-02-2	BRD-K68232650		VPPJLAIAVCUEMN			broad_id_20170327			
BRD-K68346641-001-02-2	BRD-K68346641	amsacrine	XCPGHVQEEXUHNC	topoisomerase inhibitor	KCNH2|TOP2A	broad_id_20170327	Launched		
BRD-K68392338-003-02-0	BRD-K68392338	ZK-93426	VMDUABMKBUKKPG	benzodiazepine receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA5	broad_id_20170327	Phase 1		
BRD-K68488863-001-04-9	BRD-K68488863	ENMD-2076	BLQYVHBZHAISJM	Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor	AURKA|FLT3|KDR|PDGFRA|PTK2|SRC	broad_id_20170327	Phase 2		
BRD-K68532323-003-02-8	BRD-K68532323	SB-743921	PGXYIBJJCLWJST	kinesin-like spindle protein inhibitor	KIF11	broad_id_20170327	Phase 1/Phase 2		
BRD-K68552125-001-05-3	BRD-K68552125	12-O-tetradecanoylphorbol-13-acetate	PHEDXBVPIONUQT	PKC activator	KCNT2|TRPV4	broad_id_20170327	Phase 2		
BRD-K68693535-001-03-4	BRD-K68693535	lidamidine	RRHJHSBDJDZUGL	adrenergic receptor agonist		broad_id_20170327	Launched		
BRD-K68747584-001-02-0	BRD-K68747584	PF-03814735	RYYNGWLOYLRZLK	Aurora kinase inhibitor	AURKA|AURKB	broad_id_20170327	Phase 1		
BRD-K68867920-051-11-5	BRD-K68867920	quetiapine	URKOMYMAXPYINW	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR3A|HTR6|HTR7|SLC6A2	broad_id_20170327	Launched		
BRD-K68870568-066-01-5	BRD-K68870568	flumatinib	BJCJYEYYYGBROF	Bcr-Abl kinase inhibitor	ABL1|PDGFRB	broad_id_20170327	Phase 3		
BRD-K68938568-001-01-7	BRD-K68938568	GDC-0152	WZRFLSDVFPIXOV	XIAP inhibitor	BIRC2|BIRC3|BIRC7|XIAP	broad_id_20170327	Phase 1		
BRD-K69001009-001-02-8	BRD-K69001009	golvatinib	UQRCJCNVNUFYDX	VEGFR inhibitor	KDR|MET	broad_id_20170327	Phase 2		
BRD-K69116396-001-04-1	BRD-K69116396	sertindole	GZKLJWGUPQBVJQ	dopamine receptor antagonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA1D|DRD2|DRD3|DRD4|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR1F|HTR2A|HTR2C|HTR6|KCNH2	broad_id_20170327	Withdrawn		
BRD-K69122748-001-10-1	BRD-K69122748	diacerein	TYNLGDBUJLVSMA	interleukin inhibitor	IL1B	broad_id_20170327	Launched		
BRD-K69236721-001-02-7	BRD-K69236721	lumacaftor	UFSKUSARDNFIRC	CFTR channel agonist	CFTR	broad_id_20170327	Launched		
BRD-K69247067-001-01-8	BRD-K69247067	afloqualone	VDOSWXIDETXFET	acetylcholine receptor antagonist		broad_id_20170327	Launched		
BRD-K69688083-004-23-1	BRD-K69688083	mestinon	RVOLLAQWKVFTGE	cholinesterase inhibitor	ACHE|BCHE	broad_id_20170327	Launched		
BRD-K69726342-238-02-4	BRD-K69726342	atorvastatin	XUKUURHRXDUEBC	HMGCR inhibitor	AHR|DPP4|HMGCR	broad_id_20170327	Launched		
BRD-K69726595-001-01-2	BRD-K69726595	mericitabine	MLESJYFEMSJZLZ	HCV inhibitor		broad_id_20170327	Phase 2		
BRD-K69776681-001-03-8	BRD-K69776681	volasertib	SXNJFOWDRLKDSF	PLK inhibitor	PLK1	broad_id_20170327	Phase 3		
BRD-K70301465-001-02-6	BRD-K70301465	ibrutinib	XYFPWWZEPKGCCK	Bruton's tyrosine kinase (BTK) inhibitor	BLK|BMX|BTK	broad_id_20170327	Launched		
BRD-K70301876-034-13-7	BRD-K70301876	citalopram	WSEQXVZVJXJVFP	selective serotonin reuptake inhibitor (SSRI)	ADRA1A|CHRM1|HRH1|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched	selective serotonin reuptake inhibitor (SSRI)	SLC6A4
BRD-K70330367-003-07-9	BRD-K70330367	amantadine	DKNWSYNQZKUICI	glutamate receptor antagonist	DRD2|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A	broad_id_20170327	Launched		
BRD-K70358946-001-15-7	BRD-K70358946	aripiprazole	CEUORZQYGODEFX	serotonin receptor agonist|serotonin receptor antagonist	ADRA1A|ADRA1B|ADRA2A|ADRA2B|ADRA2C|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A|HTR2C|HTR3A|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K70401845-003-09-6	BRD-K70401845	erlotinib	AAKJLRGGTJKAMG	EGFR inhibitor	EGFR|NR1I2	broad_id_20170327	Launched		
BRD-K70463136-001-01-5	BRD-K70463136	BAY-87-2243	CDJNNOJINJAXPV	hypoxia inducible factor inhibitor	HIF1A	broad_id_20170327	Phase 1		
BRD-K70464547-003-01-2	BRD-K70464547	sertraline	VGKDLMBJGBXTGI	selective serotonin reuptake inhibitor (SSRI)	SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-K70490179-300-01-2	BRD-K70490179	rimcazole	GUDVQJXODNJRIJ	sigma receptor antagonist	SIGMAR1	broad_id_20170327	Phase 1		
BRD-K70505054-003-12-4	BRD-K70505054		VMXUWOKSQNHOCA			broad_id_20170327			
BRD-K70507123-001-09-7	BRD-K70507123	doxofylline	HWXIGFIVGWUZAO	adenosine receptor antagonist	ADORA1|PDE4A|PDE4B|PDE4C|PDE4D	broad_id_20170327	Launched		
BRD-K70511574-001-06-9	BRD-K70511574	HMN-214	OCKHRKSTDPOHEN	PLK inhibitor	PLK1	broad_id_20170327	Phase 1		
BRD-K70557564-305-03-6	BRD-K70557564	zosuquidar	IHOVFYSQUDPMCN	P glycoprotein inhibitor	ABCB1|ABCB4	broad_id_20170327	Phase 3		
BRD-K70592483-001-01-0	BRD-K70592483	phenylacetylglutamine	JFLIEFSWGNOPJJ	DNA methylase inhibitor|protein synthesis inhibitor		broad_id_20170327	Phase 2		
BRD-K70610771-001-02-9	BRD-K70610771	VX-222	WPMJNLCLKAKMLA	HCV inhibitor		broad_id_20170327	Phase 2		
BRD-K70778732-003-26-7	BRD-K70778732	trazodone	PHLBKPHSAVXXEF	adrenergic receptor antagonist|serotonin receptor antagonist|serotonin reuptake inhibitor	ADRA1A|ADRA2A|HRH1|HTR1A|HTR2A|HTR2B|HTR2C|SLC6A4	broad_id_20170327	Launched		
BRD-K70792160-003-04-6	BRD-K70792160	10-DEBC	GYBXAGDWMCJZJK	AKT inhibitor	PIM1	broad_id_20170327	Preclinical		
BRD-K70912147-001-01-8	BRD-K70912147	CO-102862	MHUUDVZSPFRUSK	sodium channel blocker	SCN4A|SCN9A	broad_id_20170327	Phase 1		
BRD-K70914287-300-02-8	BRD-K70914287	BIBX-1382	FTFRZXFNZVCRSK	EGFR inhibitor	EGFR|ERBB2	broad_id_20170327	Phase 1		
BRD-K70924353-001-01-2	BRD-K70924353	amtolmetin-guacil	CWJNMKKMGIAGDK	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K71035033-001-07-1	BRD-K71035033	masitinib	WJEOLQLKVOPQFV	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|SRC inhibitor	FGFR3|KIT|PDGFRA|PDGFRB	broad_id_20170327	Launched		
BRD-K71058253-001-01-9	BRD-K71058253	luliconazole	YTAOBBFIOAEMLL	sterol demethylase inhibitor		broad_id_20170327	Launched		
BRD-K71075609-003-01-0	BRD-K71075609	dorzolamide	IAVUPMFITXYVAF	carbonic anhydrase inhibitor	CA1|CA12|CA14|CA2|CA4|CA7	broad_id_20170327	Launched		
BRD-K71103788-003-12-0	BRD-K71103788	duloxetine	ZEUITGRIYCTCEM	norepinephrine reuptake inhibitor|serotoninânorepinephrine reuptake inhibitor (SNRI)	HTR2A|HTR2C|HTR6|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Launched		
BRD-K71106091-001-06-1	BRD-K71106091	fludarabine-phosphate	GIUYCYHIANZCFB	ribonucleotide reductase inhibitor	POLA1|POLD1|POLE|RRM1|RRM2|RRM2B	broad_id_20170327	Launched		
BRD-K71164191-001-01-0	BRD-K71164191	KD-023	CZRCFAOMWRAFIC	ACAT inhibitor	ACACA|ACACB	broad_id_20170327	Phase 2		
BRD-K71221037-001-01-6	BRD-K71221037	birinapant	PKWRMUKBEYJEIX	XIAP inhibitor	BIRC2|XIAP	broad_id_20170327	Phase 2		
BRD-K71281111-001-04-3	BRD-K71281111	SNX-2112	ZFVRYNYOPQZKDG	HSP inhibitor		broad_id_20170327	Phase 1		
BRD-K71289571-001-11-4	BRD-K71289571	zafirlukast	YEEZWCHGZNKEEK	leukotriene receptor antagonist	CYSLTR1|CYSLTR2	broad_id_20170327	Launched		
BRD-K71480163-001-01-4	BRD-K71480163	GDC-0068	GRZXWCHAXNAUHY	AKT inhibitor	AKT1|AKT2|AKT3|PRKG1	broad_id_20170327	Phase 3		
BRD-K71603915-003-01-8	BRD-K71603915	EVP-6124	SSRDSYXGYPJKRR	acetylcholine receptor agonist	CHRNA7	broad_id_20170327	Phase 3		
BRD-K71799949-001-36-4	BRD-K71799949	carbamazepine	FFGPTBGBLSHEPO	carboxamide antiepileptic	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K71822263-001-03-2	BRD-K71822263	D-serine	MTCFGRXMJLQNBG	glutamate receptor agonist	GLRA1|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|SERPINB3	broad_id_20170327	Launched		
BRD-K72005722-001-01-2	BRD-K72005722	VT-464	ZBRAJOQFSNYJMF	cytochrome P450 inhibitor	CYP17A1	broad_id_20170327	Phase 2		
BRD-K72029282-001-22-0	BRD-K72029282	probucol	FYPMFJGVHOHGLL	atherogenesis inhibitor	ABCA1|ABCB11|CES1	broad_id_20170327	Launched		
BRD-K72093121-001-16-3	BRD-K72093121	adenosine	OIRDTQYFTABQOQ	adenosine receptor agonist	ADORA1|ADORA2A|ADORA2B|ADORA3|PI4K2A|PI4K2B|TRPM4	broad_id_20170327	Launched	antiviral	ADA
BRD-K72166146-066-05-4	BRD-K72166146	dihydroergotamine	LUZRJRNZXALNLM	serotonin receptor agonist	ADRA2A|DRD2|HTR1B|HTR1D|HTR1E|HTR1F|HTR2B|HTR7	broad_id_20170327	Launched		
BRD-K72215350-001-06-5	BRD-K72215350	acexamic-acid	WDSCBUNMANHPFH	5 alpha reductase inhibitor	GAST	broad_id_20170327	Launched		
BRD-K72222507-003-16-8	BRD-K72222507	quinapril	JSDRRTOADPPCHY	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Launched		
BRD-K72414522-001-06-7	BRD-K72414522	AZD5438	WJRRGYBTGDJBFX	CDK inhibitor	KCNH2	broad_id_20170327	Phase 1		
BRD-K72827473-001-01-0	BRD-K72827473	CEP-37440	BCSHRERPHLTPEE	ALK tyrosine kinase receptor inhibitor	ALK	broad_id_20170327	Phase 1		
BRD-K72922393-003-15-2	BRD-K72922393	linsidomine	XZYRDNUZENBYFI	nitric oxide donor		deprecated_broad_id_20180907	Launched		
BRD-K72951360-001-01-4	BRD-K72951360	valrubicin	ZOCKGBMQLCSHFP	DNA inhibitor|topoisomerase inhibitor	TOP2A	broad_id_20170327	Launched		
BRD-K73088654-001-01-9	BRD-K73088654	floxuridine	ODKNJVUHOIMIIZ	DNA synthesis inhibitor	TYMS	broad_id_20170327	Launched		
BRD-K73107279-003-12-5	BRD-K73107279	levamisole	HLFSDGLLUJUHTE	acetylcholine receptor agonist	ALPL	broad_id_20170327	Withdrawn	immunostimulant	ALPPL2|CHRNA3
BRD-K73109821-001-20-1	BRD-K73109821	diazoxide	GDLBFKVLRPITMI	potassium channel activator	ATP1A1|CA1|CA2|KCNJ11|KCNJ8|KCNMA1|SLC12A3	broad_id_20170327	Launched		
BRD-K73196317-003-14-8	BRD-K73196317	urapidil	ICMGLRUYEQNHPF	adrenergic receptor antagonist	HTR1A	broad_id_20170327	Launched		
BRD-K73237276-001-01-0	BRD-K73237276	tacalcitol	BJYLYJCXYAMOFT	vitamin D receptor agonist	VDR	broad_id_20170327	Launched		
BRD-K73319509-001-08-0	BRD-K73319509	PF-04217903	PDMUGYOXRHVNMO	c-Met inhibitor	MET	broad_id_20170327	Phase 1		
BRD-K73381542-003-23-4	BRD-K73381542	phenylephrine	SONNWYBIRXJNDC	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D	broad_id_20170327	Launched		
BRD-K73395020-001-02-3	BRD-K73395020								
BRD-K73440166-001-01-3	BRD-K73440166	cinaciguat	WPYWMXNXEZFMAK	guanylate cyclase activator	GUCY1A3|GUCY1B3	broad_id_20170327	Phase 2		
BRD-K73524797-001-01-1	BRD-K73524797	ST-1859	ZPANWZBSGMDWON	antiamyloidogenic agent		broad_id_20170327	Phase 1		
BRD-K73541271-001-03-6	BRD-K73541271	etofenamate	XILVEPYQJIOVNB	cyclooxygenase inhibitor	PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K73691377-001-01-6	BRD-K73691377	alprostadil	GMVPRGQOIOIIMI	prostanoid receptor agonist	CATSPER1|CATSPER2|CATSPER3|CATSPER4|PTGDR|PTGER1|PTGER2|PTGER4|PTGIR	broad_id_20170327	Launched		
BRD-K73794685-001-01-5	BRD-K73794685	azithromycin	MQTOSJVFKKJCRP	bacterial 50S ribosomal subunit inhibitor	MLNR	broad_id_20170327	Launched		
BRD-K73815512-001-02-5	BRD-K73815512	HC-030031	HEQDZPHDVAOBLN	TRPA1 channel blocker	TRPA1	broad_id_20170327	Phase 1		
BRD-K73999723-001-11-3	BRD-K73999723	telmisartan	RMMXLENWKUUMAY	angiotensin receptor antagonist	AGTR1|PPARG	broad_id_20170327	Launched		
BRD-K74057757-001-01-9	BRD-K74057757	indibulin	SOLIIYNRSAWTSQ	tubulin polymerization inhibitor		broad_id_20170327	Phase 1/Phase 2		
BRD-K74065929-001-07-2	BRD-K74065929	doramapimod	MVCOAUNKQVWQHZ	p38 MAPK inhibitor	MAPK11|MAPK12|MAPK13|MAPK14	broad_id_20170327	Phase 2		
BRD-K74141488-003-11-2	BRD-K74141488	naftifine	OZGNYLLQHRPOBR	fungal squalene epoxidase inhibitor		broad_id_20170327	Launched		
BRD-K74190368-001-04-3	BRD-K74190368	resorcinol	GHMLBKRAJCXXBS	phosphodiesterase inhibitor	CA12|CA14|CA2|PTGS1	broad_id_20170327	Launched		
BRD-K74195153-050-12-1	BRD-K74195153	irsogladine	ATCGGEJZONJOCL	phosphodiesterase inhibitor	PDE4A	broad_id_20170327	Launched		
BRD-K74305673-001-06-2	BRD-K74305673	IKK-2-inhibitor-V	CHILCFMQWMQVAL	IKK inhibitor|NFkB pathway inhibitor	IKBKB	broad_id_20170327	Phase 1		
BRD-K74339692-001-01-9	BRD-K74339692	tamsulosin	DRHKJLXJIQTDTD	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D	broad_id_20170327	Launched		
BRD-K74363950-004-01-0	BRD-K74363950	aclidinium	ASMXXROZKSBQIH	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-K74371986-001-01-7	BRD-K74371986	NSI-189	DYTOQURYRYYNOR	neurotrophic agent		broad_id_20170327	Phase 2		
BRD-K74514084-001-03-9	BRD-K74514084	pazopanib	CUIHSIWYWATEQL	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	CSF1R|FGF1|FGFR1|FGFR3|FLT1|FLT4|ITK|KDR|KIT|PDGFRA|PDGFRB|SH2B3	broad_id_20170327	Launched		
BRD-K74717603-001-02-2	BRD-K74717603	etravirine	PYGWGZALEOIKDF	non-nucleoside reverse transcriptase inhibitor	CYP2C19|CYP2C9|CYP3A4	broad_id_20170327	Launched		
BRD-K74763371-002-04-0	BRD-K74763371	bosentan	GJPICJJJRGTNOD	endothelin receptor antagonist	EDNRA|EDNRB	broad_id_20170327	Launched		
BRD-K74765201-001-16-7	BRD-K74765201	tomelukast	MWYHLEQJTQJHSS	leukotriene receptor antagonist	CYSLTR1	broad_id_20170327	Phase 3		
BRD-K75024268-001-01-0	BRD-K75024268	lesinurad	FGQFOYHRJSUHMR	uric acid diuretic	SLC22A12	broad_id_20170327	Launched		
BRD-K75037734-003-13-9	BRD-K75037734	carbachol	VPJXQGSRWJZDOB	cholinergic receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|CHRNA2	broad_id_20170327	Launched		
BRD-K75089421-003-24-5	BRD-K75089421	procainamide	REQCZEXYDRLIBE	sodium channel blocker	DNMT1|SCN5A	broad_id_20170327	Launched		
BRD-K75295174-001-05-0	BRD-K75295174	alisertib	ZLHFILGSQDJULK	Aurora kinase inhibitor	AURKA	broad_id_20170327	Phase 3		
BRD-K75641298-003-25-0	BRD-K75641298	metoclopramide	TTWJBBZEZQICBI	dopamine receptor antagonist|serotonin receptor antagonist	CHRM1|DRD2|HTR3A|HTR3B|HTR4	broad_id_20170327	Launched		
BRD-K75649340-001-13-1	BRD-K75649340	tioguanine	OTDJAMXESTUWLO	purine antagonist		broad_id_20170327	Launched		
BRD-K75699339-057-08-1	BRD-K75699339	rizatriptan	ULFRLSNUDGIQQP	serotonin receptor agonist	HTR1A|HTR1B|HTR1D|HTR1E|HTR1F	broad_id_20170327	Launched		
BRD-K75844781-003-08-0	BRD-K75844781	mCPP	VHFVKMTVMIZMIK	serotonin receptor agonist	HTR1A|HTR1D|HTR1E|HTR2A|HTR2B|HTR2C|HTR6	broad_id_20170327	Phase 2		
BRD-K75911534-001-01-6	BRD-K75911534	SU014813	CTNPALGJUAXMMC	PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	KDR	broad_id_20170327	Phase 2		
BRD-K75958547-238-01-0	BRD-K75958547	pitavastatin	VGYFMXBACGZSIL	HMGCR inhibitor	HMGCR	broad_id_20170327	Launched		
BRD-K76022557-003-02-7	BRD-K76022557	(R)-(-)-apomorphine	VMWNQDUVQKEIOC	dopamine receptor agonist	ADRA2A|ADRA2B|ADRA2C|CALY|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR5A	broad_id_20170327	Launched		
BRD-K76197012-001-01-2	BRD-K76197012	ulipristal	OOLLAFOLCSJHRE	progesterone receptor antagonist	PGR	broad_id_20170327	Launched		
BRD-K76205745-237-16-5	BRD-K76205745	losartan	PSIFNNKUMBGKDQ	angiotensin receptor antagonist	AGTR1	broad_id_20170327	Launched		
BRD-K76210423-001-01-6	BRD-K76210423	resiquimod	BXNMTOQRYBFHNZ	toll-like receptor agonist	TLR7|TLR8	broad_id_20170327	Phase 3		
BRD-K76617868-003-11-9	BRD-K76617868	fasudil	NGOGFTYYXHNFQH	rho associated kinase inhibitor	PKIA|PRKACA|ROCK1|ROCK2	broad_id_20170327	Launched		
BRD-K76674262-001-03-3	BRD-K76674262	homoharringtonine	HYFHYPWGAURHIV	protein synthesis inhibitor	RPL3	broad_id_20170327	Launched		
BRD-K76703230-004-04-1	BRD-K76703230	YM-155	OTSOOHRUMBRSHZ	survivin inhibitor	BIRC5	broad_id_20170327	Phase 2		
BRD-K76775527-001-30-2	BRD-K76775527	nimesulide	HYWYRSMBCFDLJT	cyclooxygenase inhibitor	LTF|PLA2G2E|PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K76810206-001-07-3	BRD-K76810206	nicergoline	YSEXMKHXIOCEJA	adrenergic receptor antagonist	ADRA1A	broad_id_20170327	Launched		
BRD-K76812510-236-14-8	BRD-K76812510	metamizole	LVWZTYCIRDMTEY	cyclooxygenase inhibitor|opioid receptor agonist	PTGS1	broad_id_20170327	Withdrawn		
BRD-K76841105-001-04-7	BRD-K76841105	tazarotene	OGQICQVSFDPSEI	retinoid receptor agonist	RARA|RARB|RARG|RXRB	broad_id_20170327	Launched		
BRD-K76908866-001-07-6	BRD-K76908866	CP-724714	LLVZBTWPGQVVLW	EGFR inhibitor|protein tyrosine kinase inhibitor	ERBB2	broad_id_20170327	Phase 2		
BRD-K76953762-001-08-5	BRD-K76953762	indoramin	JXZZEXZZKAWDSP	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2B|ADRA2C	broad_id_20170327	Launched		
BRD-K77396579-300-01-0	BRD-K77396579	NVP-DPP728	VFFZWMWTUSXDCB	dipeptidyl peptidase inhibitor	DPP4	broad_id_20170327	Phase 2		
BRD-K77561571-001-01-1	BRD-K77561571	topiroxostat	UBVZQGOVTLIHLH	xanthine oxidase inhibitor	XDH	broad_id_20170327	Launched		
BRD-K77625799-001-07-7	BRD-K77625799	vandetanib	UHTHHESEBZOYNR	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	EGFR|EPHA1|EPHA10|EPHA2|EPHA3|EPHA4|EPHA5|EPHA6|EPHA7|EPHA8|EPHB1|EPHB2|EPHB3|EPHB4|EPHB6|ERBB2|ERBB3|ERBB4|FLT1|FLT4|KDR|PTK6|RET|SRC|TEK|VEGFA	broad_id_20170327	Launched		
BRD-K77641333-003-27-1	BRD-K77641333	naphazoline	CNIIGCLFLJGOGP	adrenergic receptor agonist	ADRA1A|ADRA2A	broad_id_20170327	Launched		
BRD-K77685957-300-09-1	BRD-K77685957	dequalinium	PCSWXVJAIHCTMO	PKC inhibitor	KCNN1|KCNN3	broad_id_20170327	Launched		
BRD-K77695569-001-30-0	BRD-K77695569	tiabendazole	WJCNZQLZVWNLKY	angiogenesis inhibitor		broad_id_20170327	Launched		
BRD-K77771411-003-10-7	BRD-K77771411	moxonidine	WPNJAUFVNXKLIM	imidazoline receptor agonist	ADRA2A|ADRA2B|ADRA2C	broad_id_20170327	Launched		
BRD-K77908580-001-09-6	BRD-K77908580	entinostat	INVTYAOGFAGBOE	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC9	broad_id_20170327	Phase 3		
BRD-K77947974-001-16-3	BRD-K77947974	fluspirilene	QOYHHIBFXOOADH	dopamine receptor antagonist	CACNG1|DRD2|HRH1|HTR1A|HTR1D|HTR1E|HTR2A	broad_id_20170327	Launched		
BRD-K77987382-001-13-2	BRD-K77987382	mebendazole	OPXLLQIJSORQAM	tubulin polymerization inhibitor	TUBA1A|TUBB|TUBB4B	broad_id_20170327	Launched		
BRD-K78010432-001-21-5	BRD-K78010432	furosemide	ZZUFCTLCJUWOSV	diuretic	CA2|GPR35|SLC12A1|SLC12A2	broad_id_20170327	Launched		
BRD-K78055238-001-01-8	BRD-K78055238	LY2090314	HRJWTAWVFDCTGO	glycogen synthase kinase inhibitor	GSK3B	broad_id_20170327	Phase 2		
BRD-K78096648-001-05-7	BRD-K78096648	oxiperomide	NVDBBGBUTKLRSN	dopamine receptor antagonist		broad_id_20170327	Phase 2		
BRD-K78113049-001-16-2	BRD-K78113049	enoxacin	IDYZIJYBMGIQMJ	topoisomerase inhibitor	TOP2A	broad_id_20170327	Launched		
BRD-K78118466-001-03-3	BRD-K78118466	LY2157299	IVRXNBXKWIJUQB	TGF beta receptor inhibitor	TGFBR1	broad_id_20170327	Phase 2/Phase 3		
BRD-K78126613-001-28-5	BRD-K78126613	menadione	MJVAVZPDRWSRRC	mitochondrial DNA polymerase inhibitor|phosphatase inhibitor	AOX1|BGLAP|F10|F2|F7|F9|GGCX|NQO1|NQO2|PROC|PROS1|PROZ|VKORC1|VKORC1L1	broad_id_20170327	Launched		
BRD-K78303961-001-02-3	BRD-K78303961	glycitein	DXYUAIFZCFRPTH	tumor necrosis factor release inhibitor	TNF	broad_id_20170327	Phase 3		
BRD-K78431006-001-10-2	BRD-K78431006	crizotinib	KTEIFNKAUNYNJU	ALK tyrosine kinase receptor inhibitor	ALK|MET	broad_id_20170327	Launched	MTH1 inhibitor	NUDT1
BRD-K78485176-001-07-8	BRD-K78485176	olmesartan-medoxomil	UQGKUQLKSCSZGY	angiotensin receptor antagonist	AGTR1	broad_id_20170327	Launched		
BRD-K78513633-001-15-7	BRD-K78513633	lonidamine	WDRYRZXSPDWGEB	glucokinase inhibitor	GCK	broad_id_20170327	Launched		
BRD-K78567475-001-01-4	BRD-K78567475	dolastatin-10	OFDNQWIFNXBECV	tubulin polymerization inhibitor	TUBB	broad_id_20170327	Phase 2		
BRD-K78659596-001-03-9	BRD-K78659596	ixazomib	MXAYKZJJDUDWDS	proteasome inhibitor		broad_id_20170327	Launched		
BRD-K78692225-001-24-5	BRD-K78692225	leflunomide	VHOGYURTWQBHIL	dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor	AHR|DHODH|PTK2B	broad_id_20170327	Launched		
BRD-K79095980-001-09-6	BRD-K79095980	broxuridine	WOVKYSAHUYNSMH	antimetabolite		broad_id_20170327	Phase 2		
BRD-K79102359-003-01-6	BRD-K79102359	idalopirdine	YBAWYTYNMZWMMJ	serotonin receptor antagonist	HTR6	broad_id_20170327	Phase 3		
BRD-K79131256-001-17-9	BRD-K79131256	albendazole	HXHWSAZORRCQMX	tubulin polymerization inhibitor	TUBA1A|TUBB|TUBB4B	broad_id_20170327	Launched		
BRD-K79254416-001-22-6	BRD-K79254416	decitabine	XAUDJQYHKZQPEU	DNA methyltransferase inhibitor	DNMT1|DNMT3A	broad_id_20170327	Launched		
BRD-K79404599-001-09-3	BRD-K79404599	enzastaurin	AXRCEOKUDYDWLF	PKC inhibitor	AKT1|GSK3B|PRKCA|PRKCB|PRKCD|PRKCG	broad_id_20170327	Phase 3		
BRD-K79501723-001-04-6	BRD-K79501723	cyclizine	UVKZSORBKUEBAZ	histamine receptor modulator	HRH1|SULT1E1	broad_id_20170327	Launched		
BRD-K79595931-312-01-3	BRD-K79595931	bavisant	BGBVSGSIXIIREO	histamine receptor antagonist	HRH3	broad_id_20170327	Phase 2		
BRD-K79602928-003-19-9	BRD-K79602928	metformin	XZWYZXLIPXDOLR	insulin sensitizer	ACACB|PRKAB1	broad_id_20170327	Launched		
BRD-K79759585-048-04-8	BRD-K79759585	sildenafil	BNRNXUUZRGQAQC	phosphodiesterase inhibitor	PDE5A|PDE6G|PDE6H|SLCO1B1|SLCO1B3	broad_id_20170327	Launched		
BRD-K79989959-001-01-4	BRD-K79989959	nesbuvir	WTDWVLJJJOTABN	RNA polymerase inhibitor		broad_id_20170327	Phase 2		
BRD-K80043866-236-01-1	BRD-K80043866	sodium-gualenate	VIZXMHCBZLGUET	antacid		broad_id_20170327	Launched		
BRD-K80082640-001-01-0	BRD-K80082640	otamixaban	PFGVNLZDWRZPJW	coagulation factor inhibitor	F10	broad_id_20170327	Phase 3		
BRD-K80267133-001-17-7	BRD-K80267133	aminosalicylate	WUBBRNOQWQTFEX	cyclooxygenase inhibitor	ALOX5|CHUK|PLA2G2E|PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K80343549-001-02-6	BRD-K80343549	TAK-285	ZYQXEVJIFYIBHZ	EGFR inhibitor	ERBB2	broad_id_20170327	Phase 1		
BRD-K80396088-001-12-0	BRD-K80396088	gliquidone	LLJFMFZYVVLQKT	sulfonylurea	ABCC8|KCNJ10|KCNJ8	broad_id_20170327	Launched		
BRD-K80535353-001-01-4	BRD-K80535353	enoxolone	MPDGHEJMBKOTSU	gap junction modulator	HSD11B1	broad_id_20170327	Launched		
BRD-K80608265-001-01-6	BRD-K80608265	erteberel	XIESSJVMWNJCGZ	estrogen receptor agonist	ESR1|ESR2	broad_id_20170327	Phase 2		
BRD-K80700417-001-04-2	BRD-K80700417	SGI-1776	MHXGEROHKGDZGO	Pim kinase inhibitor	FLT3|PIM1|PIM2|PIM3	broad_id_20170327	Phase 1		
BRD-K80738081-001-26-0	BRD-K80738081	resveratrol	LUKBXSAWLPMMSZ	cytochrome P450 inhibitor|SIRT activator	CSNK2A1|NQO2|PTGS1|PTGS2	broad_id_20170327	Launched		
BRD-K81144366-003-19-7	BRD-K81144366	moxisylyte	VRYMTAVOXVTQEF	adrenergic receptor antagonist		broad_id_20170327	Withdrawn		
BRD-K81258678-001-01-0	BRD-K81258678	triptolide	DFBIRQPKNDILPW	RNA polymerase inhibitor	RELA	broad_id_20170327	Phase 3		
BRD-K81272440-236-13-5	BRD-K81272440	dantrolene	OZOMQRBLCMDCEG	calcium channel blocker	RYR1|RYR3	broad_id_20170327	Launched		
BRD-K81332461-001-01-4	BRD-K81332461	maxacalcitol	DTXXSJZBSTYZKE	vitamin D receptor agonist	VDR	broad_id_20170327	Launched		
BRD-K81458380-001-04-9	BRD-K81458380	CX-4945	MUOKSQABCJCOPU	casein kinase inhibitor	CSNK2A1|CSNK2A2|DAPK3|HIPK3	broad_id_20170327	Phase 1/Phase 2		
BRD-K81473089-003-26-1	BRD-K81473089	tacrine	YLJREFDVOIBQDA	acetylcholinesterase inhibitor	ACHE|BCHE	broad_id_20170327	Launched		
BRD-K81528515-001-13-8	BRD-K81528515	nilotinib	HHZIURLSWUIHRB	Abl kinase inhibitor|Bcr-Abl kinase inhibitor	ABL1|KIT	broad_id_20170327	Launched		
BRD-K81672972-001-03-1	BRD-K81672972	dinoprost	PXGPLTODNUVGFL	prostacyclin analog	PTGDR|PTGDR2|PTGER1|PTGER2|PTGER3|PTGER4|PTGFR|TBXA2R	broad_id_20170327	Launched		
BRD-K81694556-003-01-9	BRD-K81694556	VTP-27999	NXWASIVXQMMPLM	renin inhibitor	REN	broad_id_20170327	Phase 1		
BRD-K81795818-019-01-4	BRD-K81795818	exherin	FQVLRGLGWNWPSS	cadherin antagonist	CDH2	broad_id_20170327	Phase 2		
BRD-K81916719-001-13-9	BRD-K81916719	triclabendazole	NQPDXQQQCQDHHW	microtubule inhibitor	DNMT1	broad_id_20170327	Launched		
BRD-K81957469-001-01-0	BRD-K81957469	semagacestat	PKXWXXPNHIWQHW	gamma secretase inhibitor	PSEN1	broad_id_20170327	Phase 3		
BRD-K82135108-001-04-3	BRD-K82135108	elesclomol	BKJIXTWSNXCKJH	oxidative stress inducer	HSPA1A	broad_id_20170327	Phase 3		
BRD-K82164249-001-03-5	BRD-K82164249	andarine	YVXVTLGIDOACBJ	androgen receptor modulator	AR	broad_id_20170327	Phase 1		
BRD-K82225283-001-03-1	BRD-K82225283	isosorbide-mononitrate	YWXYYJSYQOXTPL	nitric oxide stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3	broad_id_20170327	Launched		
BRD-K82234479-001-09-4	BRD-K82234479	tramiprosate	SNKZJIOFVMKAOJ	beta amyloid protein neurotoxicity inhibitor	APP	broad_id_20170327	Phase 3		
BRD-K82236179-213-01-0	BRD-K82236179	dicoumarol	DOBMPNYZJYQDGZ	NADPH inhibitor	CRYZ|NQO1|VKORC1	broad_id_20170327	Launched		
BRD-K82244583-001-01-3	BRD-K82244583	binimetinib	ACWZRVQXLIRSDF	MEK inhibitor	MAP2K1|MAP2K2	broad_id_20170327	Launched		
BRD-K82467063-001-02-7	BRD-K82467063	SB-271046	LOCQRDBFWSXQQI	serotonin receptor antagonist	HTR6	broad_id_20170327	Phase 1		
BRD-K82522873-001-01-1	BRD-K82522873	N6022	YVPGZQLRPAGKLA	alcohol dehydrogenase inhibitor	ADH5	broad_id_20170327	Phase 1/Phase 2		
BRD-K82603084-408-01-1	BRD-K82603084	ethylenediaminetetraacetic-acid	KCXVZYZYPLLWCC	PKC inhibitor		broad_id_20170327	Launched		
BRD-K82677201-001-01-6	BRD-K82677201	almitrine	OBDOVFRMEYHSQB	neurotransmitter agonist	ATP1A1	broad_id_20170327	Launched		
BRD-K82746043-001-15-1	BRD-K82746043	navitoclax	JLYAXFNOILIKPP	BCL inhibitor	BCL2|BCL2L1|BCL2L2	broad_id_20170327	Phase 2		
BRD-K82767007-001-01-1	BRD-K82767007	dazoxiben	XQGZSYKGWHUSDH	thromboxane synthase inhibitor	TBXAS1	broad_id_20170327	Phase 2		
BRD-K82795137-001-26-2	BRD-K82795137	loratadine	JCCNYMKQOSZNPW	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K82846253-001-15-4	BRD-K82846253	repaglinide	FAEKWTJYAYMJKF	insulin secretagogue	ABCC8|KCNJ11|PPARG	broad_id_20170327	Launched		
BRD-K82928847-001-04-7	BRD-K82928847	ACY-1215	QGZYDVAGYRLSKP	HDAC inhibitor	HDAC1|HDAC2|HDAC3|HDAC6|HDAC8	broad_id_20170327	Phase 1/Phase 2		
BRD-K82941592-238-04-5	BRD-K82941592	rosuvastatin	BPRHUIZQVSMCRT	HMGCR inhibitor	HMGCR	broad_id_20170327	Launched		
BRD-K82967685-300-01-2	BRD-K82967685	mirodenafil	MIJFNYMSCFYZNY	phosphodiesterase inhibitor	PDE5A	broad_id_20170327	Launched		
BRD-K83057217-001-01-2	BRD-K83057217	doxifluridine	ZWAOHEXOSAUJHY	thymidylate synthase inhibitor	TYMS	broad_id_20170327	Launched		
BRD-K83186168-001-01-8	BRD-K83186168	AZD1981	JWYIGNODXSRKGP	CRTH receptor antagonist	PTGDR2	broad_id_20170327	Phase 2		
BRD-K83405785-001-01-5	BRD-K83405785	pimavanserin	RKEWSXXUOLRFBX	serotonin receptor inverse agonist	DRD2|HTR2A	broad_id_20170327	Launched		
BRD-K83508485-001-02-7	BRD-K83508485	FK-888	BFNKQTIJVFGCKQ	tachykinin antagonist	TACR1|TACR2	broad_id_20170327	Phase 2		
BRD-K83699324-001-01-1	BRD-K83699324	NMS-1286937	QHLVBNKYJGBCQJ	PLK inhibitor	FLT3|PLK1|PLK2|PLK3	broad_id_20170327	Phase 2		
BRD-K83720053-001-03-8	BRD-K83720053	avagacestat	XEAOPVUAMONVLA	gamma secretase inhibitor	PSEN1	broad_id_20170327	Phase 2		
BRD-K83794243-001-01-8	BRD-K83794243	palovarotene	YTFHCXIPDIHOIA	retinoid receptor agonist	RARG	broad_id_20170327	Phase 3		
BRD-K83837640-001-04-8	BRD-K83837640	JNJ-26481585	PAWIYAYFNXQGAP	HDAC inhibitor	HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9|MDM2	broad_id_20170327	Phase 2		
BRD-K83963101-001-06-9	BRD-K83963101	MLN8054	HHFBDROWDBDFBR	Aurora kinase inhibitor	AURKA	broad_id_20170327	Phase 1		
BRD-K84011460-051-01-7	BRD-K84011460	nizofenone	WZGBZLHGOVJDET	ion channel antagonist		broad_id_20170327	Launched		
BRD-K84091759-001-07-1	BRD-K84091759	candesartan	HTQMVQVXFRQIKW	angiotensin receptor antagonist	AGTR1	broad_id_20170327	Launched		
BRD-K84163249-001-01-9	BRD-K84163249	ercalcitriol	ZGLHBRQAEXKACO	vitamin D receptor agonist	VDR	broad_id_20170327	Phase 1		
BRD-K84466663-001-05-4	BRD-K84466663	nelarabine	IXOXBSCIXZEQEQ	DNA synthesis inhibitor|T cell inhibitor	POLA1	broad_id_20170327	Launched		
BRD-K84564571-001-02-4	BRD-K84564571	telatinib	QFCXANHHBCGMAS	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	KDR	broad_id_20170327	Phase 2		
BRD-K84683831-001-01-0	BRD-K84683831	radezolid	BTTNOGHPGJANSW	bacterial 30S ribosomal subunit inhibitor|bacterial 50S ribosomal subunit inhibitor		broad_id_20170327	Phase 2		
BRD-K84698278-001-03-4	BRD-K84698278	agomelatine	YJYPHIXNFHFHND	melatonin receptor agonist|serotonin receptor antagonist	HTR2A|HTR2B|HTR2C|MTNR1A|MTNR1B	broad_id_20170327	Launched		
BRD-K84748119-050-01-1	BRD-K84748119	vicriviroc	CNPVJJQCETWNEU	CC chemokine receptor antagonist	CCR5	broad_id_20170327	Phase 3		
BRD-K84783599-001-01-0	BRD-K84783599	riociguat	WXXSNCNJFUAIDG	guanylate cyclase stimulant	GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3	broad_id_20170327	Launched		
BRD-K84794093-001-07-5	BRD-K84794093	dideoxyadenosine	WVXRAFOPTSTNLL	nucleoside reverse transcriptase inhibitor		broad_id_20170327	Phase 1		
BRD-K84798689-236-02-9	BRD-K84798689	sodium-tanshinone-II-A-sulfonate	UJCACMLMPLLRGW	potassium channel activator		broad_id_20170327	Phase 2		
BRD-K84810405-003-01-1	BRD-K84810405	almorexant	DKMACHNQISHMDN	orexin receptor antagonist	HCRTR1|HCRTR2	broad_id_20170327	Phase 3		
BRD-K84892605-001-01-1	BRD-K84892605	IOWH032	DSFNLJXHXBIKDS	CFTR channel antagonist	CFTR	broad_id_20170327	Phase 2		
BRD-K84925803-001-01-9	BRD-K84925803	T-5224	DALCQQSLNPLQFZ	AP inhibitor	JUN	broad_id_20170327	Phase 2		
BRD-K84986517-001-01-8	BRD-K84986517	darunavir	CJBJHOAVZSMMDJ	HIV protease inhibitor	CYP3A4	broad_id_20170327	Launched		
BRD-K84996356-001-01-1	BRD-K84996356	AZD3514	JMEYDSHPKCSIJC	androgen receptor modulator	AR	broad_id_20170327	Phase 1		
BRD-K85090592-008-22-7	BRD-K85090592	pilocarpine	QCHFTSOMWOSFHM	acetylcholine receptor agonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-K85119730-001-28-9	BRD-K85119730	tolbutamide	JLRGJRBPOGGCBT	ATP channel blocker	ABCC8|KCNJ1|KCNJ11|KCNJ8	broad_id_20170327	Launched		
BRD-K85140930-001-12-7	BRD-K85140930	aphidicolin	NOFOAYPPHIUXJR	RNA synthesis inhibitor		broad_id_20170327	Phase 1		
BRD-K85307935-236-09-5	BRD-K85307935	novobiocin	YJQPYGGHQPGBLI	bacterial DNA gyrase inhibitor		broad_id_20170327	Launched		
BRD-K85337334-004-02-6	BRD-K85337334	otilonium	NQHNLNLJPDMBFN	acetylcholine receptor antagonist	CACNA1C	broad_id_20170327	Launched		
BRD-K85406984-001-01-0	BRD-K85406984	sobetirome	QNAZTOHXCZPOSA	thyroid hormone receptor agonist	THRA|THRB	broad_id_20170327	Phase 1/Phase 2		
BRD-K85606544-001-09-1	BRD-K85606544	neratinib	JWNPDZNEKVCWMY	EGFR inhibitor	EGFR|ERBB2|KDR	broad_id_20170327	Launched		
BRD-K85679373-001-01-1	BRD-K85679373	sulbactam	FKENQMMABCRJMK	beta lactamase inhibitor		broad_id_20170327	Launched		
BRD-K85751432-001-03-3	BRD-K85751432	refametinib	RDSACQWTXKSHJT	MEK inhibitor	MAP2K1|MAP2K2	broad_id_20170327	Phase 2		
BRD-K85833139-001-01-9	BRD-K85833139	dehydroepiandrosterone	FMGSKLZLMKYGDP	protein synthesis stimulant	ESR1|ESR2|G6PD|GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B|HSD17B1|NR1I2|NR1I3|PPARA|SIGMAR1|SULT2A1|SULT2B1	broad_id_20170327	Launched		
BRD-K85925969-001-17-4	BRD-K85925969	zalcitabine	WREGKURFCTUGRC	nucleoside reverse transcriptase inhibitor		broad_id_20170327	Launched		
BRD-K86118762-001-01-8	BRD-K86118762	linsitinib	PKCDDUHJAFVJJB	IGF-1 inhibitor	IGF1R|INSR|INSRR	broad_id_20170327	Phase 3		
BRD-K86301799-001-34-8	BRD-K86301799	dipyridamole	IZEKFCXSFNUWAM	phosphodiesterase inhibitor	ADA|PDE10A|PDE1A|PDE1B|PDE1C|PDE2A|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A|PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H|PDE7A|PDE7B|PDE8A|PDE8B|PDE9A|SLC29A1	broad_id_20170327	Launched		
BRD-K86307448-001-17-5	BRD-K86307448	allopurinol	OFCNXPDARWKPPY	xanthine oxidase inhibitor	XDH	broad_id_20170327	Launched		
BRD-K86525559-001-04-5	BRD-K86525559	AZD7762	IAYGCINLNONXHY	CHK inhibitor	CHEK1|CHEK2	broad_id_20170327	Phase 1		
BRD-K86797399-001-04-4	BRD-K86797399	SB-939	JHDKZFFAIZKUCU	HDAC inhibitor	HDAC1|HDAC10|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC9	broad_id_20170327	Phase 3		
BRD-K86816506-001-01-8	BRD-K86816506	PF-04457845	BATCTBJIJJEPHM	FAAH inhibitor	FAAH	broad_id_20170327	Phase 2		
BRD-K86882815-001-03-2	BRD-K86882815	cabergoline	KORNTPPJEAJQIU	dopamine receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR1B|HTR1D|HTR2A|HTR2B|HTR2C|HTR7	broad_id_20170327	Launched		
BRD-K86892782-001-17-0	BRD-K86892782	edoxudine	XACKNLSZYYIACO	DNA directed DNA polymerase inhibitor		broad_id_20170327	Launched		
BRD-K86930074-001-05-0	BRD-K86930074	cediranib	XXJWYDDUDKYVKI	KIT inhibitor|VEGFR inhibitor	CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRA|PDGFRB	broad_id_20170327	Phase 3		
BRD-K87156652-001-12-7	BRD-K87156652	carbimazole	CFOYWRHIYXMDOT	antithyroid agent	TPO	broad_id_20170327	Launched		
BRD-K87202646-061-04-9	BRD-K87202646	isoniazid	QRXWMOHMRWLFEY	FABI inhibitor	CYP1A2|CYP2C19|CYP2C8|CYP2E1|CYP3A4	broad_id_20170327	Launched		
BRD-K87278688-001-01-0	BRD-K87278688		YFGHCGITMMYXAQ			broad_id_20170327			
BRD-K87300616-001-01-9	BRD-K87300616	chenodeoxycholic-acid	RUDATBOHQWOJDD	11-beta hydroxysteroid dehydrogenase inhibitor|FXR agonist	HSD11B1|NR1H4	broad_id_20170327	Launched	nuclear factor erythroid derived|like (NRF2) activator	AKR1C2|NR1H4
BRD-K87737963-001-06-0	BRD-K87737963	cyt387	ZVHNDZWQTBEVRY	JAK inhibitor	JAK1|JAK2|JAK3	broad_id_20170327	Phase 3		
BRD-K87782578-001-01-4	BRD-K87782578	AVL-292	KXBDTLQSDKGAEB	Bruton's tyrosine kinase (BTK) inhibitor	BTK|YES1	broad_id_20170327	Phase 2		
BRD-K87909389-003-03-4	BRD-K87909389	alvocidib	BIIVYFLTOXDAOV	CDK inhibitor	CDK1|CDK2|CDK4|CDK5|CDK6|CDK7|CDK8|CDK9|EGFR|PYGM	broad_id_20170327	Phase 2		
BRD-K87990216-001-10-2	BRD-K87990216	piretanide	UJEWTUDSLQGTOA	glucocorticoid receptor agonist	SLC12A1|SLC12A2	broad_id_20170327	Launched		
BRD-K88025533-003-03-3	BRD-K88025533	fingolimod	KKGQTZUTZRNORY	immunosuppressant|sphingosine 1-phosphate receptor agonist	S1PR1|S1PR5	broad_id_20170327	Launched		
BRD-K88052444-001-08-8	BRD-K88052444	urea	XSQUKJJJFZCRTK	hydroxy radical formation stimulant	ARG1|CA2|CTNNB1	broad_id_20170327	Launched		
BRD-K88358234-003-04-8	BRD-K88358234	xaliproden	WJJYZXPHLSLMGE	serotonin receptor agonist	HTR1A	broad_id_20170327	Phase 3		
BRD-K88366685-300-06-0	BRD-K88366685	trimetazidine	UHWVSEOVJBQKBE	3-ketoacyl CoA thiolase inhibitor	ACAA2	broad_id_20170327	Launched		
BRD-K88429204-001-35-1	BRD-K88429204	pyrimethamine	WKSAUQYGYAYLPV	dihydrofolate reductase inhibitor	DHFR|SLC47A1	broad_id_20170327	Launched		
BRD-K88506063-001-01-8	BRD-K88506063	KD025	GKHIVNAUVKXIIY	rho associated kinase inhibitor	ROCK2	broad_id_20170327	Phase 2		
BRD-K88510285-001-11-1	BRD-K88510285	bortezomib	GXJABQQUPOEUTA	NFkB pathway inhibitor|proteasome inhibitor	PSMA1|PSMA2|PSMA3|PSMA4|PSMA5|PSMA6|PSMA7|PSMA8|PSMB1|PSMB10|PSMB11|PSMB2|PSMB3|PSMB4|PSMB5|PSMB6|PSMB7|PSMB8|PSMB9|PSMD1|PSMD2|RELA	broad_id_20170327	Launched		
BRD-K88544581-001-06-1	BRD-K88544581	CI-976	WAFNZAURAWBNDZ	ACAT inhibitor	ACAT1|CES1	broad_id_20170327	Phase 1		
BRD-K88611939-001-22-4	BRD-K88611939	aniracetam	ZXNRTKGTQJPIJK	glutamate receptor agonist	DRD2|GRIA1|GRIA2|GRIA3|GRIA4|HTR2A	broad_id_20170327	Launched		
BRD-K88789588-001-14-9	BRD-K88789588	letrozole	HPJKCIUCZWXJDR	aromatase inhibitor	CYP19A1	broad_id_20170327	Launched		
BRD-K88807631-001-01-3	BRD-K88807631	elacridar	OSFCMRGOZNQUSW	P glycoprotein inhibitor	ABCB1	broad_id_20170327	Phase 1		
BRD-K89014967-001-04-3	BRD-K89014967	AS-703026	VIUAUNHCRHHYNE	MEK inhibitor	MAP2K1|MAP2K2	broad_id_20170327	Phase 2		
BRD-K89015388-001-01-7	BRD-K89015388	GSK923295	WHMXDBPHBVLYRC	centromere associated protein inhibitor	CENPE	broad_id_20170327	Phase 1		
BRD-K89104321-003-14-8	BRD-K89104321	gaboxadol	ZXRVKCBLGJOCEE	benzodiazepine receptor agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRD|GABRR1|GABRR2|GABRR3	broad_id_20170327	Phase 3		
BRD-K89162000-001-06-4	BRD-K89162000	tandutinib	UXXQOJXBIDBUAC	FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor	CSF1R|FLT3|KIT|PDGFD|PDGFRB	broad_id_20170327	Phase 2		
BRD-K89208535-051-01-5	BRD-K89208535	indacaterol	QZZUEBNBZAPZLX	adrenergic receptor agonist	ADRB1|ADRB2	broad_id_20170327	Launched		
BRD-K89274813-001-02-3	BRD-K89274813	DMP-543	MUJBUUDUXGDXLW	acetylcholine release enhancer		broad_id_20170327	Phase 2		
BRD-K89348303-001-14-7	BRD-K89348303	ramipril	HDACQVRGBOVJII	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Launched		
BRD-K89375097-300-08-8	BRD-K89375097	pirenzepine	RMHMFHUVIITRHF	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-K89402695-001-02-3	BRD-K89402695	L-655240	JLPYLHLUHJOPNL	thromboxane receptor antagonist	PTGES	broad_id_20170327	Phase 1		
BRD-K89561498-001-01-7	BRD-K89561498	SN-38	FJHBVJOVLFPMQE	topoisomerase inhibitor	TOP1	broad_id_20170327	Launched		
BRD-K89704198-001-12-3	BRD-K89704198	vincamine	RXPRRQLKFXBCSJ	adrenergic receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4	broad_id_20170327	Withdrawn		
BRD-K89732114-300-08-9	BRD-K89732114	trifluoperazine	ZEWQUBUPAILYHI	dopamine receptor antagonist	ADRA1A|CALM1|CALY|DRD2|DRD4|HRH1|HTR2A|HTR2C|S100A4|TNNC1	broad_id_20170327	Launched		
BRD-K89917372-001-01-2	BRD-K89917372		PCOBBVZJEWWZFR			broad_id_20170327			
BRD-K89997465-003-43-0	BRD-K89997465	chlorpromazine	ZPEIMTDSQAKGNT	dopamine receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|CALM1|CHRM1|CHRM3|DRD1|DRD2|DRD3|DRD4|DRD5|HRH1|HRH4|HTR1A|HTR2A|HTR2B|HTR2C|HTR6|HTR7|KCNH2|ORM1|ORM2|SMPD1|TRPC5	broad_id_20170327	Launched		
BRD-K90195324-003-02-5	BRD-K90195324	bazedoxifene	UCJGJABZCDBEDK	selective estrogen receptor modulator (SERM)	ESR1|ESR2	broad_id_20170327	Launched		
BRD-K90239174-001-01-8	BRD-K90239174	AMG-487	WQTKNBPCJKRYPA	CC chemokine receptor antagonist		broad_id_20170327	Phase 2	CC chemokine receptor antagonist	CXCR3
BRD-K90333595-003-21-4	BRD-K90333595	phentolamine	MRBDMNSDAVCSSF	adrenergic receptor antagonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C	broad_id_20170327	Launched		
BRD-K90777969-300-01-2	BRD-K90777969	cutamesine	UVSWWUWQVAQPJR	sigma receptor agonist	SIGMAR1	broad_id_20170327	Phase 2		
BRD-K90789829-001-07-8	BRD-K90789829	nefazodone	VRBKIVRKKCLPHA	adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor	ADRA1A|ADRA1B|ADRA2A|CYP3A4|HTR1A|HTR2A|HTR2C|SLC6A2|SLC6A3|SLC6A4	broad_id_20170327	Withdrawn		
BRD-K90825648-001-02-0	BRD-K90825648	RS-127445	ZZZQXCUPAJFVBN	serotonin receptor antagonist	HTR2A|HTR2B|HTR2C	broad_id_20170327	Phase 1		
BRD-K90868879-001-03-8	BRD-K90868879	canagliflozin	XTNGUQKDFGDXSJ	sodium/glucose cotransporter inhibitor	SLC5A1|SLC5A2	broad_id_20170327	Launched		
BRD-K90948141-001-01-4	BRD-K90948141	indiplon	CBIAWPMZSFFRGN	benzodiazepine receptor agonist	GABRA1	broad_id_20170327	Phase 3		
BRD-K91111634-001-01-2	BRD-K91111634	rotigotine	KFQYTPMOWPVWEJ	dopamine receptor agonist	ADRA2B|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A	broad_id_20170327	Launched		
BRD-K91159026-001-01-7	BRD-K91159026	telcagepant	CGDZXLJGHVKVIE	calcitonin antagonist	CALCRL|RAMP1	broad_id_20170327	Phase 3		
BRD-K91263825-003-21-4	BRD-K91263825	nortriptyline	PHVGLTMQBUFIQQ	tricyclic antidepressant	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3|CHRM1|CHRM2|CHRM3|CHRM4|CHRM5|DRD2|HRH1|HTR1A|HTR2A|HTR2C|HTR6|KCNJ10|PGRMC1|SIGMAR1|SLC6A2|SLC6A4	broad_id_20170327	Launched		
BRD-K91290917-300-01-8	BRD-K91290917	amodiaquine	OVCDSSHSILBFBN	histamine receptor agonist	HNMT	broad_id_20170327	Launched		
BRD-K91301684-003-05-5	BRD-K91301684	noscapine	AKNNEGZIBPJZJG	bradykinin receptor antagonist|tubulin polymerization inhibitor	SIGMAR1	broad_id_20170327	Launched		
BRD-K91308639-001-02-7	BRD-K91308639	apalutamide	HJBWBFZLDZWPHF	androgen receptor antagonist		broad_id_20170327	Launched		
BRD-K91315211-300-05-7	BRD-K91315211	betahistine	UUQMNUMQCIQDMZ	histamine receptor agonist|histamine receptor antagonist	HRH1|HRH3	broad_id_20170327	Launched		
BRD-K91336023-003-01-0	BRD-K91336023	mesulergine	JLVHTNZNKOSCNB	dopamine receptor agonist	HTR2A|HTR2B|HTR2C|HTR3A|HTR3B|HTR6|HTR7	broad_id_20170327	Phase 2		
BRD-K91456750-238-01-7	BRD-K91456750	sacubitril	PYNXFZCZUAOOQC	neprilysin inhibitor	MME	broad_id_20170327	Launched		
BRD-K91495480-001-02-2	BRD-K91495480	AGP-103	UKMSUNONTOPOIO	membrane permeability inhibitor		broad_id_20170327	Launched		
BRD-K91544578-001-03-8	BRD-K91544578	nikethamide	NCYVXEGFNDZQCU	immunostimulant		broad_id_20170327	Withdrawn		
BRD-K91601245-001-12-0	BRD-K91601245	mercaptopurine	GLVAUDGFNGKCSF	immunosuppressant|protein synthesis inhibitor|purine antagonist	HPRT1|IMPDH1|IMPDH2|PPAT	broad_id_20170327	Launched		
BRD-K91740057-001-19-8	BRD-K91740057	felbinac	QRZAKQDHEVVFRX	cyclooxygenase inhibitor	CTSL	broad_id_20170327	Launched		
BRD-K91822704-003-07-2	BRD-K91822704	torcitabine	CKTSBUTUHBMZGZ	DNA polymerase inhibitor	DCK|TK2	broad_id_20170327	Phase 2		
BRD-K91825936-001-01-2	BRD-K91825936	ZK-811752	XQYASZNUFDVMFH	CC chemokine receptor antagonist	CCR1	broad_id_20170327	Phase 2		
BRD-K92041145-001-09-5	BRD-K92041145	O6-benzylguanine	KRWMERLEINMZFT	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT	broad_id_20170327	Phase 3		
BRD-K92049597-001-20-8	BRD-K92049597	triamterene	FNYLWPVRPXGIIP	sodium channel blocker	SCNN1A|SCNN1B|SCNN1D|SCNN1G	broad_id_20170327	Launched		
BRD-K92093830-003-30-8	BRD-K92093830	doxorubicin	AOJJSUZBOXZQNB	topoisomerase inhibitor	TOP2A	broad_id_20170327	Launched	topoisomerase inhibitor	CHD1|TOP2A
BRD-K92213669-001-01-3	BRD-K92213669	lomitapide	MBBCVAKAJPKAKM	microsomal trigylceride transfer protein inhibitor	MTTP	broad_id_20170327	Launched		
BRD-K92241597-001-06-0	BRD-K92241597	tosedostat	FWFGIHPGRQZWIW	peptidase inhibitor	ANPEP|LAP3|NPEPPS	broad_id_20170327	Phase 2		
BRD-K92301463-001-05-5	BRD-K92301463	16,16-dimethylprostaglandin-e2	QAOBBBBDJSWHMU	prostanoid receptor agonist	HPGD	broad_id_20170327	Phase 2		
BRD-K92303087-001-01-6	BRD-K92303087	oglemilast	OKFDRAHPFKMAJH	phosphodiesterase inhibitor		broad_id_20170327	Phase 2		
BRD-K92428153-001-04-4	BRD-K92428153	mycophenolate-mofetil	RTGDFNSFWBGLEC	dehydrogenase inhibitor|inositol monophosphatase inhibitor	IMPDH1|IMPDH2	broad_id_20170327	Launched		
BRD-K92428232-001-10-6	BRD-K92428232	GSK461364	ZHJGWYRLJUCMRT	PLK inhibitor	PLK1	broad_id_20170327	Phase 1		
BRD-K92441787-001-04-1	BRD-K92441787	bexarotene	NAVMQTYZDKMPEU	retinoid receptor agonist	RXRA|RXRB|RXRG	broad_id_20170327	Launched		
BRD-K92467929-001-01-1	BRD-K92467929		QSLJIVKCVHQPLV			broad_id_20170327			
BRD-K92613113-066-02-7	BRD-K92613113	safinamide	NEMGRZFTLSKBAP	dopamine reuptake inhibitor|glutamate inhibitor|monoamine oxidase inhibitor	MAOB	broad_id_20170327	Launched		
BRD-K92657060-001-05-7	BRD-K92657060		HUNXMJYCHXQEGX			broad_id_20170327			
BRD-K92723993-001-06-7	BRD-K92723993	imatinib	KTUFNOKKBVMGRW	Bcr-Abl kinase inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor	ABL1|CSF1R|DDR1|KIT|NTRK1|PDGFRA|PDGFRB|RET	broad_id_20170327	Launched		
BRD-K92731339-227-04-9	BRD-K92731339	perindopril	IPVQLZZIHOAWMC	angiotensin converting enzyme inhibitor	ACE	broad_id_20170327	Launched		
BRD-K92758126-001-18-8	BRD-K92758126	MD-920	IXORZMNAPKEEDV	NFkB pathway inhibitor	AADACL2	broad_id_20170327	Phase 1		
BRD-K92848252-001-01-9	BRD-K92848252	diminazene-aceturate	XNYZHCFCZNMTFY	angiotensin converting enzyme activator	AOC1|PRDX5|PRSS1	broad_id_20170327	Phase 3		
BRD-K92968657-001-01-6	BRD-K92968657	tirapazamine	ORYDPOVDJJZGHQ	DNA inhibitor		broad_id_20170327	Phase 3		
BRD-K92984783-003-05-7	BRD-K92984783	melperone	DKMFBWQBDIGMHM	dopamine receptor antagonist|serotonin receptor antagonist	DRD2|HTR2A	broad_id_20170327	Launched		
BRD-K93034159-001-25-8	BRD-K93034159	cladribine	PTOAARAWEBMLNO	adenosine deaminase inhibitor|ribonucleotide reductase inhibitor	ADA|PNP|POLA1|POLE|POLE2|POLE3|POLE4|RRM1|RRM2|RRM2B	broad_id_20170327	Launched		
BRD-K93123848-001-04-1	BRD-K93123848	RAF265	YABJJWZLRMPFSI	RAF inhibitor|VEGFR inhibitor	BRAF	broad_id_20170327	Phase 2		
BRD-K93208532-001-02-5	BRD-K93208532	apremilast	IMOZEMNVLZVGJZ	phosphodiesterase inhibitor	PDE4A|PDE4B|PDE4C|PDE4D	broad_id_20170327	Launched		
BRD-K93255255-001-02-1	BRD-K93255255	indoximod	ZADWXFSZEAPBJS	indoleamine 2,3-dioxygenase inhibitor	IDO1	broad_id_20170327	Phase 2		
BRD-K93460210-001-23-7	BRD-K93460210	lamotrigine	PYZRQGJRPPTADH	serotonin receptor antagonist|sodium channel blocker	SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A	broad_id_20170327	Launched		
BRD-K93461745-003-25-0	BRD-K93461745	buspirone	QWCRAEMEVRGPNT	serotonin receptor agonist	DRD2|HTR1A	broad_id_20170327	Launched		
BRD-K93618743-001-21-0	BRD-K93618743	ipriflavone	SFBODOKJTYAUCM	bone resorption inhibitor		broad_id_20170327	Launched		
BRD-K93633846-001-01-7	BRD-K93633846	hesperidin	QUQPHWDTPGMPEX	flavanone glycoside	AURKB|CACNA1B	broad_id_20170327	Launched		
BRD-K93645900-001-11-3	BRD-K93645900	tadalafil	WOXKDUGGOYFFRN	phosphodiesterase inhibitor	PDE11A|PDE5A	broad_id_20170327	Launched		
BRD-K93754473-048-20-2	BRD-K93754473	tamoxifen	NKANXQFJJICGDU	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	EBP|ESR1|ESR2|GPER1|PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCI|PRKCQ|PRKCZ	broad_id_20170327	Launched		
BRD-K93767137-001-01-1	BRD-K93767137	oseltamivir-carboxylate	NENPYTRHICXVCS	neuraminidase inhibitor		broad_id_20170327	Launched		
BRD-K93779381-001-01-9	BRD-K93779381	ingenol-mebutate	VDJHFHXMUKFKET	PKC activator	PRKCA|PRKCB|PRKCD|PRKCE|PRKCG	broad_id_20170327	Launched		
BRD-K93869735-001-01-1	BRD-K93869735	taltirelin	LQZAIAZUDWIVPM	thyrotropin releasing hormone receptor agonist	TRHR	broad_id_20170327	Launched		
BRD-K93880783-001-26-6	BRD-K93880783	stavudine	XNKLLVCARDGLGL	DNA directed DNA polymerase inhibitor|nucleoside reverse transcriptase inhibitor		broad_id_20170327	Launched		
BRD-K93918653-001-08-9	BRD-K93918653	quizartinib	CVWXJKQAOSCOAB	FLT3 inhibitor	CSF1R|FLT3|KIT|PDGFRA|PDGFRB|RET	broad_id_20170327	Phase 3		
BRD-K93944989-001-08-0	BRD-K93944989	safingol	OTKJDMGTUTTYMP	PKC inhibitor	TRPM3	broad_id_20170327	Phase 1		
BRD-K94288301-001-01-7	BRD-K94288301	letermovir	FWYSMLBETOMXAG	CMV terminase inhibitor		broad_id_20170327	Launched		
BRD-K94293891-001-01-3	BRD-K94293891		JYTNQNCOQXFQPK			broad_id_20170327			
BRD-K94397152-001-01-6	BRD-K94397152	ribavirin	IWUCXVSUMQZMFG	antiviral	ADK|ENPP1|IMPDH1|IMPDH2|NT5C2	broad_id_20170327	Launched		
BRD-K94420399-001-01-9	BRD-K94420399	PF-04136309	ZNSVOHSYDRPBGI	CC chemokine receptor antagonist		broad_id_20170327	Phase 2		
BRD-K94436377-001-10-2	BRD-K94436377	diosmin	GZSOSUNBTXMUFQ	aryl hydrocarbon receptor agonist|capillary stabilizing agent	AHR	broad_id_20170327	Launched		
BRD-K94534639-001-02-5	BRD-K94534639	LY2811376	MJQMRGWYPNIERM	beta-secretase inhibitor	BACE1	broad_id_20170327	Phase 1		
BRD-K94830329-001-03-0	BRD-K94830329	ataluren	OOUGLTULBSNHNF	CFTR channel agonist|dystrophin stimulant	DMD	broad_id_20170327	Launched		
BRD-K95142244-001-01-5	BRD-K95142244	talazoparib	HWGQMRYQVZSGDQ	PARP inhibitor	PARP2	broad_id_20170327	Launched		
BRD-K95237249-001-26-5	BRD-K95237249	probenecid	DBABZHXKTCFAPX	uricosuric blocker	PANX1|SLC22A11|SLC22A6|SLC22A8|SLCO1C1	broad_id_20170327	Launched		
BRD-K95260951-050-03-1	BRD-K95260951	asenapine	VSWBSWWIRNCQIJ	dopamine receptor antagonist|serotonin receptor antagonist	DRD2|HRH1|HTR1A|HTR1B|HTR1D|HTR1E|HTR2A	broad_id_20170327	Launched		
BRD-K95412502-003-01-5	BRD-K95412502	istaroxime	MPYLDWFDPHRTEG	ATPase inhibitor	ATP1A1	broad_id_20170327	Phase 2		
BRD-K95739795-001-03-7	BRD-K95739795	tetrabenazine	MKJIEFSOBYUXJB	vesicular monoamine transporter inhibitor	SLC18A1|SLC18A2	broad_id_20170327	Launched		
BRD-K95763993-001-19-3	BRD-K95763993	trapidil	GSNOZLZNQMLSKJ	PDGFR tyrosine kinase receptor inhibitor	PDGFRA	broad_id_20170327	Launched		
BRD-K95773607-004-03-8	BRD-K95773607	darifenacin	HXGBXQDTNZMWGS	acetylcholine receptor antagonist	CHRM1|CHRM2|CHRM3|CHRM4|CHRM5	broad_id_20170327	Launched		
BRD-K95880107-001-02-4	BRD-K95880107	PH-797804	KCAJXIDMCNPGHZ	p38 MAPK inhibitor	MAPK11|MAPK14	broad_id_20170327	Phase 2		
BRD-K95901403-001-04-5	BRD-K95901403	XL147	MQMKRQLTIWPEDM	PI3K inhibitor	PIK3CA|PIK3CD|PIK3CG	broad_id_20170327	Phase 2		
BRD-K95921201-001-14-6	BRD-K95921201	reserpine	QEVHRUUCFGRFIF	vesicular monoamine transporter inhibitor	SLC18A1|SLC18A2	broad_id_20170327	Launched		
BRD-K96029467-003-01-9	BRD-K96029467	alagebrium	LYLFQLCLUXOFOL	glycosylation inhibitor		broad_id_20170327	Phase 2/Phase 3		
BRD-K96042922-001-09-8	BRD-K96042922	etanidazole	WCDWBPCFGJXFJZ	bacterial cell wall synthesis inhibitor		broad_id_20170327	Phase 3		
BRD-K96123349-236-02-8	BRD-K96123349	brequinar	PHEZJEYUWHETKO	dihydroorotate dehydrogenase inhibitor	DHODH	broad_id_20170327	Phase 2		
BRD-K96194081-001-10-2	BRD-K96194081	cepharanthine	YVPXVXANRNDGTA	NFkB pathway inhibitor		broad_id_20170327	Phase 2		
BRD-K96319534-003-03-9	BRD-K96319534		DHHVAGZRUROJKS			broad_id_20170327			
BRD-K96342952-001-01-2	BRD-K96342952	tobramycin	NLVFBUXFDBBNBW	bacterial 30S ribosomal subunit inhibitor		broad_id_20170327	Launched		
BRD-K96550715-001-02-6	BRD-K96550715	linagliptin	LTXREWYXXSTFRX	dipeptidyl peptidase inhibitor	DPP4	broad_id_20170327	Launched		
BRD-K96615647-001-01-2	BRD-K96615647	AV-608	NXLUTEDAEFXMQR	tachykinin antagonist	TACR1	broad_id_20170327	Phase 2		
BRD-K96671969-001-03-1	BRD-K96671969	pretomanid	ZLHZLMOSPGACSZ	nitric oxide donor	FASN	broad_id_20170327	Launched		
BRD-K96720755-001-02-6	BRD-K96720755	relcovaptan	CEBYCSRFKCEUSW	vasopressin receptor antagonist	AVPR1A|AVPR1B|AVPR2|OXTR	broad_id_20170327	Phase 2		
BRD-K96740444-001-02-1	BRD-K96740444	itopride	QQQIECGTIMUVDS	dopamine receptor antagonist	CHRM3|DRD2	broad_id_20170327	Launched		
BRD-K96862998-001-15-5	BRD-K96862998	pirfenidone	ISWRGOKTTBVCFA	TGF beta receptor inhibitor	FURIN|TNF	broad_id_20170327	Launched		
BRD-K96936751-001-01-4	BRD-K96936751	bretazenil	LWUDDYHYYNNIQI	GABA benzodiazepine site receptor partial agonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6	broad_id_20170327	Phase 2		
BRD-K97010173-001-04-1	BRD-K97010173	deferasirox	BOFQWVMAQOTZIW	chelating agent	CYP3A4	broad_id_20170327	Launched		
BRD-K97045029-001-02-7	BRD-K97045029	pranlukast	NBQKINXMPLXUET	leukotriene receptor antagonist	CYSLTR1|CYSLTR2|IL5|MUC2|NFKB1|RNASE3|TNF	broad_id_20170327	Launched		
BRD-K97101532-001-02-8	BRD-K97101532	tezacaftor	MJUVRTYWUMPBTR	CFTR channel agonist		broad_id_20170327	Launched		
BRD-K97158071-001-18-1	BRD-K97158071	droperidol	RMEDXOLNCUSCGS	dopamine receptor antagonist	ADRA1A|DRD2|DRD3|DRD4|HTR2A	broad_id_20170327	Launched		
BRD-K97181089-003-24-7	BRD-K97181089	amiloride	XSDQTOBWRPYKKA	sodium channel blocker	AOC1|ASIC1|ASIC2|ASIC3|PKD2|PKD2L1|PLAU|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC9A1|TRPC7|TRPV2	broad_id_20170327	Launched		
BRD-K97309399-001-09-4	BRD-K97309399	thiothixene	GFBKORZTTCHDGY	dopamine receptor antagonist	DRD1|DRD2|HRH1|HTR2A	broad_id_20170327	Launched		
BRD-K97399794-001-15-3	BRD-K97399794	quercetin	REFJWTPEDVJJIY	polar auxin transport inhibitor	ATP5A1|ATP5B|ATP5C1|HCK|HIBCH|PIK3CG|PIM1|STK17B|UGT3A1	broad_id_20170327	Launched		
BRD-K97428065-001-01-2	BRD-K97428065	netupitant	WAXQNWCZJDTGBU	tachykinin antagonist	TACR1	broad_id_20170327	Launched		
BRD-K97440753-066-18-1	BRD-K97440753	dihydroergocristine	DEQITUUQPICUMR	adrenergic receptor antagonist|prolactin inhibitor	ADRA1A|ADRB1|DRD1|DRD2|DRD3|DRD4|DRD5|HTR1A|HTR2A|HTR3A|HTR4|HTR5A|HTR6|HTR7	broad_id_20170327	Launched		
BRD-K97472745-001-01-8	BRD-K97472745	gestrinone	BJJXHLWLUDYTGC	progesterone receptor antagonist	AR|ESR1|PGR	broad_id_20170327	Launched		
BRD-K97530723-001-20-9	BRD-K97530723	melatonin	DRLFMBDRBRZALE	melatonin receptor agonist|nitric oxide synthase inhibitor	ASMT|CALM1|CALR|EPX|ESR1|HTR2B|MPO|MTNR1A|MTNR1B|NQO2|RORB	broad_id_20170327	Launched		
BRD-K97564742-050-32-7	BRD-K97564742	mepyramine	YECBIJXISLIIDS	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K97643133-003-09-3	BRD-K97643133	amiprilose	YXBQLONCIPUQKO	CD antagonist		broad_id_20170327	Phase 3		
BRD-K97688263-001-03-7	BRD-K97688263	benzamil	KXDROGADUISDGY	sodium channel blocker	ASIC1|PKD2L1|SCNN1A|SCNN1B|SCNN1D|SCNN1G|SLC8A1	broad_id_20170327	Phase 2		
BRD-K97729603-001-01-2	BRD-K97729603	pimecrolimus	KASDHRXLYQOAKZ	calcineurin inhibitor		broad_id_20170327	Launched		
BRD-K97746869-001-27-0	BRD-K97746869	chlorpropamide	RKWGIWYCVPQPMF	ATP channel blocker	ABCC8|KCNJ10	broad_id_20170327	Launched		
BRD-K97799481-001-16-0	BRD-K97799481	aminophylline	ZFXYFBGIUFBOJW	adenosine receptor antagonist	ADORA1|ADORA2A|ADORA2B|ADORA3|HDAC2|PDE3A|PDE3B|PDE4A|PDE4B|PDE4C|PDE4D|PDE5A	broad_id_20170327	Launched		
BRD-K97884852-001-05-4	BRD-K97884852	malotilate	YPIQVCUJEKAZCP	protein synthesis stimulant		broad_id_20170327	Launched		
BRD-K97963946-001-01-3	BRD-K97963946	EMD-1214063	AHYMHWXQRWRBKT	hepatocyte growth factor receptor inhibitor	MET	broad_id_20170327	Phase 2		
BRD-K98004573-051-02-8	BRD-K98004573	rupatadine	WUZYKBABMWJHDL	histamine receptor antagonist|platelet activating factor receptor antagonist	HRH1|PTAFR	broad_id_20170327	Launched		
BRD-K98453471-001-01-7	BRD-K98453471	salirasib	WUILNKCFCLNXOK	mTOR inhibitor	TRPA1	broad_id_20170327	Phase 2		
BRD-K98493452-001-14-9	BRD-K98493452	honokiol	FVYXIJYOAGAUQK	AKT inhibitor	ALOX5|PTGS1|PTGS2	broad_id_20170327	Phase 3		
BRD-K98530306-003-18-3	BRD-K98530306	clonidine	GJSURZIOUXUGAL	adrenergic receptor agonist	ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C	broad_id_20170327	Launched		
BRD-K98572433-001-02-9	BRD-K98572433	AZD8931	DFJSJLGUIXFDJP	EGFR inhibitor	EGFR|ERBB2|ERBB3	broad_id_20170327	Phase 2		
BRD-K98624455-074-02-8	BRD-K98624455	bepotastine	YWGDOWXRIALTES	histamine receptor antagonist	HRH1	broad_id_20170327	Launched		
BRD-K98733875-001-01-4	BRD-K98733875	baicalin	DAIGSUHCWOZEQG	beta glucuronidase inhibitor	PREP	deprecated_broad_id_20200324	Launched		
BRD-K98769987-001-23-7	BRD-K98769987	flumazenil	OFBIFZUFASYYRE	benzodiazepine receptor antagonist	GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ	broad_id_20170327	Launched		
BRD-K99023089-001-03-7	BRD-K99023089	AZD5363	JDUBGYFRJFOXQC	AKT inhibitor	AKT1|AKT2|AKT3	broad_id_20170327	Phase 3		
BRD-K99092662-001-01-1	BRD-K99092662	PS178990	KEJORAMIZFOODM	androgen receptor modulator	AR	broad_id_20170327	Phase 1		
BRD-K99107520-001-24-1	BRD-K99107520	felbamate	WKGXYQFOCVYPAC	glutamate receptor antagonist	GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B	broad_id_20170327	Launched		
BRD-K99113996-001-02-0	BRD-K99113996	AZD2014	JUSFANSTBFGBAF	mTOR inhibitor	MTOR	broad_id_20170327	Phase 2		
BRD-K99257182-310-01-6	BRD-K99257182	quinidine	LOUPRKONTZGTKE	sodium channel blocker	KCNA5|KCNA7|KCNH1|KCNH2|KCNH5|KCNK1|KCNK6|SCN5A|SLC29A4	broad_id_20170327	Launched	hemozoin biocrystallization inhibitor	GP9|KCNB2|KCNN4|SLC29A4
BRD-K99383816-001-02-7	BRD-K99383816	ftorafur	WFWLQNSHRPWKFK	thymidylate synthase inhibitor	TYMS	broad_id_20170327	Launched		
BRD-K99451608-001-07-3	BRD-K99451608	lopinavir	KJHKTHWMRKYKJE	HIV protease inhibitor		broad_id_20170327	Launched		
BRD-K99475619-001-01-2	BRD-K99475619	genz-644282	BAORCAMWLWRZQG	topoisomerase inhibitor	TOP1	broad_id_20170327	Phase 1		
BRD-K99504665-001-01-2	BRD-K99504665	goserelin-acetate	BLCLNMBMMGCOAS	gonadotropin releasing factor hormone receptor agonist	GNRHR|LHCGR	broad_id_20170327	Launched		
BRD-K99545815-001-06-3	BRD-K99545815	PF-562271	MZDKLVOWGIOKTN	focal adhesion kinase inhibitor	PTK2|PTK2B	broad_id_20170327	Phase 1		
BRD-K99604664-001-01-1	BRD-K99604664	tanaproget	PYVFWTPEBMRKSR	progesterone receptor agonist	PGR	broad_id_20170327	Phase 2		
BRD-K99749624-001-07-0	BRD-K99749624	linifanib	MPVGZUGXCQEXTM	PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	CSF1|CSF1R|FLT1|FLT3|FLT4|KDR|KIT|PDGFRB|RET|TEK	broad_id_20170327	Phase 3		
BRD-K99792991-001-34-9	BRD-K99792991	hexachlorophene	ACGUYXCXAPNIKK	potassium channel activator	GLUD1|SDHD	broad_id_20170327	Launched		
BRD-K99964838-001-11-9	BRD-K99964838	bosutinib	UBPYILGKFZZVDX	Abl kinase inhibitor|Bcr-Abl kinase inhibitor|SRC inhibitor	ABL1|BCR|CAMK1D|CAMK2G|CDK2|FRK|FYN|HCK|LYN|MAP2K1|MAP2K2|MAP3K2|MAP4K5|SRC|STK10|STK24|STK4|TNK2|TXK	broad_id_20170327	Launched		
BRD-M39350793-334-01-1	BRD-M39350793		XGSCYTRLSDKRRZ			broad_id_20170327			
BRD-M80207679-001-01-5	BRD-M80207679		QCYCDKUNJFKYEI			broad_id_20170327			
BRD-M89827113-001-01-5	BRD-M89827113	cromakalim	BVMDRSUIADWFLV		KCNJ8	broad_id_20170327	Phase 2		
BRD-M98279124-300-01-1	BRD-M98279124		YMMKDPCCYMGDHD			broad_id_20170327			
